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Background: Thumb carpometacarpal (CMC) osteoarthritis (OA) is a common, 
disabling condition, affecting substantial numbers of working and older-age people. It is 
the single commonest site affected by OA yet its unique characteristics, distinct from 
general hand OA, have received little individual attention – far less than hip and knee 
OA. In particular, little is known from patients’ perspectives about the impact of thumb 
CMC OA. Furthermore, international guidelines recommend splinting as a non-surgical, 
non-pharmacological treatment option for CMC OA; however, evidence supporting 
splinting in people with thumb CMC OA is sparse and inconsistent.  
The aims of this research were to: 1) explore the impact of thumb CMC OA from the 
perspective of people living with the condition; 2) investigate the effectiveness of 
splinting interventions for thumb CMC OA.  
Methods: Three main studies were conducted: 1) a pragmatic qualitative study 
exploring the impact of thumb CMC OA in 30 individual interviews of people with the 
condition; 2) a systematic review with meta-analyses of previous studies reporting on 
the effectiveness of splinting for thumb CMC OA; 3) a feasibility study for a future fully-
powered randomised controlled trial (RCT) investigating the effectiveness of a soft 
splint intervention combined with standardised best practice usual care vs best practice 
usual care alone comparator intervention. Design of the feasibility study was based on 
the findings from the qualitative study and the systematic review. 
Results: The qualitative study identified five main themes representing five inter-
related levels of health impact: negative experience of symptoms, functional limitations, 
restricted social activities and roles, negative thoughts and feelings, and altered sense of 
self. Pain, including pain at night, was the major concern. CMC OA impact was influenced 
by: dominant hand involvement; cold climate; people’s financial, social, and societal 
support; and attitudes to the condition. Many areas of impact are unidentified and 
missing in currently recommended patient-reported outcomes. The study found a 
strong desire for access to high-quality information about self-management and 





All evidence for splinting was of low quality. Splints cause a moderate-to-large 
reduction in pain (SMD -0.7 [95% CI -1.04, -0.35], < 0.0001) and small-to-moderate 
improvement in function (SMD -0.42 [-0.77, -0.08], p = 0.02) in the medium-term  
(3-12 months). No effect exists in the short-term. The review identified: variability in 
self-reported outcomes, case definitions, and rationale for splinting; low and variable 
splint dosage; lack of standardised usual care; unassessed QoL; and inappropriate study 
designs.  
In the feasibility study, all primary outcomes surpassed the a priori thresholds for 
feasibility. Of thirty enrolled participants, 29 (97%) were retained at the 4-week and  
6-month follow-ups. Interventions were acceptable and safe. Preliminary clinical 
findings suggested greater improvements in pain in the splint group vs comparator 
intervention in the short-term.  
Conclusions: Thumb CMC OA has a profound impact on a person’s health and well-
being. Splinting is an acceptable and promising intervention although good quality 
evidence to support its use is lacking. A full RCT of splinting in addition to standardised 
best practice usual care for thumb CMC OA pain is feasible but should be preceded by 
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1.1 Thesis aims and outline 
Thumb carpometacarpal (CMC) osteoarthritis (OA) is a common and disabling 
condition, but little is known about its impact from the perspective of people with 
thumb CMC OA. Therefore, the first aim of this thesis is to explore the impact of thumb 
CMC OA from the perspective of people with the condition. Splinting is a non-surgical, 
non-pharmacological treatment option for thumb CMC OA which is recommended in 
international guidelines. However, evidence of the effectiveness of splinting for people 
with thumb CMC OA is sparse and inconsistent, and recommendations can only be 
speculative. Therefore, the second aim of this thesis is to investigate the effectiveness of 
orthotic (splinting) interventions for the management of thumb CMC OA.  
The thesis is presented in three parts, structured around the three studies conducted as 
part of the research (Figure 1.1). Each study represents a stand-alone inquiry, but all are 
inter-related. The first is a qualitative study exploring the impact of thumb CMC OA 
from the perspective of people with the condition. This study follows a pragmatic 
methodological approach oriented to the clinical questions: ‘what needs to be treated?’ 
and ‘how should we do it?’. The second study is a systematic review of studies reporting 
effectiveness of splinting for thumb CMC OA. The third is a feasibility study informed by 
the first two studies and designed to test the study elements for a future                                                                                                                                                                                          
randomised controlled trial (RCT) of splinting for thumb CMC OA.   
Chapter 1 introduces the problem of thumb CMC OA and outlines the research questions 
for the thesis. Chapter 2 reviews the anatomy, aetiology, clinical assessment, and 
classification of thumb CMC OA to understand the problem from a biomedical 
perspective. Chapter 3 reports the qualitative study which explores the impact of thumb 
CMC OA for people with the condition; it includes relevant literature, the methodology, 
and results, and discusses the study findings which inform, from the patient 
perspective, the subsequent chapters. Chapter 4 reports the systematic review of 





and quality of life in people with thumb CMC OA. Findings are synthesised narratively. 
Selected findings are also synthesised quantitatively in meta-analyses. This chapter 
examines both the state of the existing literature and identifies features of splint use 
and design, outcome measures, and study design to inform a future study to investigate 
the effectiveness of splinting. Chapter 5 presents the final empirical work of this thesis, 
a feasibility study designed to examine the study elements identified in Chapters 3 and 
4 and required for conducting a future high-quality trial powered to investigate the 
effectiveness of splinting for thumb CMC OA when compared with a standardised best 
practice usual care comparator intervention. Chapter 6 completes the thesis by bringing 
together the key findings of the three studies and knowledge of the condition from 
Chapter 2 and discusses their implications for clinical practice, health service delivery, 
and future research.  
 





1.2 The problem 
1.2.1 Osteoarthritis including the thumb CMC joint 
Osteoarthritis involving the CMC joint of the thumb causes persisting pain, limits hand 
function, and interferes with health-related quality of life (HR-QoL) (Bijsterbosch, 
Wassenaar, et al., 2010; Marshall et al., 2009). The thumb CMC joint is the commonest 
site of radiographic OA (Dahaghin et al., 2005; Haara et al., 2004; Wilder, Barrett, & 
Farina, 2006), yet thumb CMC OA, as a distinct entity, has received little attention to 
date compared with large joint OA of the hip and knee (Kloppenburg & Kwok, 2012; 
Kloppenburg, van Beest, & Kroon, 2017).  
Thumb CMC OA involves the CMC joint of the thumb, a small-shaped saddle joint 
comprising the base of the thumb (1st) metacarpal and the trapezium bone in the wrist 
(Figure 1.2). Its shallow, biconcave surfaces are only congruous when the joint is fully 
rotated into opposition (Edmunds, 2011; Ladd et al., 2014). The joint’s relative 
incongruence along with its loose capsule allows greater planes of motion than at 
adjacent joints (Komatsu & Lubahn, 2018). Its comparative instability is intensified by 
the location of its base, the trapezium, at the radial side of the wrist with no radial 
buttress and no fixed base of support on the mobile scaphoid (Bettinger, Linscheid, 
Berger, Cooney, & An, 1999).  
 
Figure 1.2 The thumb carpometacarpal (CMC) joint. (Reprinted from 
Gray’s basic anatomy Fig. 7.82 (Drake, 2018), with permission from 
Elsevier) (Appendix A) 







Because of its inherent instability, the thumb CMC joint is highly reliant on ligamentous 
structures and coordinated motor activity for functional use (Komatsu & Lubahn, 2018; 
Zancolli, Ziadenberg, & Zancolli, 1987). Balanced muscle forces in concert with ligament 
complexes are required to transform the mobile thumb CMC unit suited to fine 
manipulation into a stable column for power grip (Bettinger et al., 1999; Edmunds, 
2011). The joint forces endured by the thumb CMC joint with everyday activities are 
high. In a 70 Kg person, thumb CMC joint reactive forces with power grasp are up to 120 
Kg (Cooney & Chao, 1977). The concentrated shear forces that occur when the thumb 
CMC joint is under load are currently thought to be the main mechanism governing 
onset of OA at this joint (Edmunds, 2011; Ladd et al., 2014; Riordan et al., 2018). Like at 
other joints, the onset or progression of primary or idiopathic OA is influenced by 
multiple potential risk factors including genetic, metabolic, biomechanical factors, and 
increasing age. (Dieppe, 2011; Martel-Pelletier et al., 2016). The resultant condition has 
been found to involve all joint structures with the presence of inflammation suggestive 
of an active repair process (Dieppe, 2011).  
The clinical presentation of thumb CMC OA has been described to reflect that of OA 
generally with joint-specific signs and symptoms. Pain, stiffness, swelling, and loss of 
function are typically reported (Sellam & Berenbaum, 2010; van Heest & Kallemeier, 
2008). Physical examination may find pain on loading or palpation of the joint, warmth, 
crepitus, bony deformity, muscle atrophy, shortening of the first web space, and joint 
collapse (van Heest & Kallemeier, 2008). A more detailed description of the anatomy, 
potential mechanisms, and definition of thumb CMC OA are given in Chapter 2.  
A challenge in understanding the problem of thumb CMC OA is that there is no agreed 
case definition – thumb CMC OA is usually considered part of hand OA. However, 
because thumb CMC OA often occurs in isolation and has a different clinical profile to 
nodal OA, it is arguably a distinct disease entity (Bijsterbosch, Visser, et al., 2010; 
Dahaghin et al., 2005) requiring specific treatment approaches (Kloppenburg & Kwok, 
2012; Kloppenburg et al., 2017; Zhang et al., 2009). Furthermore, thumb CMC OA 
appears to contribute to more pain and disability than other hand joint OA 
(Bijsterbosch, Visser, et al., 2010; Dahaghin et al., 2005; Tenti et al., 2020), though not 





Osteoarthritis affecting one or more joints has long been recognised as one of the most 
prevalent long-term conditions with substantial individual, economic, and societal 
burdens (March et al., 2016; March & Bachmeier, 1997; Martel-Pelletier et al., 2016). 
World-wide, OA is reported as affecting around 240 million people; however, this 
underestimates true impact of the condition as this statistic includes only hip and knee 
OA (Vos et al., 2016). Furthermore, most of the published data on prevalence derive 
from radiographic surveys; plain radiographs are insensitive to early disease so these 
studies also tend to underestimate the prevalence of disease (O'Neill, McCabe, & 
McBeth, 2018).  
Osteoarthritis accounts for 2.4% of total global years lived with disability (YLD) and has 
been ranked as the 10th leading contributor to global YLDs (March et al., 2016). By 
2030 the overall number of people with OA is predicted to increase by a further 50% 
(Ackerman, Pratt, Gorelik, & Liew, 2018) due to ageing populations and other health 
and lifestyle factors including obesity (Ackerman et al., 2018; Turkiewicz, Petersson, 
Björk, Dahlberg, & Englund, 2013). The World Health Organisation recognised this in 
declaring the ‘Bone and Joint Decade’ 2000-2010 (Lidgren, 2003). In New Zealand in 
2018 arthritis, of which OA was the most common type, was associated with annual 
health sector costs of $993 million, other financial costs including carer costs and 
productivity costs of $3.3 billion, and loss of well-being estimated at $7.9 billion 
(Deloitte Access Economics, 2018). Osteoarthritis contributed to more than one third of 
these costs.    
1.2.2 Thumb CMC OA problem 
The natural history of thumb CMC OA can either result in less symptomatic or stable 
end stage disease (Bijsterbosch, Watt, et al., 2011), or progress to pain and functional 
limitations interfering with people’s lives (Bijsterbosch, Watt, et al., 2011; Dahaghin et 
al., 2005; Michon, Maheu, & Berenbaum, 2011; Sonne-Holm & Jacobsen, 2006).  
The estimated prevalence of symptomatic thumb CMC OA is comparable to, or greater 
than that of hip and knee OA. Symptomatic thumb CMC OA has an estimated age-
adjusted prevalence of 22% in the U.K. community-dwelling population aged 50 years 





symptomatic hip OA has an estimated prevalence of 4.2% to 9% in similar aged United 
States and European populations (Kim 2014), and for knee OA, 7% to 19% (Neogi, 
2013). In a North American population the life-time risk of developing symptomatic 
hand OA by age 85 was reported as 40% (Qin et al., 2017), compared to 45% for knee 
OA (Neogi, 2013). The thumb CMC joint is the single most commonly affected site in the 
hand (Haara et al., 2004), often occurring in isolation (Bijsterbosch, Visser, et al., 2010) 
and may be the primary source of symptoms (Dahaghin et al., 2005; Kloppenburg & 
Kwok, 2012; Kloppenburg et al., 2017). These data indicate that thumb CMC OA 
presents a substantial individual and societal burden, and an aging population heralds a 
rapidly rising prevalence. 
Despite the high prevalence and significant burden of thumb CMC OA, it attracts far less 
attention than hip or knee OA in both clinical health practice and research, 
(Kloppenburg et al., 2017). Osteoarthritis affecting the hand, compared with lower limb 
OA, appears to attract a lower quality of care, as measured on quality indicator 
questionnaires including, for example, patient education and information, regular 
assessments, referrals, and pharmacological treatment (Osteras, Hagfors, & Hagen, 
2016). In the clinical setting this has been attributed, in part, to clinical uncertainty 
regarding optimal management – insufficient research in the area results in insufficient 
evidence for treatments – and creates the impression that ‘nothing helps’; consequently 
treatment is seldom offered (Hill, Dziedzic, & Nio Ong, 2011). Furthermore, thumb CMC 
OA is less visible than hip or knee OA: the patient does not limp into the office; personal 
care tasks can be delegated or strategically managed to keep up appearances; 
limitations in most activities of daily living (ADLs) are not evident; and hand function 
and capacity are often felt to be more personal in nature, for example in personal 
hygiene, social relations, and self-identity (Bromann Bukhave, la Cour, & Huniche, 2014; 
Hill et al., 2011). In nearly all settings the significant economic impact of surgical 
management for hip and knee OA, and public expectations around this, command the 
overwhelming majority of academic, policy, public, and clinician attention (Deloitte 
Access Economics, 2018; Vos et al., 2016); hence the impact of OA affecting the hand, 
including the thumb CMC, remains underestimated and under-investigated (Deloitte 





1.3 Management of thumb CMC OA 
A diverse range of treatments is suggested to manage thumb CMC OA and all have 
benefits and limitations. Treatments include:  
• Surgical interventions; 
• Pharmacological therapies; and 
• Non-surgical, non-pharmacological therapies. 
1.3.1 Surgical interventions 
Surgical intervention can provide relief for thumb CMC OA but is associated with high 
health system costs, common adverse events, such as complex regional pain syndrome, 
scar contracture or tenderness, nerve injury, or unstable thumb base (Rhee & Shin, 
2014), and does not provide definitive benefit as in the hip or knee (Spaans et al., 2015; 
Wajon, Vinycomb, Carr, Edmunds, & Ada, 2015); therefore, surgery is usually reserved 
as the last option. Furthermore, surgery is not available to everyone, not least because 
of a lack of appropriately trained surgeons.  
There is very little research, based on outcomes, into surgery for thumb CMC OA, 
compared with hip and knee replacements (Wajon et al., 2015). Several procedures are 
in common use: removal of the trapezium bone (trapeziectomy); trapeziectomy with 
ligament reconstruction; trapeziectomy with ligament reconstruction and coiled tendon 
interposition arthroplasty, designed to maintain height; and joint fusion (arthrodesis). 
Joint resurfacing and arthroplasty options are also available but not widely used. Joint 
replacement has not proven as successful in the hand as it has for hip or knee OA 
(Thillemann, Thillemann, Munk, & Kroner, 2016; Wajon et al., 2015). No procedure has 
yet demonstrated superiority over another in terms of pain, physical function, adverse 
events, failure, i.e. re-surgery, or imaging (Wajon et al., 2015). Low quality evidence 
suggests the more complicated procedures confer no benefit over trapeziectomy alone 
and may have more adverse events; however, most studies had an unclear risk of most 
biases (Wajon et al., 2015). No studies have compared surgery with sham surgery or 
surgery with non-surgical interventions (Wajon et al., 2015). More high-quality 





focus on robust patient-reported outcomes, has been recommended (Wajon et al., 
2015).  
1.3.2 Pharmacological therapies 
Pharmacological treatments for thumb CMC OA include injection, oral, and topical 
treatments; these are directed at symptomatic relief and confer little or no disease-
modifying effects (Spaans et al., 2015). Conflicting findings and recommendations 
reflect a lack of high-quality evidence (Spaans et al., 2015). 
While injection therapies, hyaluronate more so than corticosteroid, have previously 
reported some benefit (Spaans et al., 2015), more recent evidence indicates no clear 
benefit from any injection therapy over placebo (Riley et al., 2019) and recent 
guidelines only conditionally support injection (Kolasinski et al., 2020) or do not 
recommend them (Kloppenburg et al., 2019). There are also concerns associated with 
the potential long-term effects of injected therapies which are unknown (Riley et al., 
2019). The lack of robust outcome measures may be an additional factor in determining 
effectiveness of these interventions. 
Oral non-steroidal anti-inflammatories (NSAIDs) remain the main-stay of the 
pharmacological treatment of OA (Kolasinski et al., 2020) though have been 
investigated primarily for their short-term effect (Kloppenburg et al., 2019; Kolasinski 
et al., 2020). NSAIDs are only recommended for short term use at the lowest possible 
dose due to risks such as adverse gastrointestinal, cardiovascular, and renal events, 
especially in the older population (Altman, 2010a; Kloppenburg et al., 2019; Kolasinski 
et al., 2020). Paracetamol (Acetaminophen) is conditionally recommended for short-
term use but has small effect sizes and there are growing concerns about its risk profile 
(Kloppenburg et al., 2019; Kolasinski et al., 2020). Other medications conditionally 
recommended in hand OA are Duloxetine and Tramadol (Kolasinski et al., 2020). 
Limited evidence is available to demonstrate the effectiveness of neutraceuticals for 
hand OA; only one well-performed study investigating the effect of chondroitin sulfate 






Topical NSAIDs are a preferred approach for hand OA as their effectiveness appears to 
be similar to that of oral NSAIDs but with an improved safety profile (Altman, 2010b; 
Kloppenburg et al., 2019). Although topical NSAIDs are strongly recommended for hand 
OA in recent European guidelines (Kloppenburg et al., 2019), they remain conditionally 
recommended in recent United States guidelines due to the small body of evidence 
(Kolasinski et al., 2020). Topical Capsaicin is not recommended for hand OA as there is 
no direct evidence of its effectiveness, and greater risk of eye contamination (Kolasinski 
et al., 2020). Further research into the effectiveness of all pharmacological treatments 
for thumb CMC OA is required.  
1.3.3 Non-surgical, non-pharmacological therapies 
Non-surgical, non-pharmacological therapies for thumb CMC OA include a range of 
social and behavioural interventions, physical therapies and modalities, complementary 
therapies, and orthoses. Although these options are lower cost and lower risk than 
surgical and pharmacological treatments, they are seldom investigated in hand OA and 
even less frequently in thumb CMC OA.  
Education is a key component of all OA guidelines, including training in joint care 
principles and assistive devices and support in self-management and self-efficacy 
(Kloppenburg et al., 2019; Kolasinski et al., 2020; NICE, 2014). However, evidence for 
educational interventions is available for hand OA only and no studies have investigated 
this specifically for thumb CMC OA. Findings for hand OA have been mixed. In one study,  
those who received joint protection education in addition to a leaflet and advice were 
statistically more likely to be responders to treatment 6 months later (33% vs 21%) 
(Dziedzic et al., 2015); in contrast, another study found no benefit for an intensive 
multi-modal intervention of self-management education, ergonomic principles, and 
exercises (Stukstette et al., 2013). Issuing assistive devices together with information 
has been found to be effective at 6 months in hand OA (Amaral et al., 2018). Cognitive 
behavioural therapy has also been conditionally recommended in hand OA (Kolasinski 
et al., 2020). 
Exercise is now recommended by all OA guidelines as a core intervention (Kloppenburg 





exercise has proven beneficial in knee and hip OA, there has been a lack of evidence to 
date in hand OA and therefore only non-specific recommendations regarding exercise 
have been made. A Cochrane review of the effect of exercise for hand OA found only a 
small effect on pain and function, but the evidence was of low quality and no specific 
recommendations for thumb CMC OA were reported (Osteras et al., 2017). Some 
exercise programmes specifically designed for thumb CMC OA have been investigated; 
however, these are small studies of low quality (Davenport, Jansen, & Yeandle, 2012; 
DeMott, 2017; O'Brien & Giveans, 2013; Villafañe & Valdes, 2013).  
Very little is known about the mechanistic effects of exercises prescribed for thumb 
CMC OA in living models, including to what degree exercises should target dynamic 
stability rather than strength or range of motion (ROM). The restoration of thumb CMC 
dynamic stability, defined as “… where musculo-tendinous units stabilise articular 
surfaces during movement or gripping to excessive shear forces or subluxation of the 
joint.” (O'Brien & Giveans, 2013; Taylor, 2000), has been promoted as the primary goal 
of exercises for thumb CMC OA (O'Brien & Giveans, 2013) and of management of the 
condition generally (Colditz, 2000). However, there is little evidence that this can be 
achieved. A small retrospective study of exercise for thumb CMC OA using a dynamic 
stability modelled approach found promising results for pain and function (O'Brien & 
Russell Giveans, 2013). However, there are conflicting views on the relative importance 
of different musculature and neuromuscular training approaches (Colditz, 2013; 
O'Brien & Giveans, 2013; Valdes & Von Der Heyde, 2013). Few studies have investigated 
electromyography of thumb muscles during functional tasks and these have only 
preliminary findings (Calder, Galea, Wessel, MacDermid, & MacIntyre, 2011; Ooishi, 
Izumi, Ueba, & Ikeuchi, 2019). Other literature upon which exercises are based is 
limited to mathematical or cadaveric methods (Valdes & von der Heyde, 2012). 
Exercises may also include techniques to improve ROM, for example, for palmar 
abduction, or pain-relieving techniques such as traction (Scott, 2018; Taylor, 2000). 
Overall, the current literature on exercise prescription in this population is incomplete 
and treatments are more commonly informed by expert opinion and experience 
(Colditz, 2000, 2013; Dziedzic et al., 2015; Kjeken et al., 2013; O'Brien & Giveans, 2013; 






Manual therapy, taping, and acupuncture are examples of other therapeutic or 
complementary modalities used for thumb CMC OA; however, the evidence for their 
effectiveness is of low quality (Kolasinski et al., 2020; Spaans et al., 2015). Heat and cold 
are low risk and easily available options; however, there is little or no evidence for their 
effectiveness (Kloppenburg et al., 2019; Kolasinski et al., 2020; Spaans et al., 2015). 
Orthoses, also known as ‘splints’ especially when applied to the hand, (Australian 
Orthotic Prosthetic Association, 2020) are proposed for thumb CMC OA to provide 
external support to the thumb CMC joint, to reduce pain, prevent contracture, and 
maintain hand function (Colditz, 2000; Poole & Pellegrini, 2000). Clinicians commonly 
prescribe splints (Davenport, 2009; O'Brien & McGaha, 2014) and previous clinical 
studies have shown positive results, with significant reductions in pain and reduced 
demand for surgery (Berggren, Joost-Davidsson, Lindstrand, Nylander, & Povlsen, 2001; 
Gomes Carreira, Jones, & Natour, 2010; Rannou et al., 2009). However, because the 
strength and quality of the published evidence for splinting in thumb CMC OA is variable 
and often poor, international treatment guidelines make only weak recommendations 
for the use of splints for thumb CMC OA (Hochberg et al., 2012; Zhang et al., 2007). A 
recent guideline update advocates long-term use of splints but this is based on an older 
single study of participants wearing a thermoplastic splint at night for 12 months 
(Kroon, Carmona, Schoones, & Kloppenburg, 2018; Rannou et al., 2009), a protocol 
neither widely used nor well-aligned to the commonly proposed mechanisms of effect, 
i.e. to provide support during function (Colditz, 2000; Deveza et al., 2017; O'Brien & 
McGaha, 2014; Poole & Pellegrini, 2000).  
The role of biomechanical interventions such as splints has been highlighted as a key 
area of OA management in need of more research (NICE, 2014). Previous systematic 
reviews have examined the effectiveness of splinting for thumb CMC OA, with mixed 
results (Egan & Broisseau, 2007; Lue, Koppikar, Shaikh, Mahendira, & Towheed, 2017; 
Mahendira & Towheed, 2009; Spaans et al., 2015; Towheed, 2005; Valdes & Marik, 
2010; Ye, Kalichman, Spittle, Dobson, & Bennell, 2011). Furthermore, little information 
exists about which type of splint is more effective or for whom, nor are the mediating 
effects of splints clear. The systematic review reported in Chapter Four and the 





In summary, there exists a dearth of high-quality evidence to support clinicians, 
patients, and policy makers in decision-making about interventions for thumb CMC OA. 
The key challenges which impede progress in this area are outlined below.  
1.3.4 Challenges in thumb CMC OA 
Studies of thumb CMC OA face several challenges. In addition to the lack of agreed case 
definition described above, other challenges are 1) no gold standard outcome measure 
and 2) limited knowledge of patients’ perspective of the impact of thumb CMC OA. 
A core set of outcome domains for investigating potential interventions for hand OA has 
been recommended, namely, pain, physical function, HR-QoL, joint activity, and hand 
strength (Kloppenburg, Maheu, et al., 2015); however, in studies investigating 
interventions such as splinting for thumb CMC OA, there appears to be no consensus 
about which measurement tools to use (Kloppenburg, Maheu, et al., 2015). In addition 
to being non-specific for thumb CMC OA, some tools also have other problems. The two 
instruments recommended by Osteoarthritis Research Society International (OARSI) for 
design and conduct of clinical trials for hand OA to assess self-reported function – the 
Functional Index of Hand Osteoarthritis (FIHOA), and the Australian/Canadian Hand 
Osteoarthritis Index (AUSCAN) – are clinician-centric in their development and have in 
recent years faced criticism for being outmoded (Kloppenburg, Maheu, et al., 2015; 
Stamm et al., 2009; Wittoek et al., 2019). For example, the AUSCAN was principally 
developed from eight existing health status measures and an iterative process involving 
four rheumatologists, two physiotherapists and an orthopaedic surgeon (Bellamy et al., 
2002). Furthermore, access to the AUSCAN requires permission and payment of a fee 
(Kloppenburg, Maheu, et al., 2015).  
Little is known about the specific impact of thumb CMC OA from the perspective of 
those with the condition, and this contributes to the deficiency of the current evidence 
for interventions for thumb CMC OA.  Previous studies of patients’ perspective of the 
impact of thumb CMC OA have been limited to clinician-derived surveys and 
questionnaires which have been conducted, almost exclusively, in northern-hemisphere 
Western European populations (Bijsterbosch, Visser, et al., 2010; Bijsterbosch, Watt, et 





Hazes, & Koes, 2006; Haara et al., 2004; Hoogendam et al., 2019; Hwang & Ring, 2011; 
Kwok et al., 2014; Lee, Paik, Lim, Kim, & Gong, 2012; Slatkowsky-Christensen, Haugen, 
& Kvien, 2010; Spacek et al., 2004; Tenti et al., 2020), with the exception of one study 
conducted in Korea (Lee et al., 2012). Deeper, richer data are required to better inform 
the design of better, fit for purpose interventions, and outcome assessment instruments. 
There is also a need to understand how this condition manifests more broadly, 
including within the cultural contexts of Aotearoa – New Zealand.  
There is a need for clinically effective and cost-effective treatments and care pathways 
to manage thumb CMC OA for the large and growing number of people who have the 
condition. It is also necessary to know how thumb CMC OA impacts patients and people 
with the condition in order to design treatments and care pathways that meet patients’ 
needs, and to evaluate these treatments and pathways on the basis of outcomes that are 
important to patients – in simple terms, how to deliver patient-centred care for thumb 
CMC OA.  
1.4 Research aims 
The principal aims of this thesis are: 
1. To explore the impact of thumb CMC OA from the perspective of people with the 
condition.  
2. To investigate the effectiveness of splinting for improving outcomes important 
for people with thumb CMC OA.  
These aims generate the following research questions:  
• Question 1: What is the experience of people in New Zealand with thumb CMC 
OA? 
• Question 2: What outcomes are important for people with thumb CMC OA? 
• Question 3: What treatment targets are important for people with thumb CMC 
OA? 
• Question 4: What is the existing evidence for the effectiveness of splinting in 





• Question 5: What is a feasible study design to investigate the effectiveness of 
splinting for outcomes important in people with thumb CMC OA? 
The first three questions address the need for an understanding of the needs of 
individuals with thumb CMC OA from their perspective. In order to elucidate important 
matters such as how patients are treated and what outcomes should be used to evaluate 
effectiveness, study designs need to incorporate patients’ lived experience and to 
investigate the outcomes that are important to them. Eliciting patient perspectives 
about what they feel is important is a main aim of this thesis and drove the design of the 
study described in Chapter 3. The fourth and fifth questions address the need to 
determine the evidence for the effectiveness of splinting in addressing the needs of 
people with thumb CMC OA.  
1.5 The terms and scope of this research 
This thesis considers the condition of thumb CMC OA which primarily involves the 
articular surface of the base of the first metacarpal (MC1) and the reciprocal articular 
surface of the trapezium in the wrist. Further detail regarding relevant anatomy, 
pathology and aetiology is given in Chapter 2. It is widely recognised that more severe 
thumb CMC OA can also involve additional articulations of the carpal bones - the 
scapho-trapezial (ST) articulation between the scaphoid and the trapezium, or the 
scapho-trapezial-trapezoid (STT) articulations where the trapezoid is also involved. 
Involvement of the ST or STT articulations is common, some reports indicate 
occurrences in up to 60% of CMC OA (Katzel et al., 2016). Combined CMC and STT 
involvement were purported to be more symptomatic (Armstrong, Hunter, & Davis, 
1994) although a recent study found little difference in pain intensity between those 
with or without STT involvement (Hoogendam et al., 2019). Because ST or STT 
involvement is not routinely reported in studies of CMC OA and is hard to identify 
clinically, it is recognised that more severe symptoms could be the result of multi-joint 
involvement. For the purpose of this thesis, the term ‘thumb CMC OA’ is used to refer to 
both isolated thumb CMC OA and additional ST or STT involvement, when present.  
Advanced or severe thumb CMC OA may present in the presence of a specific subset of 





more than joints elsewhere (Marshall et al., 2015). Erosive OA frequently affects the 
proximal interphalangeal (PIP) and distal interphalangeal (DIP) joints and, but less 
commonly, the thumb CMC (Marshall et al., 2015). Specific characteristics are an abrupt 
onset with inflammation, central erosions with subchondral collapse and subsequent 
large osteophyte growths (Marshall et al., 2015). Erosive OA is reported to have a higher 
clinical burden with more severe disability (Marshall et al., 2015; Marshall et al., 2013; 
Monfort et al., 2015). While erosive OA is an accepted concept, a clearly defined clinical 
and radiological definition is lacking (Gazeley, Yeturi, Patel, & Rosenthal, 2017; Marshall 
et al., 2013). Reporting of erosive vs non-erosive OA is not routine in cases of hand OA. 
This thesis does not differentiate between ‘thumb CMC OA’ and ‘erosive thumb CMC OA’. 
This thesis focusses specifically on the condition of ‘thumb CMC OA’, whilst 
acknowledging that its classification has yet to be clearly defined. The literature 
predominantly describes thumb CMC OA as part of the OA phenotype of ‘hand OA’; 
thumb CMC OA is also known as trapeziometacarpal (TMC) OA or ‘thumb base OA’.  
Accepted classification criteria for hand OA may include thumb CMC OA (Altman et al., 
1990). However, a limitation of these criteria is that thumb CMC OA cannot be classified 
in isolation even though thumb CMC OA is commonly a ‘lone’ presentation (Dahaghin et 
al., 2005; Marshall et al., 2011; Zhang et al., 2009). Radiographic and other imaging 
classification criteria exist. While there is some evidence of a positive association 
between radiographic hand OA and hand pain (Dahaghin et al., 2006), the poor 
correlation between imaging results and symptomatology is widely recognized (Calfee 
et al., 2015; Haugen, Slatkowsky-Christensen, Boyesen, van der Heijde, & Kvien, 2013; 
Hwang & Ring, 2011; Niu et al., 2003; Zhang et al., 2009). Furthermore, imaging is 
expensive, not routinely accessible, and has consequences albeit minor, for example, 
exposure to radiation. This thesis does not aim to offer a definitive classification for 
thumb CMC OA. Rather, in each of the chapters and studies, classification criteria for 
study inclusion criteria are appraised or considered according to a pragmatic clinical 
approach. This thesis considers the clinical syndrome of thumb CMC OA rather than the 





The term ‘patient’ is used throughout the thesis to describe persons who experience 
problems related to thumb CMC OA. They may not necessarily be currently, or ever, 
recipients of health services  but they are affected by the condition and may have 
instigated their own forms of ‘treatment’ or sought information. The term ‘patient’ is 
used interchangeably with ‘person’ or ‘people’ and ‘public’ in preference to other terms 
such as ‘client’ or ‘consumer’ to avoid colluding with transactional or commodified 
views of health and health care. 
1.6 Significance of the research 
The studies that make up this thesis are part of a broader programme of OA research 
that aims to enable equitable access to low cost non-surgical, non-pharmacological 
treatments to improve daily life and maintain healthy ageing for people with OA in New 
Zealand. The previous and ongoing clinical experience of the researcher, along with the 
contribution of other expert clinicians in the study development for the final study, will 
enhance relevance and uptake of the study findings to the real-world clinical setting. 
It is anticipated that results of this research will enable tailoring of treatments and 
outcome measures to the unique impact of thumb CMC OA. In turn, this will have the 
potential to improve outcomes for people with the condition, and improve the 
effectiveness and efficiency of health services. The findings will also enable clinicians, 
health services, and funders to be better-informed in current evidence about the 
effectiveness of splinting for thumb CMC OA, and will highlight key gaps in the evidence 
to assist researchers planning future research. The findings will also provide 
information about the success of study design elements for use in future research. 
Specifically, results will inform a future full RCT to investigate the effectiveness of a 
splint intervention for thumb CMC OA. If shown to be effective, the splint intervention 
would be a good first-line non-pharmacological, non-surgical option to be prescribed by 
health professionals or accessed directly by patients.  
The importance of patient perspectives in understanding impact, informing the design 
of interventions, and developing outcome measures is critical to ensure that the needs 
of people are addressed and evaluated by outcomes that are important to them 





substantially to efficiency and cost-effectiveness in health care and health services. 
Moreover, using clearly described and justified methods to elicit patient perspectives 
gives transparency and credibility to the process, i.e. it is made clear from whom views 
and input were sought, and the method by which those views were sought. Research 
methods that address, in a credible fashion, the pragmatic needs of health service 
knowledge requirements are extremely valuable for working towards authentic 
patient-centred care.  
This thesis aims to explore and give voice to the patient perspective but does not 
approach the topic from either a ‘participatory action research’ model or ‘patient-
partner’ relationship. Rather, the research topics and questions arise from the author’s 
17 years’ clinical practice as a physiotherapist and hand therapist working in the New 
Zealand public health system and as the result of encountering many people with thumb 
CMC OA. The researcher has observed that thumb CMC OA is a common problem 
causing significant distress, but that referral to therapy services often occurs late in the 
condition, if at all, and in many cases any initial referrals are made to a surgical or 
rheumatology specialist rather than allied health services. Practice experience and 
knowledge of common clinical practice patterns gained over 17 years have revealed 
that splint interventions seemed to give good results in relieving patients’ symptoms, 
enabling continued function, and in some cases deferring or avoiding medication or 
surgery. However, evidence for the effectiveness of splint interventions was poorly 
addressed in the health literature. Furthermore, no literature could be found about the 
specific impact of thumb CMC OA from the perspective of patients. Both these areas are 
key to understanding what the need is, and what sensible first-line treatment options 
should be available to primary health clinicians for managing patients with thumb CMC 
OA. 
1.7 The theoretical framework 
In a thesis, a theoretical framework is important to ensure intellectual rigour – it gives 
consistency to the argument and decisions and makes the major underlying 





In this thesis, I have used a post-positivist approach to assess the evidence for treatment 
effectiveness. However, I have also used constructivism to take a step back and enquire 
into what it is that needs treating, to explain findings, and to design a study fit for the 
real-world setting. From these ontological positions follow the epistemological 
approaches outlined below and the study methodologies. Given the setting of the 
research in post-colonial, neoliberal Aotearoa New Zealand, I have also employed the 
additional lens of structural violence. This is elaborated on in the penultimate 
paragraph of this chapter.      
Post-positivism holds that the world is a stable reality independent of human thought 
but that our knowledge of this reality is only partial (Padgett, 2012). Hence, to best 
approximate reality, enquiry is necessary by many investigators from many 
perspectives (Padgett, 2012). Accordingly, a post-positivist epistemology entails 
measuring and recording empirical observations but recognises error as inherent in any 
finding (Creswell, 2014; Padgett, 2012). Depending on the research question, a post-
positivist methodology may employ either quantitative or qualitative methods or both 
(Creswell, 2014). A quantitative methodology may engage methods including RCT, with 
‘pragmatic’ RCT being more aligned to post-positivism than to positivism (Creswell, 
2014). To answer the fourth research question: “What is the effectiveness of splinting 
for improving pain, function, and QoL in people with thumb CMC OA?" it is necessary to 
collect data that enable calculation of measures of effectiveness. While such data and 
calculations are quantitative, the assumed presence of error yields findings as 
‘estimates’ rather than actual true reality.  
In contrast to the philosophical paradigm of post-positivism, constructivism holds that 
reality is constructed through communication and interaction (Krauss, 2005; Padgett, 
2012). Therefore, since the world can be understood in a multitude of ways, the aim is 
to gain an understanding of one, some, or many of the different realities (Creswell; 
Krauss, 2005; Padgett, 2012). Thus a multitude of methodologies are available through 
which to gain knowledge of the world – most of which are underpinned by qualitative 
methods (Creswell, 2014; Padgett, 2012). The researcher is recognised as an actor in 
the knowledge acquisition process. Constructivist methodologies aim to produce partial 





The first three research questions deal with the experience of living with thumb CMC 
OA and, as such, are best addressed by the constructivist paradigm. These questions are 
approached using a pragmatic qualitative methodology and, in determining the study 
methods and design, the practical clinical questions of how patients should be treated 
and what outcomes should be measured were used (Padgett, 2012; Shaw, Connelly, & 
Zecevic, 2010). The richness of patients’ views was sought in order to gain a deep 
understanding to enable the design of interventions that can match patient need 
effectively. Interventions can then be evaluated according to what is meaningful to 
patients. For example, methods can include face-to-face interviews using a semi-
structured schedule.  
Constructivism is not incongruent with post-positivism (Krauss, 2005; Padgett, 2012). 
In reacting to the scientistic traditions of positivism, both hold that our knowledge of 
reality is always uncertain (Creswell, 2014; Padgett, 2012). Although both subscribe to 
realism (Krauss, 2005), they differ in that post-positivism posits a single, unitary (but 
un-apprehendable) reality while constructivism posits the existence of multiple 
realities. Both accept that there are multiple perspectives and the construction of ‘data’ 
as susceptible to bias (Padgett, 2012). The two approaches are complementary and can 
be deployed in parallel to explore reality, to build and test theory, to identify where to 
study the detail, and to explain and understand findings (Creswell, 2014; Krauss, 2005; 
Padgett, 2012).  
The final research question is premised on a post-positivist approach in that it aims to 
test a hypothesis, but it includes a constructivist viewpoint that aims to explain findings 
by understanding their context. This allows a more accurate and successful testing of 
the theory.     
The additional lens of ‘structural violence’ is used to take a more critical view of the 
historical and socio-economic forces that put certain populations at greater risk of 
experiencing health and other problems as well as making them less likely to receive 
treatment (Padgett, 2012). In New Zealand it can be argued that structural violence 
operates in a number of ways: through the ubiquitous application of a bio-medical 





Pacific Islands culture; through socio-economic disparities that provide unequal access 
to healthcare and to health care professions; and through the ongoing consequences of 
colonisation which have resulted in indigenous people being at greater risk of health 
and other problems, and less likely to access healthcare (National Ethics Advisory 
Council, 2020; O'Brien et al., 2020; Perry, Hudson, Clode, Wright, & Baxter, 2015). This 
lens is used to inform the design of study recruitment strategies and data collection 
schedules, for example the interview schedule in Chapter 3.  
This theoretical framework of a shared post-positivist and constructivist ontology and 
epistemology viewed through the lens of structural violence, applying quantitative and 
qualitative methodology as appropriate to each research question, provides the basis 






Thumb CMC OA: Anatomy, aetiology, assessment, and 
classification 
In order to understand the biomechanics and pathology that arise at the thumb CMC 
joint it is helpful first to consider the unique anatomy of this complex and highly 
evolved joint. The first section in Chapter 2 reviews the key anatomical characteristics 
of the thumb CMC joint and their relationship to localised thumb CMC OA. The second 
section appraises contemporary knowledge of the pathophysiology of OA and the 
specific disease pattern seen at the thumb CMC joint. The third section delineates the 
signs and symptoms typically seen in thumb CMC OA presentation. In the fourth section, 
the challenge of classification, both radiographic and clinical, is elucidated. The overall 
aim of the chapter is to provide an understanding of the biomedical problem of thumb 
CMC OA as a foundation and context for the work of the following chapters.    
2.1 Anatomy 
2.1.1 Osseous anatomy 
The first CMC articulation is a saddle-type joint, comprising the shallow bi-concave 
articular surfaces of the base of the MC1 and the trapezium (Bettinger et al., 1999) 
(Figure 2.1). The articular surfaces have unequal radii of curvature that are congruous 
only at the ends of motion (Ladd et al., 2014). The volar apex of the metacarpal articular 
surface protrudes like a ‘beak’, from which originates the deep anterior oblique 
ligament (dAOL). The metacarpal beak articulates with a recess on the volar surface of 
the trapezium, just proximal to the dAOL attachment (Komatsu & Lubahn, 2018). In 
addition, the trapezium articulates with the second metacarpal, trapezoid, and scaphoid. 
The trapezium sits at the radial side of the wrist with no radial buttress and no fixed 
base of support on the mobile scaphoid, making for an unstable platform for the thumb 






Figure 2.1 The CMC joint has been hinged open from the dorsum to 
reveal the saddle shaped articular surfaces of the base of the first 
metacarpal and the trapezium. Also revealed is the deep anterior 
oblique ligament (dAOL). Anticlockwise from left to right are: DRL, 
dorsal radial ligament; APL, abductor pollicis longus; SAOL, superficial 
anterior oblique ligament; DRL, dorsal radial ligament; POL, posterior 
oblique ligament; DTT, dorsal trapezial-trapezoid ligament; DT-II MC, 
dorsal trapezial-second metacarpal ligament ; POL (distal 
attachment); DIML, dorsal intermetacarpal ligament; IML, 
intermetacarpal ligament. (Used by permission of Mayo Foundation 
(Bettinger et al., 1999), Appendix A) 
    
The CMC trapezial facet is saddle-shaped in the central-distal part and spherical on the 
palmar aspect (Zancolli et al., 1987). The spherical portion is convex in all directions 
and is in contact with the reciprocally concave parts of the MC1, enabling axial rotation 
(circumduction) of the MC1 during opposition and retroposition movements (Zancolli 
et al., 1987). The resultant joint mechanics enable the tip of the thumb to be positioned 
opposite the tips of the remaining digits, thus permitting the areas of highest sensory 





Motion at the thumb CMC joint is primarily in two planes: flexion-extension and 
abduction-adduction. However, just about any angular motion can be achieved when 
these two planes are superimposed (Komatsu & Lubahn, 2018). Further, a third, 
rotational plane involving varus-valgus and supination-pronation can occur because the 
planes are off-set rather than perpendicular (Komatsu & Lubahn, 2018). Only two of the 
three planes of motion can be controlled by the surrounding musculature. Pronation 
automatically accompanies flexion to bring the thumb to fingertips for pinch and grasp 
(Komatsu & Lubahn, 2018). There is no ability to vary the amount of pronation and 
supination without flexion-extension or abduction-adduction. Independent control of 
rotation as in ball-and-socket joints at the hip or shoulder would require a greater 
number of muscles, too bulky for the hand to effectively perform grasp and fine motion 
functions (Komatsu & Lubahn, 2018).   
While the saddle-shape of the thumb CMC provides some bony stability, its relative 
incongruence and loose capsule allow greater planes of motion than available at 
adjacent digits and joints (Komatsu & Lubahn, 2018). The semi-constrained osseous 
arrangement sacrifices stability for mobility, leaving the thumb CMC more reliant for 
stability on the capsule and ligamentous structures (Gluck, Balutis, & Glickel, 2015; 
Komatsu & Lubahn, 2018), and coordinated muscular activity (Zancolli et al., 1987).  
2.1.2 Ligamentous anatomy 
Despite considerable detailed investigation over the past six decades, the complex 
ligamentous anatomy of this joint has yet to be fully explained and understood 
(Bettinger et al., 1999; D'Agostino et al., 2014; Komatsu & Lubahn, 2018). The volar 
ligaments (Figure 2.2) have long been held to contribute the greatest to thumb CMC 
stability and joint health (Bettinger et al., 1999; Eaton & Littler, 1973; Pellegrini Jr, 
1991). However, more recent authors disagree. Compared to the AOL, the dorsal 
ligament complex (DLC) has been found to be thicker, stiffer, and more important to 
joint stability (Bettinger et al., 1999; Bettinger, Smutz, Linscheid, Cooney, & An, 2000; 
Colman, Mass, & Draganich, 2007; D'Agostino et al., 2014; Ladd, Lee, & Hagert, 2012; 
Zhang, Van Nortwick, Hagert, Yao, & Ladd, 2013). Further, the volar beak insertion in 
the trapezial recess has recently been identified as the joint’s pivot point (Edmunds, 







Figure 2.2 The volar thumb CMC ligaments from a right hand, showing 
the attenuated anterior oblique ligament (AOL) and ulnar collateral 
ligament (UCL), which course from the trapezial ridge (Tz) onto the 
volar base of metacarpal 1 (MC1). Also seen are the abductor pollicis 
longus (APL) and flexor carpi radialis (FCR) tendons, as well as the base 
of metacarpal 2 (MC2). (Used by permission of Amy L. Ladd, MD (Ladd 
et al., 2014), Appendix A) 
 
The DLC comprises the dorsal radial ligament (DRL), the posterior oblique ligament 
(POL), and the ulnar collateral ligament (UCL) (Bettinger et al., 1999) (Figure 2.3). This 
dorsal complex is overlaid by the abductor pollicis longus (APL) and extensor pollicis 
longus (EPL) tendons and resists dorsal or dorsal-radial subluxating force and ulnar 
translation of the MC base during abduction opposition, extension and pronation 
(Bettinger et al., 1999). The DLC is now understood to operate as part of a cantilever 
force complex that, in concert with balanced muscle force, transforms the mobile unit 
into a stable column by locking the volar beak of MC1 into the trapezial recess on 
opposition (Edmunds, 2011). The dorsal complex has also been found to be more richly 
innervated with mechano receptors, which support its role in proprioception and 






Figure 2.3 The dorsal thumb CMC ligaments from a right hand showing 
the dorsal ligament complex consisting of the dorsal radial ligament 
(DRL), dorsal central ligament (DCL), and posterior oblique ligament 
(POL), all emanating from the dorsal tubercle of the trapezium (Tz). 
Also seen are the dorsal bases of metacarpal 1 and 2 (MC1, MC2) and 
the abductor longus (APL) tendon. (Used by permission of Amy L. Ladd, 
MD (Ladd et al., 2014), Appendix A)  
Several other ligaments including the intermetacarpal ligament (IML) (Figure 2.1, 
Figure 2.4) act along with the DLC to support the volar beak pivot function (Edmunds, 
2011) and to tenodese the MC1 to the MC2 (Bettinger et al., 1999; Edmunds, 2011). 
More proximally, a number of intercarpal ligaments act to secure the trapezium to the 
trapezoid to compensate for the lack of radial bony buttress and to stabilize the 
trapezium against cantilever bending forces during pinch (Bettinger et al., 1999). 
Without these restraints, the trapezium would displace into extension and radial 






Figure 2.4 Trapezial cantilever bending. This diagram shows the zig-zag 
collapse of the first ray and the associated radial deviation and extension 
that occurs in the trapezium due to cantilever bending forces. Also 
depicted is the presumed laxity of the ligaments restraining the trapezium 
and CMC joint. (Used by permission of Mayo Foundation (Bettinger et al., 
1999), Appendix A) 
2.1.3 Muscular anatomy and function 
Nine muscles contribute to thumb CMC stability and function (Figure 2.5): the three 
thenar muscles on the volar aspect of the hand (abductor pollicis brevis [APB], flexor 
pollicis brevis [FPB], opponens pollicis [OP]); adductor pollicis (AP); the flexor pollicis 
longus (FPL); the APL and extensor pollicis brevis , and the EPL in the first and third 
dorsal compartments respectively; and the first dorsal interosseous (FDI) on the ulnar 






   
Figure 2.5 The thumb muscles from two right hands showing: A. flexor pollicis brevis  (FPB), 
abductor pollicis brevis (APB), B. adductor pollicis (AP), opponens pollicis (OP), and the extrinsic 
flexor pollicis longus (FPL) on the volar aspect; C. the extrinsic muscles of the first and third 
dorsal compartments (abductor pollicis longus [APL] and extensor pollicis brevis [EPB], and the 
extensor pollicis [EPL]) on the dorsal aspect; and the first dorsal interosseous muscle (FDI). 
(Photographs taken by permission of WD Trotter Anatomy Museum, University of Otago)   
With thumb functions, for example, pinch, normal translation and coupling of 
movements and forces occur. The intrinsic and extrinsic muscles abduct, translate 
ulnar-ward, and rotate the thumb CMC (Ladd et al., 2014). The APB, OP, and AP, along 
with the powerful FPL then contract to lock the volar beak into the trapezial recess, 
tensioned by the dorsal ligaments (Edmunds, 2011). In addition, the FDI by virtue of its 
origin on MC2 and insertion into MC1, works to ‘seat’ the MC1 on the trapezium and to 
increase medial stability further (van Heest & Kallemeier, 2008). In opposition the 
thumb CMC is compressed into maximal congruency as it is held near the end of its 
‘saddle range’ (Edmunds, 2011). The rotation that accompanies thumb CMC motion into 
opposition creates a ‘screw home torque’ at the thumb CMC joint, converting a lax, 
unstable incongruous joint into a rigidly stable, congruous joint (Edmunds, 2011). This 
mechanism is fit for purpose for meeting the demands of both pinch grip and powerful 
rotational forces such as unscrewing a lid (Taylor, 2000). The unique joint surface 
topography therefore serves a dual purpose: to permit the mobility required for delicate 






















precision pinch, and to provide the stability (through dynamic force coupling) necessary 
for power grip and pinch. Success of the dynamic screw home mechanism is dependent 
on the integrity of the volar beak and its trapezial recess, and sufficient length in the 
first web space tissues to achieve the requisite rotation-opposition ROM. Insufficient 
first web space length is seen as adduction contracture, or loss of palmar abduction 
ROM. 
The forces exerted at the CMC joint with pinch and grasp functions are substantial being 
up to 12 times higher than those applied at the thumb tip and shear forces are up to 2.5 
times greater (Cooney & Chao, 1977). Thumb CMC joint reactive forces with power 
grasp are up to 120kgF in a 70kg human (Cooney & Chao, 1977). Therefore, it is not 
surprising that the thumb CMC is such a frequent site of OA (Cooney, Lucca, Chao, & 
Linscheid, 1981) 
In summary, the anatomical design of the thumb CMC joint is one that is inherently 
unstable, placing it at a distinct disadvantage given its high usage, high loads, small 
surface area, and high reliance on well-coordinated dynamic control. The joint is most 
stable in opposition but requires sufficient ligamentous integrity, capsular and first web 
space length, and motor control to achieve this. The volar beak of the first metacarpal 
plays an important role in ‘locking in’ stable opposition. There is a mobility-stability 
tradeoff to achieve the unique functions of the thumb in the confined space of the hand.  
2.2 Aetiology of thumb carpometacarpal osteoarthritis 
2.2.1 Pathophysiology of osteoarthritis   
Osteoarthritis has long been conceived of as a degenerative disease of articular 
cartilage, an inevitable consequence of ageing. However, the contemporary 
understanding is of a multi-factorial disease involving all joint structures (Dieppe, 2011; 
Martel-Pelletier et al., 2016; Sellam & Berenbaum, 2010). Local and intrinsic factors 
influence the clinical and structural presentations at any stage up to and including 
eventual joint destruction (Dieppe & Lohmander, 2005; Martel-Pelletier et al., 2016). 
Subchondral bone, ligaments, capsule, synovial membrane, as well as articular cartilage 
are all recognised as sites of involvement (Dieppe & Lohmander, 2005; Martel-Pelletier 





imaging modalities include loss of cartilage seen as joint space narrowing (JSN), 
osteophyte formation, and subchondral bone changes (Dieppe & Lohmander, 2005; 
Martel-Pelletier et al., 2016). These changes, which may or may not be accompanied by 
clinical signs, can take place gradually over many years or may occur in a series of 
accelerated phases (Martel-Pelletier et al., 2016; Sellam & Berenbaum, 2010). Peak 
incidence of symptomatic hand OA has been reported to occur at 45 years (Hart & 
Spector, 2000). 
Osteoarthritis is broadly classified into primary and secondary OA. In secondary OA, 
previous injury, surgical trauma, or congenital abnormalities contribute to the onset of 
disease (Dieppe & Lohmander, 2005; Martel-Pelletier et al., 2016). In contrast, primary 
or idiopathic OA is a result of multiple potential risk factors including genetic, 
metabolic, and biomechanical factors and, most commonly, increasing age (Dieppe & 
Lohmander, 2005; Martel-Pelletier et al., 2016). The fact that OA does not occur in 
individuals who have congenital or longstanding upper limb paralysis (Hart & Spector, 
2000; Marshall, Watt, Vincent, & Dziedzic, 2018) supports the role of mechanical 
loading.  
2.2.1.1 Articular cartilage changes 
At a molecular level cartilage is an avascular tissue with a relatively acellular matrix, 
poor repair capacity, and no neuronal innervation (Dieppe & Lohmander, 2005). With 
advancing age and in OA, cartilage has a diminishing capacity to recover or ‘turnover’ in 
response to mechanical loading (Martel-Pelletier et al., 2016). Consequently, the 
cartilage-forming cells (chondrocytes) fall into a state of progressive structural and 
nutritional decline which can end in chondrocyte death (Martel-Pelletier et al., 2016). 
This state of disrepair is accompanied by inflammatory and catabolic upregulation 
which ultimately results in tissues being much less capable of withstanding everyday 
mechanical loads (Martel-Pelletier et al., 2016).  
In OA joints, articular cartilage is seen to undergo molecular changes, including gradual 
proteolytic degradation of the matrix, associated with intensified synthesis of matrix 
components by the chondrocytes (Dieppe & Lohmander, 2005). These molecular level 





fibrillation, cleft formation, and loss of cartilage volume (Dieppe & Lohmander, 2005). 
Pain in OA joints comes not from cartilage damage itself, but from exposure of 
subchondral nerve endings when fissures form in the cartilage (Dieppe & Lohmander, 
2005). Other sources of joint pain in OA include periosteum, synovium, ligaments, and 
the joint capsule (Bacon, LaValley, Jafarzadeh, & Felson, 2020); these, like subchondral 
bone, are richly innervated and contain nerve endings that could relay nociceptive 
stimuli (Dieppe & Lohmander, 2005).  
2.2.1.2 Bony (structural) changes 
The onset of bony changes is closely linked to the development of local cartilage 
pathology; both are responses to altered mechanical loading although it is not yet clear 
how each contributes to the other (Dieppe & Lohmander, 2005; Martel-Pelletier et al., 
2016). Speculation exists that advanced OA changes of bone marrow lesions and 
subchondral cysts represent a progressively unstable or decompensated OA joint, 
whereas osteophyte formation likely contributes to joint stability representing a 
compensated joint state (Dieppe, 2011; Martel-Pelletier et al., 2016). Pain inhibition of 
neuromotor control can result in further loss of joint stability resulting in a 
decompensated presentation (Dieppe & Lohmander, 2005). Advanced deformity is 
usually associated with pronounced loss of movement but is not necessarily more 
symptomatic having potentially moved on to a compensated state (Dieppe, 2011; 
Dieppe & Lohmander, 2005).  
2.2.1.3 The role of synovitis 
Inflammatory processes, particularly those involving the synovial membrane, appear to 
be directly responsible for several clinical signs in OA and reflect the structural 
progression of the disease (Bacon et al., 2020; Sellam & Berenbaum, 2010; Wang, 
Hunter, Jin, & Ding, 2018). The pro-inflammatory and catabolic products produced by 
cartilage damage appear to involve synovial membrane and synovial fluid in the 
inflammatory response; this synovial involvement further contributes to chondrocyte 
deregulation (Martel-Pelletier et al., 2016). Inflammatory mediators detected in 
synovial fluid of OA joints have been found to derive from cartilage, subchondral bone, 
and the synovium, all of which undergo histopathological change (Sellam & Berenbaum, 





cytokines involved in the pathogenesis of OA (Sellam & Berenbaum, 2010). The 
immunological presentations of advanced OA and rheumatoid arthritis (RA) are similar 
with the main difference being the divergent profiles of the cytokines released (Sellam 
& Berenbaum, 2010).  
The pathogenic role of synovitis in OA may act via TNF, IL-1β, other soluble mediators, 
and through large quantities of matrix metalloproteases (MMP-1, MMP-3, MMP-9, and 
MMP-13) produced by both synovial membrane and chondrocytes (Sellam & 
Berenbaum, 2010). For example, MMP3, which appears to directly breakdown cartilage, 
is synthesised predominantly on the border of hyaline cartilage – suggesting it is 
secreted by OA synovial tissue (Sellam & Berenbaum, 2010). Other work has identified 
synovial macrophages as possible intermediaries in changes to subchondral bone; and 
other cytokines, including T cells, interferon-γ, and IL-2 as potential drivers of chronic 
inflammation (Sellam & Berenbaum, 2010). Overall, these findings indicate that 
inflammation both contributes to and results from the breakdown products of cartilage 
extracellular matrix (Sellam & Berenbaum, 2010). Thus, a vicious cycle can ensue in 
which cartilage breakdown and synovial inflammation occur simultaneously (Sellam & 
Berenbaum, 2010).  
In late phase hand OA, including thumb CMC OA, synovial inflammation has been found 
to be present and linked to clinical joint signs of swelling and inflammatory pain 
(Kortekaas et al., 2010; Mathiessen, Slatkowsky-Christensen, Kvien, Hammer, & Haugen, 
2016; Sellam & Berenbaum, 2010). Furthermore, synovitis has been identified as a 
predictor of the appearance and progression of structural changes such as erosions in 
hand OA (Balueva, Sarapulova, & Teplyakova, 2018; Kortekaas, Kwok, Reijnierse, & 
Kloppenburg, 2014; Mathiessen et al., 2016). Therefore, therapies that target 
inflammation or can break the negative feedback cycle may delay or prevent articular 
cartilage damage and the formation of osteophytes, particularly in early OA (Sellam & 
Berenbaum, 2010). Such non-pharmacological therapies may include, for example, rest, 





2.2.1.4 Metabolic factors 
Obesity is speculated to contribute to the immunological response in OA through 
induction of pro-inflammatory cytokines in the synovium and chondrocytes by 
adipokines released by adipose tissue (Martel-Pelletier et al., 2016). There is some 
evidence that obesity increases the risk of hand OA (Magnusson, Turkiewicz, Timpka, & 
Englund, 2018; Reyes et al., 2016), but not to the extent seen in knee OA (Dieppe & 
Lohmander, 2005; Reyes et al., 2016), suggesting a complex interplay between 
metabolic and other factors, for example, mechanical. The metabolic risk factor of being 
diabetic has also been found to be associated with radiographic progression of nodal 
hand OA (Marshall et al., 2019; Neuprez et al., 2018). However, metabolic syndrome 
was not found to be associated with the presence of hand OA in the large Framingham 
cohort (Strand, Neogi, Niu, Felson, & Haugen, 2018). No clear associations have yet been 
identified between metabolic factors and the incidence or progression of thumb CMC OA 
specifically (Marshall et al., 2019).  
2.2.1.5 Genetic factors 
While heterogeneity in OA disease manifestations is undoubtedly influenced by 
environmental factors, a growing body of evidence indicates that genetic and epigenetic 
factors also play important roles (Jeffries, 2019). In hand OA, only a small body of 
evidence exists to date; this has shown concordance in monozygotic twins at rates 
similar to recent moderate and strong findings for knee and hip OA respectively 
(Doherty, 2000; Jeffries, 2019), with osteophytes at the thumb CMC showing the 
strongest tendency of all hand joints (Doherty, 2000). Familial aggregation has also 
been demonstrated for hand OA (Doherty, 2000). A polygenic risk is likely with some 
candidate genes from a recent genome-wide association study including the association 
between a matrix Gla protein (MGP) gene variant and increased risk for hand OA caused 
by a lower expression of MGP; the latter may increase hand OA burden through reduced 
inhibition of cartilage calcification (den Hollander et al., 2017). However, no specific 
information is yet available for CMC OA. 
Taken together, these data indicate that OA is a heterogeneous, long term whole-of-joint 
condition influenced by multiple intrinsic and extrinsic factors. Newer imaging 





unsalvageable degenerating cartilage, and transformed it into an exciting challenge 
involving an active repair process (Dieppe, 2011). There is a strong indication that 
treatment targets include both bio-mechanical factors and synovial inflammation.   
2.2.2 Aetiology of thumb CMC OA 
Recent investigations have substantially influenced prevailing opinion regarding the 
aetiology of thumb CMC OA. For a long time laxity of the AOL and shallowness of the 
trapezial facet (resulting in greater joint incongruency) have been cited as primary 
factors in the onset of thumb CMC OA (Bettinger et al., 1999; Gluck et al., 2015; Jonsson 
& Valtysdottir, 1995; Pellegrini Jr, 1991; van Heest & Kallemeier, 2008). Consequently 
management, including surgical procedures, targeted the AOL to restore stability (Gluck 
et al., 2015; van Heest & Kallemeier, 2008). In much of this literature authors have also 
associated both factors with female sex (Gluck et al., 2015; Jonsson & Valtysdottir, 1995; 
Poole & Pellegrini, 2000; van Heest & Kallemeier, 2008). 
However, data supporting these aetiological views came primarily from cadaveric 
studies and clinical observations because, unlike in hip and knee OA, there is no suitable 
animal model of thumb CMC OA to gain an appreciation of the manifestations of the 
disease in living tissues. Contemporary technological advancements, including 3-
dimensional computed tomography (CT) imaging, enable more accurate assessments 
(K. K. Wang et al., 2018). Consequently, the hypothesis that the pathogenesis of thumb 
CMC OA is primarily due to incompetence of the AOL has been replaced by the 
understanding that the main mechanism governing onset is the concentrated 
compressive rotational shear forces in the pivot area of the trapezial recess resulting 
from screw home torque in the final phase of opposition (Edmunds, 2011; Ladd et al., 
2014; Riordan et al., 2018). In advanced disease the volar beak may become so ground 
off that screw home torque rotation stability is lost and instability sets in (Edmunds, 
2011). Furthermore, new CT data do not support incongruency as an aetiological factor 
(Halilaj et al., 2015) and kinematic analysis suggests no association between sex, 
handedness, or thumb ROM capability in onset of thumb CMC OA (Hamann, Heidemann, 





Regarding the pattern of articular changes in thumb CMC OA, consistent wear patterns 
focused on the volar aspect of MC1, but evenly spread over the trapezial surface have 
been identified (Miyamura et al., 2019). Osteophyte formation has also been found to be 
consistent in non-opposing regions of MC1 and trapezium: on the dorsal and volar 
aspects of the thumb CMC and the radial and ulna borders of the trapezium, creating a 
net effect of an overall increase in joint mechanical stability (Crisco et al., 2019) and 
possibly suggesting a tendency towards a compensated joint state. Pain has been 
associated with loss of cartilage (Crisco et al., 2016) but rate of cartilage thinning has 
not been found to differ between males and females (Crisco, Moore, Morton, Ladd, & 
Weiss, 2017).  
Some evidence exists that occupational factors play a role in the development of general 
hand OA (Castano Betancourt, Marchi, & Lipay, 2018; Hart & Spector, 2000). Tasks or 
postures presumed to cause strain or high load at the thumb CMC joint such as 
secretaries, dressmakers, and cleaners, repetitive thumb use, and few breaks in the day 
characterise occupations associated with increased risk for thumb CMC OA (Fontana, 
Neel, Claise, Ughetto, & Catilina, 2007). However, little data about the role of mechanical 
factors such as sport and occupation exist for thumb CMC OA in comparison with hip 
and knee OA (Burkholder, 2000; Castano Betancourt et al., 2018). 
The aetiological processes outlined here, in addition to the CMC features described in 
earlier sections indicated that biomechanical interventions, positively affecting joint 
stability and reducing articular contact forces, are justified. 
2.3 Signs and symptoms 
Typical symptoms of OA generally include pain, morning stiffness, and crepitus on joint 
motion (Martel-Pelletier et al., 2016). Palpable joint swelling may indicate inflamed 
synovium, or the development of pannus (synovial thickening) (Sellam & Berenbaum, 
2010). Other typical signs of inflammation include redness, pain, or heat. Inflammatory 
OA pain is suggested by a sudden increase in pain, night pain, and morning stiffness that 
lasts for at least 30 minutes (Sellam & Berenbaum, 2010). However, cardinal features of 





(Dieppe & Lohmander, 2005), with rest pain and night pain only seen in more advanced 
cases (Dieppe & Lohmander, 2005). 
In thumb CMC OA, physical examination may find pain with pinching and gripping, 
clicking or grinding, tenderness on palpation of the thumb CMC, as well as swelling and 
warmth (van Heest & Kallemeier, 2008). Thumb CMC subluxation ‘squaring’, or 
‘shoulder sign’ (Figure 2.6) may be observed with or without adjacent 
metacarpophalangeal joint (MCP) collapse into hyperextension or less commonly 
hyperflexion (van Heest & Kallemeier, 2008). A reduction in joint ROM, first web space 
contracture, and thenar muscle wasting may also be present (van Heest & Kallemeier, 
2008).  
 
Figure 2.6 Thumb CMC joint shoulder sign: the base of the 
first metacarpal is mildly subluxed and prominent in 
relation to the trapezium, giving a ‘squared’ appearance 
Various special tests for thumb CMC OA have also been described, perhaps the most 
popular is the grind test involving compression and rotation of the thumb CMC (van 
Heest & Kallemeier, 2008) (Figure 2.7). A positive grind test reproduces pain or 
crepitus, or both at the thumb CMC. This test has fair interrater reliability (Kappa [k] = 
0.48) (Merritt, Roddey, Costello, & Olson, 2010). Face validity is considered to be high, 





specificity (80% -100%) and low-moderate sensitivity (30% - 64%)(Choa, Parvizi, & 
Giele, 2014; Merritt et al., 2010; Sela, Seftchick, Wang, & Baratz, 2019). A more recently 
described test, the pressure shear test, involves compression and anterior-posterior 
translation of the thumb CMC (Figure 2.7) with pain reproduction or crepitus as a 
positive test. This test has been found to have excellent validity with both high 
sensitivity (99%) and specificity (95%) (Sela et al., 2019). Although the measurement 
properties of these tests appear good, they should not be considered definitive because 
the studies describing them are not of high-quality.  
  
Figure 2.7 Special tests for the thumb CMC joint: A. The grind test involves compression and 
rotation of the thumb CMC. B. The pressure shear test involves compression and anterior-posterior 
translation of the thumb metacarpal on the trapezium.  
Carpal tunnel syndrome, trigger thumb, STT OA, and de Quervain’s tenosynovitis are 
important differential diagnoses as well as common concurrent presentations (van 
Heest & Kallemeier, 2008). Along with thumb CMC OA, these conditions have 
collectively been described as ‘basal thumb syndrome’ (Melone, Beavers, & Isani, 1987). 
Other differential diagnoses include scaphoid pathology and flexor carpi radialis 
tendonitis (van Heest & Kallemeier, 2008). 
Like OA at other joints, thumb CMC OA is much easier to diagnose when well established 
because in the early stages objective features may be subtle or absent on examination 
(Felson & Hodgson, 2014). Clinical signs are associated with physical limitations and 






2.4 Classification  
2.4.1 Radiographic classification 
Classification of thumb CMC OA has traditionally been based on radiographic changes as 
originally described by Kellgren & Lawrence (1957) (Sonne-Holm & Jacobsen, 2006). 
While some evidence exists for a correlation between degree of radiological 
degeneration and self-reported pain (Sonne-Holm & Jacobsen, 2006), many people with 
radiographic evidence of first CMC OA remain asymptomatic (Niu et al., 2003; Wilkens, 
Tarabochia, Ring, & Chen, 2019). Furthermore, radiographic criteria can fail to classify 
up to 20% of people with radiographic changes; combinations of JSN, osteophyte 
graduations, sclerosis and cysts fall outside the commonly used Kellgren-Lawrence (K-
L) classification criteria (Sonne-Holm & Jacobsen, 2006). For all locations, inclusion of 
asymptomatic radiographic OA as a clinical disease entity in clinical or population 
studies, is controversial (Hart et al., 1991). Furthermore, there are ethical and practical 
problems in using radiography (Hart et al., 1991). However, on entry into symptom-
modifying or structure-modifying studies radiographic imaging has been recommended 
at baseline, in order to give insights into who is likely to respond, how better to describe 
the study population, and to explore any structurally-related factors mediating the 
effectiveness of interventions (Fitzgerald et al., 2015; Kloppenburg, Maheu, et al., 2015). 
There are several limitations to visualisation of the thumb CMC when using 
radiographic imaging. The complex topography means slight changes in position or x-
ray beam can reveal or obscure osteophytes or other structural changes (Hunter et al., 
2015). However, it has been recommended that where standard scoring, for example, K-
L, is required additional specialised views are not necessary (Hunter et al., 2015). 
Several radiographic classifications exist, all of which evaluate structural changes 
including JSN and osteophytes. The K-L system has 0-4 stages with OA being 
determined at stage 2 or greater (Sonne-Holm & Jacobsen, 2006). The original K-L 
system’s emphasis on the presence of osteophytes has since been modified (Sonne-
Holm & Jacobsen, 2006). Reported intra-rater reliability for K-L grading is k = 0.79 and 
inter-rater k = 0.65 for thumb CMC OA (Sonne-Holm & Jacobsen, 2006). The Eaton-
Littler (E-L) system recognises joint space widening indicating effusion or synovitis 
with early disease (stage 1 of 4) and also accounts for involvement of pan-trapezial 





reliability for E-L grading has been reported as k = 0.54 to 0.66 and inter-rater k = 0.11 
to 0.56 (Berger et al., 2014). The newer OARSI atlas grades individual features 
independently, including JSN and osteophytes (Altman & Gold, 2007). 
A disadvantage of x-ray imaging is its poor capacity to identify early disease (Hunter et 
al., 2015). Other imaging modalities such as magnetic resonance imaging (MRI) and CT 
have better capability for this. They are excellent for capturing soft tissue changes and 
bony topography respectively; however, both are expensive and come with other 
limitations, for example, difficulty in acquiring identical repeat images.   
Ultrasound is an alternative modality for capturing both soft tissue and bony changes 
and may be the most feasible alternative to x-ray (Guermazi, Roemer, Crema, Englund, & 
Hayashi, 2014). Ultrasound can be used to visualise synovial inflammation in 
osteoarthritic joints (X. Wang et al., 2018) and is sensitive in identifying changes in 
small joints of the hand, including the first CMC (Balueva et al., 2018; Kortekaas et al., 
2014; Kortekaas, Kwok, Reijnierse, Stijnen, & Kloppenburg, 2016; Kortekaas et al., 2010; 
Mathiessen et al., 2016). However, reproducibility in terms of image acquisition and 
interpretation remain a challenge and it is highly operator dependent (Hunter et al., 
2015). In hand OA, clinimetrics for ultrasound assessment of synovitis, effusion, and 
osteophytes has been found to be excellent when a binary system is used (Oo et al., 
2018), and also substantial on semi-quantitative scoring for synovitis and osteophytes 
(Oo et al., 2018).  
2.4.2 Clinical classification  
For non-operative rehabilitation, such as splinting, which focusses on improving 
symptoms and function established clinical criteria may suffice for determining study 
inclusion (Fitzgerald et al., 2015). Further, rather than focusing on whether 
radiographic evidence represents ‘disease’, it has been argued that symptomatic hand 
OA reflects the condition of clinical significance and should be the focus of research and 
clinical practice (Niu et al., 2003). However, a reliable and reproducible clinical 
examination has long been considered essential (Hart et al., 1991). Classification criteria 
provide general standards to improve consistency, comparability, and quality of 





and hand (Altman et al., 1990; Altman, 1991); the American College of Rheumatology 
(ACR) hand OA criteria are problematic due to the multiplicity of joints in the hand. 
Since thumb CMC OA often occurs in isolation, ACR criteria do not allow it to be reliably 
captured (Kloppenburg & Kwok, 2012).  
Where a condition such as OA is difficult to define, the sensitivity of any given clinical 
test is likely to be low. One approach that can be used is to have a raft of clinical 
assessments with high specificity and to use an inclusive approach whereby the 
presence of one or more positive findings indicates a high likelihood of identifying the 
presence of the condition. The clinical assessments proposed for this are 1) presence of 
the shoulder sign; 2) tenderness on palpation of the CMC; 3) a positive grind test; and 4) 
a positive pressure shear test. Such an approach has been used to classify other 
conditions with similar diagnostic difficultly such as sacro-iliitis (Castro, Stebbings, 
Milosavljevic, & Bussey, 2015). It is hypothesised that this approach, as well as a history 
suggestive of first CMC OA, would successfully identify people with symptomatic thumb 
CMC OA suitable for inclusion in the clinical study in this thesis (Chapter 5). A history 
suggestive of OA is a recommended approach to inclusion for studies in hand OA 
(Kloppenburg & Kwok, 2012); this approach has been described and validated for use in 
knee OA (Hawker et al., 2008). A history suggestive of thumb CMC OA is hypothesised to 
suitably include people with symptomatic thumb CMC OA for the qualitative study 
(Chapter 3). Adaptation of these approaches for thumb CMC OA is considered in 
Chapters 3 and 5 of this thesis in the study inclusion criteria. 
An optimal case definition would identify the population for whom the intervention is to 
be applied, i.e. distinguish people with thumb CMC OA from those with other conditions 
and distinguish clinical thumb CMC OA from asymptomatic histopathologic or 
radiographic OA (Palmer et al., 2012). Identifying those who are likely to benefit is also 
desirable; that is, identifying modifiable causes of illness enables targeted treatments 
and the delivery of more accurate prognostic advice to patients (Palmer et al., 2012).    
Evidence to date indicates that clinical signs appear to be good at distinguishing thumb 
CMC OA and, similar to OA at other locations, the clinical signs and symptoms appear to 





al., 2015; Dieppe & Lohmander, 2005; Haugen et al., 2013; Hwang & Ring, 2011; Niu et 
al., 2003; Zhang et al., 2009) . Therefore, clinical classification is more likely to support a 
patient-centred approach. However, as outlined in Chapter 1, the patient perspective of 
the impact of thumb CMC OA has not been thoroughly investigated and hence is not well 
understood. For this reason the thesis aims to contribute to this important area in 
Chapter 3. Furthermore, and importantly, very little evidence exists to date to suggest 
which disease characteristics might indicate those likely to respond to a given treatment 
– this is expanded on in Chapters 4 & 5.  
2.5 Summary and implications for related thesis chapters 
Thumb CMC OA, like OA at other sites, is a complex interaction of local joint mechanical 
factors and a range of systemic and environmental factors. Recent developments have 
begun to make clearer how OA begins and develops at the thumb CMC joint. However, 
another level of inquiry is how individuals or populations experience the resultant 
immunological, molecular, and gross morphologic changes (Dieppe & Lohmander, 
2005). Understanding the patient perspective of thumb CMC OA is crucial to advancing 
treatments that address effectively the problem requiring treatment and to developing 
measurement tools that are meaningful in this regard. Therefore, the patient 
perspective is the focus for the study that follows in Chapter 3.   
Key findings from this review of the literature that have implications for the design of 
the studies detailed in the following chapters are: 
• The thumb CMC joint is an inherently unstable complex that is reliant on a 
capsular and ligamentous integrity along with dynamic motor control for 
maintaining joint congruence and mechanical load distribution for joint health.  
• Osteoarthritis of the thumb CMC joint is a heterogenous, long term whole-of joint 
condition in which biomechanical factors and inflammation play significant roles.   
• Biomechanical interventions that positively affect joint stability are justified. 
• Interventions which may address inflammatory processes, for example, through 
rest, compression, and thermal effects may also be indicated. 
• Radiographic classification for thumb CMC OA is established; however, 





identifying early thumb CMC OA. A patient-centred approach requires identifying 
those who are symptomatic rather than being based on structural disease.  
• Clinical classification based on a history suggestive of thumb CMC OA and one or 
more positive clinical tests may be well-suited to identifying community-based 
populations for non-surgical intervention studies. There is good precedent for 
this approach in knee and hip OA studies (Hawker et al., 2008) and it is 
recommended in diagnosis of OA generally (NICE, 2014).  
• Ultrasound can reliably detect synovitis, a potential treatment target. On entry 
into a symptom-modifying or structure-modifying study both ultrasound and x-
rays may be useful to give insight into who is likely to respond to an intervention 
or structure-mediating effects (Hunter et al., 2015). Therefore, the feasibility of 
including x-ray and ultrasound imaging as baseline characteristics for 






Chapter 3  
The impact of thumb CMC OA: A pragmatic qualitative study 
3.1 Introduction 
This third chapter reports the design, conduct, and results of a qualitative study that 
addresses the first aim of this thesis: to explore the impact of thumb CMC OA from the 
perspective of people with the condition. The study is orientated to the three research 
questions which follow from this aim. First, to gain a broad understanding of the impact 
of thumb CMC OA from patients’ perspectives. Second, to identify outcomes that are 
important and meaningful to people with thumb CMC OA and appraise the relevance of 
currently recommended self-report measures. Third, to understand what problems 
treatments should aim to address. The study contributes to the overall thesis both by 
informing selection of outcome measures and by elucidating which treatments would 
address the need or needs identified for the feasibility study (Chapter 5). This in turn 
will inform a future RCT investigating the effectiveness of splinting. In this way the 
thesis enables study design to incorporate patients’ lived experiences and the outcomes 
that are important to them. 
3.2 Background 
As outlined in Chapter 1, the challenges faced by studies investigating thumb CMC OA 
include 1) no agreed case definition despite apparent unique clinical profile and impact, 
2) no gold standard outcome measure, and 3) limited knowledge of patients’ 
experiences.  
Deeper, richer data are needed to enable the condition of thumb CMC OA to be better 
understood by clinicians and researchers. This will then inform the design of 
interventions and of outcome assessment instruments so that they better match 
patients’ needs rather than clinicians’ descriptions of the disease. Collecting such data is 
well-suited to a qualitative approach in which the goals are to gain more in-depth 
understanding of patients’ experiences and to delve into the everyday manifestation of 





can provide information about contextual factors that may explain some of the 
variability in disease manifestation, or response to treatments, or in both.   
Another necessity is to understand how this condition is experienced in broader 
contexts, including the multiple cultural contexts of New Zealand. Although the 
prevalence of OA in New Zealand is lower among Māori (7.1%) compared with New 
Zealand Europeans (12.5%) (Ministry of Health, 2019) , largely because of the younger 
Māori age distribution, health care utilisation by Māori for OA is poor (Loyola-Sanchez, 
Hurd, & Barnabe, 2017). Clearly, OA research conducted in New Zealand must 
contribute to eliminating this inequity. 
The overall aim of this study was to explore the experiences of people in New Zealand 
with thumb CMC OA in order to understand better the unique impact of this condition, 
ascertain outcomes of importance, and identify treatment endpoints.  
3.3 Methods 
This qualitative study was undertaken employing a pragmatic approach. Practical 
clinical questions of what should be measured and how patients should be treated were 
used to determine the study methods and design (Shaw et al., 2010). Data were 
collected using semi-structured interviews. 
Consultation was completed with the University of Otago Ngāi Tahu Māori consultation 
committee (Appendix B). Ethical approval was obtained from the University of Otago 
Human Ethics Committee (Health), reference H17/032 (Appendix C). To preserve 
participant confidentiality, all names are pseudonyms. Each participant in the study was 
reimbursed for expenses incurred with a $20 petrol voucher. Potential participants 
were provided with an information sheet and consent form (Appendix D) by post or 
email. The informed consent process was completed by telephone or in person once the 
participant had had sufficient time to consider the information (see participant flow 












3.3.1 Study participants and setting 
A sample size of 30 was chosen based on previous qualitative studies in arthritis in 
which recruitment of between 26 and 31 participants enabled successful data collection 
(Bromann Bukhave et al., 2014; Gooberman-Hill et al., 2007; Hill et al., 2011; Hill, 
Dziedzic, & Ong, 2010; Leung, Li, & Thumboo, 2015). Participants were recruited by 
posters and flyers (Appendix E) or clinician invitation from community and health 
settings including general practitioner (GP) and physiotherapy practices, and hospital-
based services in two centres in the South Island of New Zealand (Dunedin and 
Invercargill). A letter of invitation was sent to clinicians inviting them to assist in study 
recruitment (Appendix F). 
Included in the study were those aged 30 years and over with a history suggestive of 
thumb CMC OA (Hawker et al., 2008); those who were asymptomatic, had previous 
surgery to the hand, or had inflammatory or auto-immune conditions were excluded 
(Table 3.1). The age criteria of 30 years was selected based on epidemiological reports 
of hand OA in people in their 30s (Kwok, Vliet Vlieland, Rosendaal, Huizinga, & 
Kloppenburg, 2011), the mean age for hand OA being on average 4 years younger than 
that for general OA (Fautrel et al., 2005), and the researcher’s anecdotal experience of 
thumb CMC OA presenting in patients in their 30s.  
3.3.1.1 Engagement and recruitment of Māori 
Prior to study design, conversations were initiated to identify specific measures to 
support the engagement and recruitment of participants of Māori descent. Advice was 
sought from the University of Otago Facilitator Research Māori, Mark Brunton; the 
Māori health and research advisor within the PhD researcher’s department, Katrina 
Pōtiki-Bryant (KP); and faculty members from other departments experienced in 
conducting research involving Māori, Dr Emma Wyeth and Dr Jude Sligo. This 
consultation resulted in the following actions. First, the second centre (Invercargill) was 
added for its higher proportion of population identifying as Māori (13.3% (Statistics 
New Zealand, 2013)), given the relatively small proportion of the population identifying 
as Māori in the first centre (6.2%) (Statistics New Zealand, 2013). Second, to counter 
the low rates of treatment utilisation for arthritis by Māori (Loyola-Sanchez et al., 





possible, consultation regarding the study recruitment and study activities was 
undertaken with local Māori health providers and the Southern District Health Board. In 
Invercargill, this identified an exercise and activity group involving older Māori where 
the study could be promoted and resulted in one Māori health centre offering a room in 
which interviews could take place. Māori health services in Invercargill and marae-
based services in Dunedin agreed to disseminate the study advertisement through their 
networks. A fourth action was that the recruitment strategies aimed at recruiting Māori 
were started 4 weeks earlier than general recruitment.  
Table 3.1 Inclusion and exclusion criteria – Qualitative study 
Inclusion criteria Exclusion criteria 
• Aged 30+ years 
• Physician diagnosis of thumb CMC OA or 
answer “yes” to the question “Have you 
experienced aching, discomfort, pain 
and/or stiffness in or around the joint at 
the base of either thumb on most days for 
at least 1 month (15 or more days of the 
month) during the past year?” and have no 
other specific diagnosis.  
• Give written informed consent 
• Thumb non-symptomatic for the past 
month 
• Previous surgery of the symptomatic joint 
• Concurrent rheumatoid arthritis or any 
other significant inflammatory or 
autoimmune conditions affecting the hand 
such as scleroderma, systemic lupus 
erythematosus and psoriatic arthritis, or 
another kind of chronic pain syndrome or 
metabolic disorder, such as fibromyalgia, 
diabetic neuropathy, or gout. 
• Unable to comprehend instructions and 
outcome measure instruments in English. 
 
3.3.1.2 Participant characteristics 
Demographic and disease characteristics were collected using a tailored questionnaire 
(Appendix G). Participants completed self-report outcome measures for function 
(FIHOA score 0-30) (Dreiser, Maheu, Guillou, Caspard, & Grouin, 1995) and quality of 
life (EQ-5D-3L) (The EuroQol Group, 1990) and hand diagrams for pain (numeric rating 
scale, NRS 0-10) and abnormal joints, that is, stiffness, swelling, or deformity (Appendix 





2010; Marshall et al., 2011), adapted with permission of the authors [Marshall; 
Bijsterbosch: Personal Communications1].  
3.3.2 Interview methods 
Semi-structured face-to-face interviews were conducted with 30 adults with thumb 
CMC OA. The pilot-tested interview schedule covered six fields of interest; in lay terms: 
participants’ story of their thumb CMC OA; difficulties occurring due to thumb CMC OA; 
pain experience; impact on health and life; experience of health services for their thumb 
OA; and what they would most like to change. The main interview questions were 
accompanied by a series of probing and sensitising questions depending on the 
responses of participants. The probing questions aimed to elicit deeper and more 
detailed information. Interview questions and sensitising prompts were generated from 
the following: concepts included in OARSI-recommended self-report measures; the 
clinical and qualitative research expertise of the researcher, her three supervisors, and 
the Māori health research advisor (KP) - the last four are all experienced clinicians and 
three are experienced qualitative researchers; and previous qualitative research 
exploring pain in OA (Hawker et al., 2008). Pilot-testing with two PhD colleagues and 
one lay person with thumb CMC OA resulted in clarification of wording, and no change 
to the schedule structure. The full interview schedule is given in Appendix I. 
Within the interview schedule, the New Zealand Māori holistic health framework of Te 
Whare Tapa Whā (Durie, 1998), familiar to most New Zealanders, was adopted and 
invited participants to reflect on four pillars of health: physical, spiritual, thoughts and 
feelings, and family and community (Tinana, Wairua, Hinengaro, and Whānau, 
respectively in the Māori language). The Whare Tapa Whā framework was 
operationalised using a visual tool which likens the impact of a health condition on a 
person’s life to the ripples created and experienced when a stone is dropped into a pool 
(Whakāro Pōkare in the Māori language) (Bryant, 2016).   
Interviews were conducted by the PhD researcher, a female in her early 40s. She is an 
experienced clinician with formal qualitative research training. She also received 
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expert- and peer-coaching in qualitative interviewing before commencing the study. Her 
ethnicity is Pākehā (European) New Zealander and she has whānau (family) of Māori 
and Samoan ethnicity. The clinical interest and expertise of the researcher is in the 
assessment and management of hand and upper limb conditions. Thumb base OA and 
hand OA generally are common presentations in her clinical practice. All except one of 
the study participants were unknown to the researcher prior to the study; this 
participant was a past patient and not under current care. 
The 40- to 50-minute interviews took place in a health setting, for example, School of 
Physiotherapy or Māori health clinic, or participant’s home or place of work, as 
preferred by each participant. In two cases a family member was present. Interviews 
were audio recorded on a high-quality audio device (Sony model ICD-UX523F) and field 
notes made following each interview. 
Participants completed written daily diaries for the week before the interview to record 
impact in a natural setting and enrich interview data (Creswell, 2009). Diaries and an 
ergonomic pen were posted out to participants and returned at the interview. Following 
the interview and collection of demographic and disease data, feedback was sought 
from participants on the research methods by asking the questions, “how did you find 
completing the daily diary?” and, “how did you find participating in the interview?”. 
Requests from participants for care for their thumb CMC OA or other health conditions 
were dealt with by offering to refer to their GP. After the interviews the interviewing 
researcher, an experienced physiotherapist and hand therapist, offered general advice 
regarding management of hand OA where appropriate, including written information 
with links to useful websites and services. 
3.3.3 Data analysis 
3.3.3.1 Analysis of interview and document data 
The PhD researcher transcribed diary entries, interviews, and field notes, entering data 
in NVivo data management software (NVivo 11 – QSR International Pty Ltd, Melbourne). 
The same researcher analysed interview and diary data primarily inductively using a 





1) close reading and familiarisation with the data helped by the researcher being the 
transcriber, 2) generating initial codes, 3) categorising codes and combining to identify 
themes or concepts, 4) checking themes with the data, 5) developing clear definitions 
and names for themes, and 6) illustration of themes with compelling extracts (quotes) 
(Braun & Clarke, 2006). The researcher’s field notes were referred to throughout the 
thematic analysis to provide context and aid understanding of the data. At intervals 
coding and categorisation were discussed and reflected on with the PhD researcher’s 
primary supervisor and with KP.  
The data obtained from participants identifying as Māori were not intended to be 
compared and contrasted with data obtained from non-Māori participants, but, rather, 
to ensure that participants identifying as Māori were included in the study. Where 
concepts specific to Māori participants were identified, these were reviewed with the 
Māori research advisor (KP). 
To aid practical application to the research and clinical setting, results were interpreted 
using the Health Impact Model of Wilson and Cleary (Wilson & Cleary, 1995). The Model 
includes psychosocial as well as biological aspects and assists in identifying outcomes 
that are significant to patients, in understanding how outcomes and impact may vary, 
and in planning patient-centred care.  
Study findings were summarised and sent to participants. Permission was sought for 
use of individual quotes; no comments or corrections were requested.  
3.3.3.2 Analysis of participant demographic and patient-report outcome data 
Participant characteristics and patient-reported outcomes were presented using 
descriptive statistics (case number and percentage or mean and standard deviation 
[SD]). The EQ-5D-3L levels were dichotomised into ‘no problems’ (level 1) or ‘problems’ 
(level 2 or 3) (van Reenen & Oppe, 2015).  
3.4 Results 
Data were collected between June and September 2017. Participant characteristics are 
reported in Table 3.2 Participant characteristics. Current and previous vocations 





Table 3.2 Participant characteristics 
Participant characteristics N = 30 (SD) or (%) 
Sex Male : Female  11 : 19 
Age (years) Mean (SD) 64.5 (11.36) 
Descent European/Pākehā (%) 





Employment status Part- or full-time (%) 
Retired (%) 
Disability pension (%) 
Student (%) 
Not working (%) 











OA at other joints Hand (%) 
Other location (%)  
5 (16.7) 
12 (40) 
Thumb CMC OA diagnosis Made by clinician (%) 
History suggestive (%) 
24 (80) 
6 (20) 
Duration of problem (years) Mean (SD) 5.74 (5.26) 
Previous treatments (non-oral 
drug) 
Splint (%) 
Physio- or Hand Therapy (%) 








Pain relief medication (for thumb 









Pain at base of thumb (NRS, 0-10) Mean (SD)  5.43 (2.1) 
Function (FIHOA, 0-30) Mean (SD) 7.7 (4.68)  
EQ-5D-3L dimension  Mobility problem (%) 
Self-care problem (%) 
Usual activity problem (%) 
Pain/discomfort problem (%) 






EQ-5D (VAS, 0-100) Mean (SD) 76.37 (14.83) 
CMC,carpometacarpal joint; NSAIDs, non-steroidal anti-inflammatories; NRS, numeric rating 
scale; FIHOA, Functional Index for Hand Osteoarthritis; EQ-5D-3L, EuroQuol 5-Dimension, 3-
Level; VAS, visual analogue scale.  







Of note, several participants, both female and male, expressed offense at the gendered 
nature of question 7 of the FIHOA questionnaire: “For women: can you sew? For men: 
can you use a screwdriver?”. Those with a history suggestive of thumb CMC OA, that is, 
who had not yet sought care and had no clinician diagnosis made up 20% of 
participants.   
All participants completed the daily diaries, some with just a few words on each day and 
some filling up to 3 pages (each day); completing the diaries was acceptable to all 
participants. All participants indicated that they found involvement in the study to be a 
positive experience and the interviews to be acceptable.  
3.4.1  Thematic analysis 
Five main themes representing five inter-related levels of health impact were identified: 
negative experience of symptoms, functional limitations, restrictions in social activities 
and roles, negative thoughts and feelings, and altered sense of self (Figure 3.2). Themes 
and sub-themes along with exemplary quotes are given in Table 3.3. No new themes or 
sub-themes were identified in the final three sets of interview data.  
The two themes ‘symptom status’ and ‘functional limitations’ matched corresponding 
levels of the Health Impact Model, while the remaining three themes aligned to the 
Model levels of ‘General Health Perceptions’ and ‘Overall Quality of Life’. The impact at 
each level was found to be influenced by personal and environmental factors.  
Participant quotes within the text are given italics for clarity.  
3.4.1.1 Symptom status 
Participants described symptoms of pain, loss of dexterity, weakness, and stiffness. For 
nearly two-thirds of participants, pain was considered the biggest impact. The most 
common pain descriptors were ‘dull ache’, followed closely by ‘sharp’ or ‘knife-like’; less 
common but still frequent were ‘shooting’, ‘stinging’, and ‘spasm’. Few participants 
described the pain as ‘burning’, ‘throb’ or ‘crunching’. Pain intensity was often moderate 
to high and in some cases unbearable, causing participants to “change what I'm doing or 






Figure 3.2 The 5 main themes representing 5 interrelated levels of health impact are aligned to the 







Predictability of pain varied with some participants reporting they “knew what they 
were in for” (Neil, 70 yr) while others reported that pain experiences were quite 
random. Pain was variably reported as both constant and intermittent, or sudden, onset, 
with constancy most often given as the worst thing about the pain. Delayed onset pain 
was common; pain at night was a problem for two thirds of participants.  
Weakness and loss of grip and dexterity were the biggest impact for around one third of 
participants and bothered most participants to some degree. Clumsiness and trouble 
manipulating small things were often associated with pain.  
Limited power grip was associated with pain, stiffness, and perceived weakness 
particularly with heavy lifting. Many participants had problems with torsional grip 
(gripping to turn) and wide grasp. Stiffness, either in the first web span or the whole 
thumb digit bothered just under half of the participants and contributed to problems 
with both fine and gross grips.  
3.4.1.2 Functional limitations 
Participants reported significant impact on their ability to carry out everyday tasks and 
self-care, on sleep, and increased time taken to do things. Difficulty undoing lids and 
dropping things were ubiquitous problems. Opening a variety of containers was 
problematic, including plastic packets, flip lids, and seals on milk bottles; child-proof 
lids caused particular difficulty.  
Driving was a problem for half of the participants, “Especially in the new cars with the 
bigger, thicker steering wheels” (Tracy, 65 yr), also turning the key, operating seat belts 
and buckles, opening and closing doors, and changing gear (manual and automatic). One 
participant reported difficulty controlling the vehicle because her hand “just completely 
froze up” (Marie, 50 yr). 
Holding a media device or book was uncomfortable but texting on a cell phone was not. 
For those who used computers, mouse use was more taxing than the keyboard. Writing 





Tasks involving impact or vibration were limited, for example, using an axe and carrying 
heavy items such as the coal bucket or firewood. Operating tools including secateurs 
frequently caused problems as did turning taps and doorknobs, holding a cup, using 
scissors, cutting with a knife, peeling vegetables, using a whisk, holding dishes to wash 
or dry, vacuuming, and ironing.  
Dressing, particularly trousers and socks, doing up buttons and bras, and tying 
shoelaces were the most frequently mentioned personal care tasks causing problems. 
Other tasks included showering, doing hair, putting on jewellery, cleaning teeth, 
shaving, and wiping one’s bottom.  
3.4.1.3 Restrictions in social activities and roles 
Participants described restrictions in social and recreational activities, and restrictions 
in their life roles including family and work.  
Commonly restricted physical activities were bike riding, going to the gym, and walking 
the dog. Pulling on tight clothing was a limiting factor in the gym and swimming. 
Problems were also reported with golf, tennis, paddling, and hiking, for example, lifting 
a pack. Kapa haka (cultural dance) was limited because of pain on performing the wiri 
(rapid hand motion). Similarly, flicking the hand, such as to shake off water, and 
clapping were painful. Gardening was an activity in which over half the participants 
experienced difficulties. 
Around one quarter of participants had difficulty in or had stopped their arts and crafts, 
including painting, jewellery making, crochet, knitting, and spinning. A smaller group 
were similarly impacted in playing musical instruments. Woodwork, photography, 
sewing, both machine and hand, playing cards and playing computer games were also 
limited. 
Participants described limitations in fulfilling roles in the home, family and community 
including caring for children and grandchildren. Just over half of the participants said 
they were limited in their current, prospective or previous paid or voluntary work roles 
or study because of their thumb CMC OA. Some had to take frequent time off; for several 





3.4.1.4 Negative thoughts and feelings 
Participants expressed negative thoughts and feelings associated with the impact of 
their thumb problem, including loss of confidence in their hand or hands, frustration 
with their functional limitations, anger about the pain and restrictions in everyday roles 
and activities, worry about what was happening in their thumb, and concern about the 
future. Loss of confidence was associated with a tendency to drop things and often 
resulted in avoidance behaviour. Feelings of frustration were closely linked to the pain 
and to the activities of everyday living becoming time-consuming and less enjoyable. 
The negative feelings contributed to negative mood which impacted on family and those 
close to them. Concern about the future arose due to difficulty or pain with activities of 
independent daily living. The importance of thumb function was summed up by one 
participant who lived alone: “My thumb is the captain of the ship” (Paula, 80 yr).  
Participants described the mental burden of always being aware of their thumb – an   
enforced vigilance required to respect functional limitations and manage pain – “self-
preservation” as one participant put it. Many participants were concerned about the 
impact of taking medications on their general health or other health conditions, and on 
their mental state. For the most part, participants were not bothered by the appearance 
of their thumb or hand.  
3.4.1.5 Altered sense of self 
Participants described an altered sense of self, relating how they perceived thumb CMC 
OA as a marker of aging, and in responding to the restrictions placed on them in 
fulfilling their important life roles.  
Some participants described being “dispirited” because of the pain, frustration, and 
seeming lack of options. On the other hand, some individuals had rationalised their 
problems and saw it as part of getting older, or relatively mild compared to other health 





Table 3.3 Themes, sub-themes and exemplary quotes relating to the impact of thumb carpometacarpal osteoarthritis 
Theme 1: Symptom status  
Pain Louise, 52 yr “I think when it's, when I've got a lot of it, the fact that it never goes away. That it's always 
sitting there in the background… Once, it stopped sort of self-healing in the days I wasn't working, it was 
there constantly. Everything that I did caused pain, whether it was turning on a tap, or picking up the kettle, 
or even patting the cat. So, it was just the constancy of it.” 
Stuart, 66 yr “ … just a little less pain, and I would actually find that I would use my thumb more.” 
Loss of dexterity and 
fine (pincer) grip 
Fabian, 62 yr “See um I'm a clock maker by trade, so all my ah, work is done with fingertips and things, so 
you're pinching, holding, squeezing all the time, tools, whatever you're working on. You know, so, having 
something like that is an absolute pain...” 
Loss of power- and 
torsional grip 
Arthur, 89 yr “I didn’t realise I’d lost my grip. I used to have a very strong grip… And then I found that when I 
clench my fist like that, it gets, it’s quite painful in there [base of thumb]”  
Inability to grip wide 
objects 
Craig, 69 yr “That wide, wide grasp, yeah, is... grabbing things like turf and trying to pull, like that. I just 
haven't got the strength to do it.” 
Stiffness Joanne, 46 yr “I can’t write for as long as I used to because it gets too sore and stiff and my handwriting gets 
worse and worse…”  
Lauren, 74 yr “The span's limited… which stops you playing the piano.”  
Theme 2: Functional limitations 
Limited in everyday 
activities  
 
Tracy, 65 yr “Every single day my thumb problem impacts on my daily life: biking, driving, twisting tops off 
jars/bottles, sewing, pincer action between thumb and forefinger, knitting and crocheting, gardening, 
cleaning, wringing out cloths, housework in general (making beds is difficult).”  
Fabian, 62 yr “That's a bloody nuisance, that is [driving]”  
Dropping things Fiona, 65 yr “I'd be quite happy if there was no pain, but I would be happier if I knew I wasn't going to drop 
stuff if I picked it up… I'll drop plates, I'll drop ah, jars, anything that before I would feel… but now my grip is 





Takes longer to do 
things 
Lauren, 74 yr “…showering has become more difficult, because your hands just won't do what you want 
them to do. And I'm longer in the shower, and I'm trying to be quick because I'm in other people's homes. So 
that, that is a stress actually. Trying to get through that, ah, quickly.” 




and fulfilling family 
roles 
Moira, 63 yr “…it's taken away my enjoyment of gardening. I used to love that but it's quite hard, now, with 
both hands like that. Because I can't… pull out the roots (laughs). You know, I'll often break it off... so I just 
have to garden a bit differently… do it in smaller amounts.” 
Kate, 48 yr “…the biggest impact I think it has on me, is not being able to do stuff. I'd like to be able to go out 
bike riding with her [primary school age daughter] but, brakes, gears... We've got our bikes in the garage… I 
bought a colouring book cause she [daughter] likes, she loves her arty stuff. I bought an adult's colouring 
book for me and one for her... I can't even sit down and do that with her.” 
Marie, 50 yr “Yeah, kapa haka definitely, it's a huge part of my life and it's... I can still do it but I can't, I could 
never compete again or anything like that… Because I can't sustain that [wiri] with my hand.” 
Jennifer, 64 yr “Well it's me! I've been a pianist since I was eight years old. And I love it, and I feel cut off from 
it… the thumb is a big deal in playing.”  
Adele, 78 yr “It's, um, an inability to do things I could do in the past, because I am, I am a practical person. I 
do a lot of handcraft, and I had to reduce that activity, fairly drastically. So you just, you just have to give it 
up... that's past.”  
Aaron, 74 yr “[she]… loves having foot massages and shoulder massages. And, I enjoy giving them to her. 
Jesus, it's painful! When she gets home eleven o'clock at night, really sore shoulders… Yes I can... it really 
stings!... really annoying that I can't do that without discomfort.”  
Lauren, 74 yr “You find they [grandchildren] don't really understand. How could they? So, and you don't like 
saying, "No no no no, my thumbs are too sore for that".  
Moira, 63 yr “…my two-year-old grandson… I really struggle to pick him up, and because you have to spread 
around, you know, at their waist and lift them that way, and that's a really painful thing to do,... the other 
thing I find really difficult is his harnesses, you know like in the pushchair and in the car seat… You know, 
squashing, pushing.” 
Restricted in work roles  Susan, 59 yr “Just the writing really and shaking people's hands, that hurts… I sort of try and avoid that, well 





Kate, 48 yr “Some days I have taken days off because I've been too sore… I can't slow down, and take my 
time.”  
Amelia, 66 yr “… I've been retired for four years… I did relieving [childcare] until this year and I found that I 
couldn't lift the kids the same… I used to do nappies and whatever was going... But I can't now… just lifting 
the kids was just too much.” 
Theme 4: Negative thoughts and feelings 
Lost confidence in hand 
 
Fabian, 62 yr “I just don't trust my left at all. I know my left hand, ah will fall open without even me knowing, 
knowing what's happened... The last thing I dropped was five kilos of oranges in the gateway. And guess 
where half them went! (laughs)”  
Charles, 76 yr “I wouldn't risk lifting a big heavy pot or, with a handle in my left hand. So I've gotta make 
sure I use my right hand for those. Anything that… involves sort of strength I've, I've learnt to, avoid.”  
Frustration Joanne, 46 yr “It’s frustrating not being able to accomplish as much as I’d like to some days, but I’d rather not 
make my condition worse, so I try to rest it and not over use it as much as possible.”  
Aaron, 74 yr “Just, frustration as much as anything else… it's bloody annoying at times…”  
Anger Paula, 80 yr “Oh, I just get angry at it I think. "Bugger old age", really. That's to be honest. You know, I just 
say, you know, "Bugger this!". I'm really, "Brassed off!" at it. Um, yes I am. Quite angry with it because you... 
you use this [thumb] all the time.”  
Robert, 56 yr “And that's the irritating thing… that's when yeah I start getting grumpy and then I just 
disappear out the family's way, because I'm a nasty swine. I don't intend to be and they say they understand 
it, but that's not the point.”  
Worry Earle, 66 yr “Um, just the fact that it's there. Um, and I know that it means that something’s degrading.”  
Concern about the 
future 
Moira, 63 yr “…when I first got diagnosed with it… I immediately thought, "Right, gosh I'll have to shift 
house, you know, I obviously won't be able to manage on my own in this house."... You know it really upset 
me and depressed me, you know, for a while, because I was then having to go over in my mind, "Oh, I won't 
be able to do that, and that... And I'd planned in retirement, and oh I won't be able to do that!".  
Robert, 56 yr “I'm only 56, I'm not old, and these [thumbs]… will get worse as time goes on, cause age will 
make them worse, the wear will get worse, the bones, well most of it... I want to prolong that distance in 





James, 32 yr “Ahh, it troubles me... you know my livelihood depends on my fingers as well… because I know 
that I'm not super young, but at the same time I'm not, you know seventy or something. So I need to know 
what's going on so I can… address them and manage them.”  
Mental burden Fiona, 65 yr “It's impacting on how I would normally live my life, I have to be more aware of what I'm going 
to do…” 
Fabian, 62 yr “…you just gotta be aware of it, you just gotta have it in your mind all the time.”  
Medication burden Amelia, 66 yr “Normally I'll just try and have two Codeine through the day and then two when I go to sleep, 
at night. Some days it's really, really quite bad. But I try to stick to that because I don't wanna have too 
much… I'm on heart pills and other pills as well.”  
Kate, 48 yr “I've been put on Gabapentin. I… used to be on Tramadol and Codeine and all of that. I took 
myself off them because... it's got addictive tendencies and in my family there is addictive tendencies and I 
didn't want to get hooked on it… I don't want to be doped up driving round with her [primary school-age 
daughter] in the car or... anything like that.” 
Theme 4(i): Not concerned about appearance 
Sarah, 73 yr “Well, I've noticed, yeah, you know if compared to this one there's a lot more knobbly bits. But, it doesn't bother me, no.”  
Aaron, 74 yr “No, couldn't care less. When you get to my age everything looks different.” 
Hilary, 59 yr “… so long as there's no pain I don't care what it looks like.” (laughs) 
Theme 5: Altered sense of self 
Marker of ageing Fiona, 65 yr “It is tied up with me getting older, I think. It’s more than just the pain, it’s the notification that 
I'm starting to get to be an older person… it’s a kind of a holistic thing… it's the whole identity of myself… I'm 
turning into an older person.”  
Dispirited Hilary, 59 yr “… I'm not prone to depression, but it's quite depressing when you know that it's not going to 
go away and there's nothing you can really do except stop everything you're doing, which isn't an option.” 
Robert, 56 yr “The actual thing that gets rid of the pain better than anything, or makes me notice it less, is 
alcohol, which is not a good thing… Then I know if I want to go to sleep I actually need a couple of decent 





3.4.1.6 Personal and environmental factors 
Personal and environmental factors significantly influenced how thumb CMC OA 
impacted on each participant. Influencing factors along with exemplary quotes are given 
in Table 3.4.  
Availability of support – family, friends, or paid home help – played a significant role in 
reducing the impact of the condition. Conversely, having no help increased the impact 
although some participants took the ‘use it or lose it’ approach. Cold weather worsened 
the problem.  
Self-efficacy, evident as ingenuity in problem solving often alleviated the impact, “You 
just gotta think of different ways to skin the cat that's all” (Fabian, 62 yr). Many 
participants took a proactive approach to the care of their thumb or thumbs with  
self-help modalities including massage, heat – including warm gloves – rest , topical 
creams, exercises and stretches, and simply avoiding painful tasks. Carrying on because 
the task needed to be completed and ignoring the pain or difficulty, was another way in 
which many participants demonstrated self-efficacy. Involvement of the dominant hand 
compounded the problem.  
For some, impact was perceived as less where other health conditions or life 
circumstances took priority or medication for other conditions masked the problem, 
while for others, life events exacerbated their thumb CMC OA symptoms. For a small 
number, religious faith played a role in keeping well in the face of their thumb problems.  
In some cases, participants did not seek care because either they had rationalised their 
problem as part of ageing or their health provider held this view and dismissed the 
problem. Accessing health care made a difference for several participants. However, 
access to care was sometimes limited by cost or distance from health services, or both, 
as was access to adaptive equipment and devices. Participants were motivated to access 
healthcare when their pain became unbearable or limited them in their most important 
activities or roles. While pain relief medication was often effective in managing pain, 
most participants were eager for non-pharmacological interventions. However, nearly 
all participants had found it hard to come by information about the condition and self-





Table 3.4 Themes and exemplary quotes relating to factors influencing the impact of thumb carpometacarpal osteoarthritis 
Personal factors: 
Self-efficacy  Neil, 70 yr “It doesn't impact on me at all because I've got that used to compensating, um that, it's just like 
favouring a sore, sore ankle if you had a sprain. You'll favour it till it comes right. I favour this to the extent 
that I don't get the pain.” 
Charles, 76 yr “…to hold the bottles… sometimes I have to go and put them in the vice.”  
Fiona, 65 yr “…we cannot undo cans, or you know screw things, that's when we had to use the pipe-wrench 
(laughs).” 
Jennifer, 64 yr “…peeling things… That's quite tricky. Now I just do as they say and just wash the carrots off 
and stick them straight in the oven.” 
Kate, 48 yr “I tend to steer clear of buttons. I've got ah like, trackies... very rarely do I wear a pair of jeans 
that's got a button on it.”  
Sarah, 73 yr “I was cleaning toilets at work, and it needed a new Janola thing… couldn't open it, couldn't find 
a pair of pliers, so I put it on the floor and put my foot on it, then gave it a twist and it worked.”  
Robert, 56 yr “I like making pastry, I'm buggered if I'm not going to make it just cause they hurt, I've got to 
find a way of doing it.” 
Tracy, 65 yr “If we do a long bike ride I think, "Ohh" and it's getting really sore. But, you just do it!... Nothing 
changes really, you just... you adjust.” 
Carry-on – use it or lose 
it approach 
Clare, 65 yr “Tops off bottles and that… I try not to give in and ask my husband because I know it's a strength 
thing you don't want to lose.”  
Sarah, 73 yr “I tackle anything and everything… As long as I can do things myself I'll do it myself. I realise 
there'll be a time that I'll need to ask for help. But in the meantime, I'm still doing it.”  
Dominant hand not 
involved 
Marie, 50 yr “I’m actually glad it’s my left hand as I wouldn’t be able to do my job if it was the right.”  
Charles, 76 yr “… it would actually affect my life, really affect my life and what I can do. But because it's in the 





Role of other health 
conditions and life 
events  
Marie, 50 yr “Since then I have been dealing with other medical issues (I have COPD [chronic obstructive 
pulmonary disease]) and my hand has been an annoyance as opposed to an issue so I tend to ignore it – until 
it flares up like this week.”  
Celia, 71 yr “I'm coping with... I've broken two ankles in three years, and I'm having a lot of pain with that. So 
this is nothing.”  
Lauren, 74 yr “My focus in the last two years has just been survival. Just learning to live um, without your 
home, and everything you've got is in storage. And also I've struggled with other aspects of my health… apart 
from my thumb.” 
Paula, 80 yr “Sometimes… if I'm going to bed and it's later at night I won't take Panadol… if I think I don't 
need it for my knee, and that's when I notice, that's really very bad [base of thumb].”  
Amelia, 66 yr “…[son-in-law] come around… came to say he is going on the fishing boat tomorrow. Their 
baby is two weeks old. I am very stressed. My thumb started to ache. [Son-in-law] could be away for three 
months.”  
Faith Jennifer, 64 yr “I'm faithful and I believe that I'm given nothing to cope with that I won't be able to cope with. 
But, it does really get to me sometimes.” 
Beliefs about ageing  Tracy, 65 yr “You just get on and do what you got to do… you just take it as you get older, you think, you 
know your joints are seizing up a bit.” 
Charles, 76 yr “Nowadays it’s something I can live with quite successfully… in old age, always something gets 
sore.” 
Lauren, 74 yr “I feel quite grateful that I’m 74 and I’m not crippled with arthritis in other joints, so… this is 
manageable.” 
Motivation to access 
health services 
Robert, 56 yr “And then it gets to the point, after 8, 9 months, when it's just unbearable and you don't get any 
break, and that's when I go back and get the injection in it.” 
Fabian, 62 yr “If that played up with my sport [shooting], I'd be going… somewhere pretty rapidly.”  
Sarah, 73 yr “If I had mentioned this to my GP two years ago, or three years ago, I probably would have been 
into the system a lot earlier. But, I didn't put much problem with it. I thought, "Nah, it's just the garden and 








Moira, 63 yr “Good team work… I'm managing quite well at work… my job's mainly hand work. But, I'm 
hoping I'll be able to keep going…” 
Clare, 65 yr “The worst thing… was putting in earrings… my husband's retired and I'm working so he does 
most of it…(laughs) lets me off the hook.”  
Lauren, 74 yr “Gardening became more difficult… I got some help from WINZ to pay for 2 hours help once a 
fortnight.”  
Louise, 52 yr “There is some stress in it because I know that I've still got to do... I live alone and I've still got 
to do the housework and I've still got to do the gardening and change the beds and all that and it doesn't 
matter whether my hand hurts or not. I don't have a choice in the matter.” 
Weather 
Tracy, 65 yr “…cold frosty days it seems to be worse. Sometimes when it's raining it seems to be worse. Go to 
Australia and I don't get any pain.”  
Access to health services 
Sarah, 73 yr “Previous to the support [splint], that was painful out in the garden. With the support I've got no 
trouble, it's great. When I take the support off, it's painful. But only for a wee short while, not for long.”  
Robert, 56 yr “The night supports were, marvelous. When I first got those, I had a night's sleep! And that was 
fabulous. It mightn't seem much but… you're just looking for incremental improvement. I'm not expecting, 
"Boom, I'm cured"… I can mitigate the ache if I get the painkillers in… if I've been up for more than two hours 
and haven't taken them, I'm going to have problems for the day.”  
Susan, 59 yr “I had that one X-rayed but it wasn't as bad... But you see it's dropped completely and even the 
GP said herself she was going to hurry them up... enquired into seeing a hand specialist but… he, she or 
whatever didn't think it was warranted… otherwise I have to pay to see them. This is on the public system. 
Something like $400 or something or other to go and see this person [private hand therapist].” 
Access to health 
information 
Adele, 78 yr “Well, if I can give things a name, I can control it better… it helps me, um, to know, this is what's 
wrong, it's got a name, instead of being... uncertain about things.” 
Marie, 50 yr “And then I got anti-inflammatories once off the doctor but then I didn't actually... I don't like 
taking pills… so is there other stuff I can be doing or is this just a part of getting old?... should I be using those 





Aaron, 74 yr “I said to the doctor, "I've got something wrong with my thumb, it's this, and this is how it 
affects me", and he said, "Oh, yeah, that'll be um arthritis. Here's your prescription for your blood pressure... 
See you later." So I thought, "Oh yeah, tough!" (laughs)” 






This study provides new insights into patient perspectives of thumb CMC OA as a 
unique disease entity and the impact of a hand OA condition. Five key inter-related 
levels of impact were identified. Also identified were personal and environmental 
factors that influence the impact of thumb CMC OA, some of which are modifiable.  
Key concerns important to participants were constant pain and pain that interrupts 
sleep; limited performance of power grip and precision tasks; and limited participation 
in work, caregiving, recreational and physical activities, and ADLs. Negative thoughts 
and feelings included frustration, anger, worry, concern about the future and the burden 
of medication. An altered sense of self was related to ageing. Impact was greater where 
the dominant hand was involved. 
The impact of pain was associated with impact at all levels and a major concern for 
participants, similar to previous findings in general hand (MacDermid, 2008; Siviero et 
al., 2016) and hip and knee OA (Hawker et al., 2008; Zambon et al., 2016). As with 
previous hand OA findings (Marshall et al., 2009), constant aching pain was of greater 
concern to participants in the current study, in contrast to large joint OA where intense, 
unpredictable pain has been found to be more distressing (Hawker et al., 2008).   
Hand weakness was frequently described in this study, also matching previous findings 
in hand OA (Lee et al., 2012; MacDermid, 2008; Zhang, 2002). The pain commonly 
accompanying weakness and loss of dexterity suggests these symptoms are closely 
linked.  
This study reported limitations in a wide variety of functional activities and life roles 
similar to previous hand OA studies (Bijsterbosch, Haugen, et al., 2011; Bromann 
Bukhave et al., 2014; Calfee et al., 2015; Dziedzic et al., 2007; Leung, Li, & Thumboo, 
2017; Leung et al., 2015; Slatkowsky-Christensen et al., 2010; Slatkowsky-Christensen, 
Mowinckel, Loge, & Kvien, 2007; Spacek et al., 2004; Stamm et al., 2009; Zhang, 2002), 
but several differences were evident. Whereas cell phone use has been raised as a 
concern in general hand OA (Stamm et al., 2009), this was not an issue for participants 





were ‘one-finger texters’. Furthermore, impact relating to computer use was specific to 
the computer mouse.  
Although manual tasks were a primary concern for participants in the current study, 
there was also a pattern of reduced general physical activity due to limited hand 
function. A previous study of patients with hand OA found reduced levels of lower limb 
as well as upper limb functioning (Moe et al., 2013) and their suggestion that hand OA 
impairments may contribute to reduced levels of general activity is supported by this 
study’s findings.  
The mental and emotional impact identified in this study concurs with previous studies 
in thumb CMC (Calfee et al., 2015), hand (Hill et al., 2010; Leung et al., 2015; Moe et al., 
2013; Stamm et al., 2009), and general OA (Baird, 2000; Gignac et al., 2006; Harris, 
Byles, Sibbritt, & Loxton, 2015; Rosemann et al., 2006). However, aesthetic appearance, 
previously identified as an area of impact in hand OA (Dziedzic et al., 2007; Hill et al., 
2010; Hodkinson, Maheu, Michon, Carrat, & Berenbaum, 2012; Leung et al., 2017; Leung 
et al., 2015; Stamm et al., 2009), was not a major concern in the present study. It may be 
that the interphalangeal joints (IPJs) are more visible or prone to disfigurement and 
that pain and function are bigger concerns when the thumb CMC is involved, or that 
aesthetic comfort is not a priority for people in the southern parts of New Zealand. In 
contrast to previous authors (Hill et al., 2010), the current study found no 
embarrassment due to disability, only high levels of frustration and anger.  
Participants experienced a negative impact on their sense of self, linked to the 
perception that their thumb CMC OA was a marker of ageing. This may be related to a 
view previously reported in a cohort of older people in the United Kingdom, that one’s 
dignity is jeopardised by ageing  (Woolhead, Calnan, Dieppe, & Tadd, 2004). Negative 
perceptions of OA as an indicator of ageing have previously been described in general 
OA populations, with OA symptoms similarly often minimised or ignored by health 
workers, and those with the condition themselves, resulting for example in postponing 





As in the current study, environmental support and strategies to continue performing 
valued activities have previously been identified as important influencing factors in the 
impact of OA generally (Bromann Bukhave et al., 2014; Gooberman-Hill et al., 2007; Hill 
et al., 2010). In addition to pain and functional limitations, potential targets for 
intervention identified in this study are beliefs about ageing; financial and other 
barriers to accessing services; understanding about the condition and interventions that 
may halt progression and enable function; and emotional impact. The presence of other 
health conditions was also identified as a barrier to accessing care for thumb CMC OA. 
Whereas maintaining physical activity helps control comorbid conditions such as heart 
disease or diabetes untreated thumb CMC OA may contribute to overall decline in 
activity levels and, consequently, health status. 
The fact that a substantial number of those who would benefit do not access health care 
has recently been confirmed in thumb CMC OA (Gravas et al., 2019) and previously in 
hand (Dziedzic et al., 2007) and general OA (Gignac et al., 2006) studies. The findings of 
previous studies that there is a need to dispel the belief of both patients and clinicians 
that OA problems are an inevitable part of ageing (Dziedzic et al., 2007; Harris et al., 
2015) is endorsed by the work of the current findings. The development of a conceptual 
model of thumb CMC OA that enables people to understand what is happening and how 
they can influence it would be extremely helpful.  
Education and access to information is a core guideline recommendation (NICE, 2014) 
but the findings of the present study and those of a previous study in hand OA (Hill et 
al., 2011) indicate that neither education nor information are readily available. In hand 
OA this unmet need has been linked to clinical uncertainty and a lack of high-quality 
evidence for therapeutic options (Hill et al., 2011). Earlier access to evidence-based 
information, advice, and non-pharmacological and non-surgical interventions in 
primary care or via public information platforms and agencies would help address this 
need (Gravas et al., 2019).  
Several functional limitations identified in this study, as well as impact at other levels 






Table 3.5 Items from OARSI-recommended outcome instruments (AUSCAN and FIHOA) and the 
impact of thumb carpometacarpal osteoarthritis from this study not included in these instruments.  
AUSCAN FIHOA Impact not included  
Pain subscale 1. Can you turn a key 
in a lock? 
2. Can you cut meat 
with a knife? 
3. Can you cut fabric 
or paper with a pair 
of scissors? 
4. Can you lift a full 
bottle with your 
hand? 
5. Can you make a fist 
completely? 
6. Can you tie a knot? 
7. For women: can 
you sew? For men: 
can you use a 
screwdriver? 
8. Can you button up 
a garment? 
6. Can you write for a 
long time (without 
interruption)? 
10. Do you accept to 
shake hands without 
reservation? 
Functional limitations 







Time tasks take to do 
Vibration or impact tasks 
Holding media devices 
Sleep interruption 
Household tasks 
Stiffness subscale Negative thoughts and feelings 
6. After first wakening in the 
morning  
Mental and emotional impact 
Medication burden 
Physical function subscale Restrictions in social activities 
and roles 
7. Turning taps/faucets on 
8. Turning a round doorknob or 
handle 
9. Doing up buttons 
10. Fastening jewellery 
11. Opening a new jar 
12. Carrying a full pot with one 
hand 
13. Peeling vegetables/ fruits 
14. Picking up large heavy objects 
15. Wringing out wash cloths 
 




Negative impact on sense of self 
 Negative indicator of ageing 
 
Development of measurement tools that better capture both the specific and broader 
impact of thumb CMC OA is needed. The empirical evidence gathered in the present 
study can be used as the basis of a conceptual framework to underpin the development 
of valid patient-reported outcomes for thumb CMC OA.  
For treatment to be patient-centred it is important to consider the impact of health 
conditions in different cultural contexts (Napier et al., 2014). The present study 
contributes new information from the New Zealand context that will broaden and 
diversify knowledge about the specific needs of people with thumb CMC OA globally. 
Although some of the findings may relate to the local culture and environment in which 





elsewhere with differences reflecting the specific focus on thumb CMC OA versus hand 
or large joint OA. Most participants in the current study were New Zealanders of 
European descent many of whose social circumstances are not dissimilar to people 
living in Western European countries. Therefore, findings will have relevance for people 
with this diagnosis generally.   
3.5.1 Strengths and weaknesses 
A strength of this study is the use of qualitative methods to yield rich and varied data. 
The explanatory nature of findings is useful since, in the case of patient’s perspectives of 
thumb CMC OA, little is known about which variables are important to examine, and 
what factors influence outcomes in studies investigating interventions for this 
condition. Furthermore, the use of solicited diaries helped to engage participants with 
self-observation in their everyday life and contributed to richer interview data by the 
thoughtfulness and attention participants gave to compiling them.  
The inclusion of participants who had not sought care is a second strength of this study 
and supports knowledge generation that includes those who access health services less 
often. The recruitment rate of participants of Māori descent (10%) was modest, 
exceeding the proportion of population in the primary centre (6.2%), but not that in the 
second centre (13.3%) or nationally (16.5%) (Statistics New Zealand, 2013).  
This study has some potential weaknesses. First, inclusion criteria were based on self-
report of either clinician diagnosis or a history suggestive of thumb CMC OA and did not 
include radiographic confirmation. However, a thorough screening process by a trained 
research assistant and the application of inclusion criteria by an experienced 
physiotherapist and hand therapist gives reasonable certainty that participants were 
symptomatic for thumb CMC OA. The low mean FIHOA score of participants in the 
current study could suggest relatively low severity of thumb CMC OA disease. However, 
the mean pain score and disease duration are comparable to those in a previous large 
qualitative study of hip and knee OA (Hawker et al., 2008). Low FIHOA scores may 
instead reflect poor validity of the outcome measure for thumb CMC OA, or alternatively 
an attitude of stoicism leading to a greater reluctance to reporting problems. This has 





(Cornally & McCarthy, 2011). It may also be a local cultural difference with a similar 
general OA cohort from the southern parts of New Zealand recording significantly lower 
functional disability on the Health Assessment Questionnaire (HAQ) than counterparts 
in Birmingham in the United Kingdom (Treharne et al., 2008).  
It may be that findings of the present study are influenced by the experience and impact 
of OA at joints other than the thumb CMC. Although involvement of IPJs is known to 
exacerbate impact in the presence of thumb CMC OA (Gravas et al., 2019), only a small 
number of participants in the current study reported involvement of other hand joints 
and the interview schedule guided participants to focus on the impact relating 
specifically to their thumb CMC OA. Therefore, there can be confidence that the findings 
of the present study substantially reflect the impact of thumb CMC OA rather than that 
of other joints, including IPJs, although it is accepted that some impact is shared.  
3.6 Conclusion 
The present study indicates that thumb CMC OA, as a unique disease entity, has a 
significant impact, largely associated with the impact of pain, on many aspects of a 
person’s health and well-being. Key areas of impact were identified which may serve as 
important treatment targets and assessment outcomes. An important novel finding was 
the common reporting of pain at night. There is a need for clinical practice and research 
to account for hand dominance; cold climate; people’s financial, family and community 
resources; and attitudes to thumb CMC OA. A current gap which needs to be addressed 
is the availability and provision of high-quality information about self-management and 
effective treatments. Development of a thumb CMC OA-specific instrument relevant to 
contemporary modes of living is also indicated. These findings from the New Zealand 
context hold relevance for populations with thumb CMC OA generally. 
3.7 Implications for the related studies in the thesis 
• People with thumb CMC OA desire better access to non-pharmacological and 
non-surgical interventions. In this regard, splinting may be an acceptable 
intervention for patients and study participants.  
• People with thumb CMC OA desire access to good information about the 





management and joint care principles are core recommendations for managing 
hand OA and thumb CMC OA and should be available to all people with the 
condition. Good quality education and advice should form part of the 
standardised best practice usual care in an intervention study and is likely to be 
acceptable to participants.  
• Pain at night should be included as an outcome measure in intervention studies 
for thumb CMC OA 
• The FIHOA poorly reflects the impact of thumb CMC for people in contemporary 
society. Alternative functional outcome measures need to be explored and 
developed. A list of 10 additional functional items tabled in the current study 
could be trialled in an intervention study. However, although indicated, the 
development of a new, thumb CMC OA specific instrument is outside the scope of 
this thesis. 
• Quality of life is a mandatory outcome measure for studies investigating 
treatment effectiveness in thumb CMC OA, particularly given the broader impact 
of the condition identified in the current study. 
• Impact is greater where the dominant hand is involved. Therefore, a feasibility 
study for a comparative intervention trial should stratify randomisation by hand 
dominance as differences in this variable between groups at baseline could cause 
confounding in clinical outcomes particularly in a small study. 
The findings of the present study support splint interventions as the focus of a 
systematic review in Chapter 4 and will inform the design of a feasibility study for a 






Effectiveness of splinting for pain, function, and quality of life in 
people with thumb CMC OA: A systematic review with meta-
analysis 
4.1 Introduction 
As outlined in Chapter 1, a diverse range of treatments is suggested to manage thumb 
CMC OA. However, there remains a paucity of evidence for non-surgical,  
non-pharmacological interventions, including splinting (Hochberg et al., 2012; NICE, 
2014). Interventions that target biomechanical factors in thumb CMC OA are indicated 
by the anatomical and aetiological literature reviewed in Chapter 2. Moreover, people 
with thumb CMC OA desire easily accessible non-pharmacological and non-surgical 
treatments, as voiced by participants in the study in the previous chapter. Splinting is 
one such intervention which may be well placed to address the biomedical problem of 
thumb CMC OA and to achieve outcomes important to patients, i.e. reduced need for 
medication and surgery and improvements in pain, function, participation in life roles, 
and overall well-being. Further investigation of the effectiveness of splinting for thumb 
CMC OA is therefore warranted.  
Systematic review of the literature supports decision-making in evidence-based 
practice and clinical research by providing a current, comprehensive understanding of 
the knowledge of a topic and identifying research gaps (Moher, Liberati, Tetzlaff, 
Altman, & Grp, 2009; Portney, 2015). Systematic review entails rigorous searching, 
appraising, and summarising of existing evidence in a way that is trustworthy and 
reproducible and makes clear the strengths and limitations of the body of evidence 
(Moher et al., 2009; Portney, 2015). This chapter reports a systematic review of studies 
which have previously investigated the effectiveness of splinting for improving pain, 
function, and quality of life in people with thumb CMC OA. The purpose of this chapter is 
two-fold. Firstly to examine the state of the existing literature, hence addressing the 
second thesis aim: to investigate the effectiveness of orthotic (splinting) interventions 





design, and to review outcome measures and study design needed to inform a future 
study to evaluate the comparative effectiveness of splinting to manage thumb CMC OA.  
The first background section of this chapter provides an operational definition for splint 
interventions, outlines knowledge of their mechanism of effect, and examines previous 
systematic reviews on the topic to situate the aims of the present review. The second 
and third sections report the methods and results respectively. In the final section, 
findings are discussed in relation to previous literature and conclusions drawn for 
clinical practice and research including implications for the design of the feasibility 
study reported in Chapter 5.  
4.2 Background 
4.2.1 Splinting for thumb CMC OA – an operational definition 
A splint or orthotic device is defined by the Australian Orthotic Prosthetic Association 
as:  
“…an externally applied device that is designed and fitted to the body to achieve 
one or more of the following goals: control biomechanical alignment, correct or 
accommodate deformity, protect and support an injury, assist rehabilitation, 
reduce pain, increase mobility, increase independence.” (Australian Orthotic 
Prosthetic Association, 2020)   
An orthotic device, or splint, is classified as a ‘medical device’ by the World Health 
Organisation (WHO) (Berumen, 2017). The WHO highlights that the performance of a 
device depends not just on the device itself but on how it is used, that is, it has to be safe 
and correct (Berumen, 2017). 
A thumb orthotic device may be soft or rigid, include the thumb CMC joint and 
optionally the thumb MCP joint or wrist or both, may be ‘off the shelf’ (prefabricated) or 
custom made, and may be worn for short or long periods during the day or night, or 
both, for a prescribed period of time or on an ongoing or self-regulated basis. The goals 
of an orthotic device in thumb CMC OA may include, for example, providing external 





support; substituting for absent, weak or imbalanced muscles; evaluating for potential 
surgery; or increasing or maintaining joint motion (Colditz, 2000; Poole & Pellegrini, 
2000). Thumb orthotic devices are commonly prescribed and fitted by physiotherapists, 
occupational therapists and hand therapists (Davenport, 2009; O'Brien & McGaha, 
2014). The devices may also be prescribed by orthopaedic surgeons, rheumatologists, 
or GPs and fitted by orthotists or purchased independently by individuals, for example, 
from pharmacies or medical suppliers. 
4.2.2 Mechanisms of effect of thumb CMC splinting 
Splinting for thumb CMC OA has been shown to have biomechanical and neuromotor 
mechanisms, with immobilisation of more or fewer joints having consequent 
advantages and disadvantages (Colditz, 2000). Mechanical effects have been 
demonstrated (Grenier, Mendonca, & Dalley, 2016; Hamann, Heidemann, Heinrich, Wu, 
Bleuel, Gonska, & Brüggemann, 2014; Weiss, LaStayo, Mills, & Bramlet, 2000, 2004) and 
more recently thermal and compressive effects have also been shown (Davis, Loyley, 
Worsley, & Adams, 2019). However, there has been little empirical study of proposed 
mechanisms for the therapeutic effect of splinting. 
In a retrospective thumb CMC OA cohort, a comparison of three splints of varying 
lengths found that pinch strength increased the most when the greatest number of 
joints were immobilised (Grenier et al., 2016). While the study had a high risk of bias 
and confounding, a similar observation was made in a small study by Hamann et. al. 
comparing four splints for their effect on thumb stabilisation and on function (Hamann, 
Heidemann, Heinrich, Wu, Bleuel, Gonska, & Brüggemann, 2014). In this study, stability, 
quantified by 3-dimensional thumb motion analysis, was greatest with the most 
supportive splint encompassing the wrist and the CMC, MCP, and IP joints of the thumb 
(Hamann, Heidemann, Heinrich, Wu, Bleuel, Gonska, & Brüggemann, 2014). On the 
other hand, function, measured on a physical performance test, was greatest with the 
least supportive splint (including only the CMC joint) (Hamann, Heidemann, Heinrich, 
Wu, Bleuel, Gonska, & Brüggemann, 2014). The splint producing the greatest 
stabilisation resulted in the lowest hand functionality, i.e. a trade-off occurred between 
greater stabilisation and greater function (Hamann, Heidemann, Heinrich, Wu, Bleuel, 





function may be necessary or splint types may need to be matched to individual 
problems, for example, pain or weakness versus function. However, the findings of the 
qualitative study in Chapter 3 indicate that people with thumb CMC OA often experience 
problems of pain as well as function or strength, or both. Systematic review of the 
literature and the rationales for splinting therein may provide additional insight into 
which splints may be more effective for which patients and the potential mechanisms by 
which splints have effect.  
4.2.3 Evidence for effectiveness 
Clinicians commonly prescribe splints (Davenport, 2009; O'Brien & McGaha, 2014) and 
clinical studies have shown positive results with significant reductions in pain and 
reduced demand for surgery (Berggren et al., 2001; Gomes Carreira et al., 2010; Rannou 
et al., 2009). Interventions combining splinting with other non-surgical interventions 
have also demonstrated positive effects (Robbins et al., 2019; Wouters et al., 2019). 
International treatment guidelines conditionally recommend the use of splints for 
thumb CMC OA (Hochberg et al., 2012; Zhang et al., 2007) but the strength and quality 
of the evidence is variable. Furthermore, splints are made from a variety of materials 
and are of varied designs and evidence is lacking as to which are the most effective 
(NICE, 2014). 
Previous systematic reviews examining the effectiveness of splinting for thumb CMC OA 
have provided mixed results. In seven prior systematic reviews four made no 
recommendations due to methodological limitations of the included studies (Lue et al., 
2017; Mahendira & Towheed, 2009; Spaans et al., 2015; Towheed, 2005), two 
concluded there was high to moderate level of evidence for use of splints (Valdes & 
Marik, 2010; Ye et al., 2011), and one concluded ‘fair’ level of evidence for the use of 
splints (Egan & Broisseau, 2007). In two prior meta-analyses, one found splints reduced 
pain at short- and long-term follow-up although long-term was anything beyond 3 
months) (Kjeken et al., 2011), while a recent meta-analysis found no effect on pain or 
function at ≤ 45 days or ≥3 months (Bertozzi et al., 2015).  
The inconsistent findings of these reviews reflect the small number and heterogeneity 





reviews, outdated and now considered flawed methods for determining study quality 
and judging the overall strength of evidence. Recently, new primary studies have been 
published which may strengthen the evidence on which to base clinical 
recommendations. An attempt at resolving previous inconsistencies using current best 
practice methodology is needed.   
4.2.4 Study aims 
Considering this background the primary aim of this present study is to perform a 
systematic review to investigate the effectiveness of splinting for reducing pain and 
increasing function and HR-QoL in people with thumb CMC OA. A secondary aim is to 
examine the comparative effectiveness of different splint types.  
4.3 Methods 
The recommendations of the Preferred Reporting Items for Systematic Reviews and 
Meta-Analysis (PRISMA) Statement guidelines were followed (Moher et al., 2009) and 
the PRISMA Checklist completed (Appendix J). The study protocol is available in the 
public domain (PROSPERO registration: CRD42016032612).  
4.3.1 Search strategy  
Seven electronic databases were searched from inception to 17 March 2018: Cochrane 
Central Register of Controlled Trials, MEDLINE (OVID), Embase (OVID), CINAHL, ISI 
Web of Science, Scopus and Google Scholar. The following were screened to identify 
ongoing or recently completed trials: trial registries, viz. WHO International Clinical 
Trials Registry Platform, ClinicalTrials.gov, and Australia New Zealand Clinical Trials 
Registry; and conference proceedings, viz. OARSI, British Society for Rheumatology, 
European League Against Rheumatism, and ACR. Grey literature directories were also 
searched including TRIP and OpenDOAR.  
A comprehensive search strategy was developed using the PICOS (Population, 
Intervention, Comparison, Outcome and Study design) framework. Medical subject 
headings and text terms describing thumb CMC OA were combined with terms 
describing the interventions. An example search strategy is given in Appendix K; this 





applied. Each database was searched independently by the PhD researcher and a second 
researcher. A manual search of reference lists of previous systematic reviews and 
included studies supplemented the electronic searches.   
Studies were included if they investigated the effect of splinting for pain, function or HR-
QoL in participants age ≥18 years with a diagnosis of thumb CMC OA (as defined by the 
authors of the included trials). Splinting was defined as a thumb orthotic intervention, 
that is an orthosis, splint, or brace with or without standardised co-interventions, 
provided co-interventions were given to both experimental and control groups. 
Studies combining a variety of conditions or joint involvement were accepted if data for 
participants with thumb CMC OA could be extracted separately. Excluded were 
participants with rheumatoid arthritis only, or where the intervention was applied after 
surgery for thumb CMC OA. Control or comparator interventions included any other 
surgical or non-surgical intervention including an alternate splint, no intervention, or 
sham intervention. Randomised controlled trials and quasi-experimental studies were 
eligible for inclusion. No restriction was applied to study setting. The primary outcome 
variable of interest was pain. The primary safety outcome was withdrawal due to 
adverse events.  
Secondary outcome variables of interest were measures of physical function or 
disability, both self-reported or performance measure, and measures of HR-QoL. Where 
multiple measures of pain were reported in the same study, the primary outcome data 
were extracted according to the following pre-specified hierarchy: pain overall, e.g. 
visual analogue scale [VAS] pain; pain on hand usage; AUSCAN pain sub-scale; other 
algofunctional scale validated for use in hand OA; and patient’s global assessment, 
physician’s global assessment. Where more than one measure of physical function or 
disability was reported, decisions about which outcome data to extract were made 
according to the following pre-specified hierarchy: FIHOA score, AUSCAN physical 
function sub-scale, other algofunctional scale validated for use in hand OA, 
performance-based tests of hand function (e.g. grip strength, pinch strength), and global 
disability score. Where more than one QoL measure was reported, the following pre-





The main time point of interest was the first assessment after completion of splint-
wearing intervention. Longer term follow-up, where available, was categorised as short-
term (<3 months), medium-term (3-12 months), and long-term (>12 months) from time 
of group allocation.  
Randomised controlled trials, quasi-experimental studies, before and after studies, 
interrupted time series studies, non-randomised controlled trials and prospective 
cohort studies were included. Journal publications, theses and conference abstracts 
were eligible where these had adequate data to determine whether they met the 
inclusion criteria. Excluded were case studies, retrospective studies, systematic reviews, 
and feasibility studies.  
4.3.2 Study selection 
All citations from database searching were exported to bibliographic software (EndNote 
X7, Clarivate Analytics [previously by Thomson Reuters], Philadelphia) and duplicates 
removed. Citations were then uploaded to online systematic review management 
software (Covidence, www.covidence.org) from where the PhD researcher and a second 
researcher independently screened titles and abstracts for possible inclusion. 
Potentially eligible studies were obtained in full text and independently assessed for 
inclusion. Any disagreement was resolved in the first instance by discussion and, where 
required, in consultation with a third reviewer. Consultation occurred in five cases and 
all disagreements were resolved.   
4.3.3 Data extraction  
Data were extracted using the Cochrane Effective Practice and Organisation of Care 
Group (EPOC) Data Abstraction Form tailored and piloted for purpose (Appendix L). 
Data were extracted by the PhD researcher and cross-checked by a second researcher. 
Data extracted were the following: type of study; recruitment method; population 
characteristics including total number of participants, severity at baseline including 
number and location of symptomatic hand joints, duration of symptoms, age, gender, 
work status, ethnicity, setting, country, and inclusion and exclusion criteria; 
interventions used in the intervention group including number of follow up clinician 





along with the theoretical basis or rationale); comparator or control group 
interventions including number of follow up clinician contacts; thumb CMC OA case 
definition or classification criteria; details of the study required for assessments of 
quality and risk of bias; data pertaining to primary and secondary outcomes, including 
type and timing; unit of allocation (thumb or individual); unit of analysis (thumb or 
individual); funding source; and key conclusions. 
Authors were contacted to obtain or clarify missing or unclear data. Data available only 
in graph form were extracted using a freely available web-based tool: 
http://arohatgi.info/WebPlotDigitizer. Missing statistics were calculated from available 
data. In the case of failure, participant attrition was treated by intention-to-treat 
analysis. 
4.3.4 Critical appraisal of risk of methodologic bias  
Critical appraisal of risk of methodologic bias in each study was undertaken 
independently by the PhD researcher and a second researcher, using the Cochrane 
Collaboration’s 7-item Risk of Bias Tool to rate each item for each outcome as 
Yes/No/Unclear (Higgins, Altman, & Sterne, 2011). Risk of detection bias was scored for 
each outcome; subjective self-reported outcomes completed by unblinded participants 
were deemed at high risk of detection bias. Judgements were compared for discrepancy 
and any disagreement resolved by discussion with a third experienced reviewer.  
In order to supplement the risk of bias appraisal and thereby gain a fuller 
understanding of the strengths and weaknesses of the cumulative evidence, both 
reviewers independently narratively assessed the overall quality of each study for RCTs, 
using the van Tulder scale (Furlan, Pennick, Bombardier, van Tulder, & Editorial Board 
Cochrane Back, 2009), and for quasi-experimental design, using the MINORS instrument 
(Slim et al., 2003). Each criterion in the quality tool was considered; and themes were 
collated and reported as overall observations rather than calculating a summary score. 
Any discrepancy or disagreement was resolved first by discussion and with a third 





4.3.5 Data synthesis and analysis 
Data analysis and interpretation were performed by the PhD researcher and cross-
checked by a second reviewer. Presentation of descriptive and inferential statistical 
information was made for each study. Study design, population characteristics, 
intervention parameters, outcome measures, and main findings were summarised. 
Narrative synthesis of all included studies was undertaken in the first instance. 
Studies were to have been included for quantitative synthesis where these met the 
minimum threshold for risk of methodologic bias. However, due to the few number of 
studies identified, the published protocol was amended to include all studies in meta-
analysis in the first instance, followed by sensitivity analysis based on risk of bias 
threshold. Owing to the inherent difficulty of blinding participants and providers in 
rehabilitation research and the frequent use of subjective outcome measures, risk of 
bias threshold was amended so that only those studies judged to be at high or unclear 
risk of selection bias pertaining to randomisation, allocation concealment, or both were 
excluded. Risk of selection bias has been shown to have the biggest impact on direction 
and magnitude of bias in studies of intervention effect (Higgins et al., 2011).  
Clinical heterogeneity was assessed in the narrative synthesis to identify any major 
differences between trials in study populations, interventions, or outcome measures. 
Statistical heterogeneity was evaluated using the Chi-square test (with statistical 
significance set at P < 0.10), and the I2 statistic computed and interpreted such that 
≥50% represented substantial heterogeneity (Higgins, Thompson, Deeks, & Altman, 
2003).  
Quantitative synthesis was undertaken in Review Manager (RevMan) software (version 
5.3, Cochrane Collaboration) using the inverse variance method. Standardised mean 
differences (SMD) and 95% confidence intervals (CI) were calculated to synthesise 
continuous outcomes. The random-effects model was used as heterogeneity was 
anticipated to be present. To aid interpretation 95% prediction intervals (PI) were 
calculated for analyses including three or more studies that met the minimum threshold 





statistical package (StataCorp LLC, College Station, TX) was used with the Hedges’ g 
option selected.    
Effect sizes were interpreted as 0.2 (small), 0.5 (medium) or 0.8 (large) (Cohen, 1988). 
The quality of the body of evidence was judged to be ‘High’, ‘Moderate’, ‘Low’ or ‘Very 
Low’ for each outcome following the Grades of Recommendation Assessment, 
Development and Evaluation (GRADE) approach (Balshem et al., 2011). Quantitative 
synthesis was undertaken by the PhD researcher and checked by a second reviewer 
with any uncertainties regarding data preparation and computation resolved by a 
consultant health-sciences biostatistician.  
If adequate data were available, subgroup analyses were planned to explore any 
differences between types of splints (soft, rigid) and across specific population 
characteristics, including age (<65 years, >65 years) and disease severity (radiographic 
grade 1, 2, 3 or 4).  
4.4 Results 
4.4.1 Study selection 
After removal of duplicates 1353 records were identified with 12 studies meeting 
eligibility criteria for inclusion in quantitative synthesis (Figure 4.1), four comparing 
splint versus no splint and eight comparing different types of splints. Of the included 
studies, nine authors provided additional information about study characteristics or 
result data (Becker, Bot, Curley, Jupiter, & Ring, 2013; Cantero-Téllez et al., 2017; 
Cantero-Tellez, Villafane, Valdes, & Berjano, 2018; Gomes Carreira et al., 2010; Hermann 






Figure 4.1 Flowchart of study selection process 
Designs of the included studies are listed in Table 4.1. Of the four cross-over design 
trials, two used paired-t tests to assess the effect of splint wearing (Sillem, Backman, 
Miller, & Li, 2011; van der Vegt et al., 2017) and two used repeated-measures analysis of 
variance (ANOVA) (Weiss et al., 2000, 2004). Funding was not received in three studies 
(Arazpour et al., 2017; Cantero-Téllez et al., 2017; Cantero-Tellez et al., 2018); four 





al., 2010; Hermann et al., 2014; Rannou et al., 2009; Weiss et al., 2004); two studies 
received complimentary splint materials from the manufacturer (McKee & Eason-Klatt, 
2006; van der Vegt et al., 2017) – the latter study  stated specifically that there was no 
influence on the study design, conduct or outcome (van der Vegt et al., 2017). In three 
studies funding sources were not stated (Sillem et al., 2011; Weiss et al., 2000) or 
unclear (Becker et al., 2013).  
4.4.2 Study characteristics  
Characteristics of the included studies are reported in Table 4.1. Study settings were 
outpatient therapy clinics. Participant ethnicity was reported in one study in which 
32.5% were reported as “non-white” [sic] (Gomes Carreira et al., 2010). In three of five 
studies where it was reported a majority of participants were in employment (Rannou 
et al., 2009; van der Vegt et al., 2017; Weiss et al., 2004) and in two studies smaller 
proportions (20% to 30%) were in work (Hermann et al., 2014; Sillem et al., 2011). The 
remaining studies did not report work status.  
Interventions comprised a range of splint designs and materials (Table 4.1). Rationales 
proposed for splint interventions included to stabilise the CMC joint (Arazpour et al., 
2017; Cantero-Téllez et al., 2017; Cantero-Tellez et al., 2018; McKee & Eason-Klatt, 
2006; Sillem et al., 2011; van der Vegt et al., 2017; Weiss et al., 2000, 2004); to prevent 
adjacent MCP joint hyperextension (Cantero-Tellez et al., 2018; Gomes Carreira et al., 
2010; McKee & Eason-Klatt, 2006; Rannou et al., 2009); to leave adjacent joints free for 
unhindered function (Arazpour et al., 2017; Cantero-Téllez et al., 2017; Cantero-Tellez 
et al., 2018; McKee & Eason-Klatt, 2006; Sillem et al., 2011); to maintain length of the 
first web space (Gomes Carreira et al., 2010; Rannou et al., 2009); to reduce CMC joint 
synovitis or inflammation (Cantero-Tellez et al., 2018; Hermann et al., 2014; van der 
Vegt et al., 2017); to reduce local muscle spasm (van der Vegt et al., 2017); and, for 
patient preference (Hermann et al., 2014). One study reported telephone follow-up at 1-
week (van der Vegt et al., 2017); remaining studies reported follow-up, ‘only if need 



















Entry criteria (actual 
disease severity and 





mean ± SD* 





Compare splint vs no splint: rigid CMC 
splint, provider NA, “Wear during 
ADLS, remove when sleeping” for 4 
weeks; control – usual medical care. 






Pain: on using pen 
(splint group) or 
average in last week 







(grade I or II) 
(symptoms 13.08 ± 
2.39) 










Compare soft CMC/MCP splint vs rigid 
CMC/MCP splint: both provided by 
study-trained occupational therapist, 
“Wear whenever symptoms day or 
night” for 5-15 weeks. (Tertiary 















5.0 ± 2.19 
28.18  
± 17.23 






Compare rigid CMC/MCP splint vs rigid 
CMC splint: provided by hand therapy 
clinician experienced in orthopaedic 
cases, “Use orthosis during the 
nighttime and also during daytime ADL 
for 3 to 4 hours per day”, for 3 months. 













Clinical criteria, pain 
VAS >40/100, 
radiographic criteria 
(Eaton-Littler grade II 
or III) 
(NA) 









Compare rigid CMC/MCP splint vs rigid 
CMC splint: both provided by 
experienced hand therapy clinician, 
“Use during the night & during daytime 




























Compare splint vs no splint: rigid 
CMC/MCP provided by occupational 
rheumatology specialist, “Wear during 
activity only”, for 3 months; control – 






Pain in past week, 







ACR clinical criteria, 
pain VAS 3≤7, ACR 
radiographic criteria  
(Grade II 97.5%, 7 ± 
4.9) 
5.1 ± 1.24† 
40.55  
± 17.5† 



















Entry criteria (actual 
disease severity and 





mean ± SD* 







Compare splint vs no splint: soft 
CMC/MCP/wrist splint, provider NA, 
“Wear whenever symptoms day or 
night”, + exercises + usual medical 
care, 2 months; control – exercises + 







Pain (right hand) 
(NRS, 0-10) 
Function (AUSCAN 




ACR hand OA clinical 
criteria, pain on 
palpation CMC joint 
(15.2, range 36) 
Median 4 
(0, 9) 
 4.8 (1.9) 






Compare rigid CMC/MCP vs rigid CMC 
splint: both provided by study-trained 
therapist, “Wear whenever symptoms 
day or night”, 4 weeks. (Hand therapy, 




























Compare splint vs no splint: rigid 
CMC/MCP/wrist splint provided by 
study-trained occupational therapist, 
“Wear at night only”, + usual medical 
care, 1 year; control – usual medical 







Pain in previous 48 








radiographic criteria – 
Kallman  











Soft CMC/MCP/wrist splint vs rigid 
CMC splint: both provided by study-
trained therapist, “Wear whenever 
symptoms day or night”, 4 weeks. 
(Outpatient hand therapy departments 






Pain (AUSCAN pain 


















Rigid CMC/MCP splint vs semi-rigid 
CMC splint: both provided by 1 of 14 
study-trained experienced hand 
therapy clinicians, instructions NA, 2 
weeks. (Hospital and medical centre 
orthopaedic, plastics, rheumatology 






Pain recorded in daily 








radiographic criteria – 
Eaton-Glickel (Grade I 
or II 43%; grade III or 
IV 57%, >1 year 49%) 
3.7 ± 2.05† 





















Entry criteria (actual 
disease severity and 





mean ± SD* 






Rigid CMC/MCP/wrist splint vs rigid 
CMC splint: both provided by study-
trained certified hand therapist, “Wear 
whenever symptoms day or night”, 1 






Pain currently, after 
functional use (VAS, 0-
10) 





radiographic criteria – 
Eaton-Littler (<6 
months to >5) 
6.23 ± 2.01§ 
3.30 ± 1.02§ 
57, range 





Soft CMC/MCP splint vs rigid CMC 
splint: provider NA, “Wear whenever 







Pain currently, after 
functional use (VAS, 0-
10) 




Radiographic criteria – 
Eaton-Littler stage I or 
II +/- clinical criteria 
(Grade I or II, <6 
months up to 5 years) 
5.42 ± 2.4 




CMC, carpometacarpal joint; ADLs, activities of daily living; NA, not available; VAS, visual analogue scale; MHQ, Michigan Hand Questionnaire; MCP, 
metacarpophalangeal joint; DASH, Disabilities of the Arm, Shoulder, and Hand questionnaire; NS, not specified; QuickDASH, Quick Disabilities of the Arm, Shoulder, 
and Hand questionnaire; ACR, American College of Rheumatology; AUSCAN, Australian-Canadian Hand Osteoarthritis Index; PRWHE, Patient-Rated Wrist and Hand 
Evaluation; FIHOA, Functional Index for Hand Osteoarthritis; Kg, kilogram 
* Unless otherwise stated 
† Values calculated from group-level data for study-level means and SD using a freely available online software 
(https://www.statstodo.com/CombineMeansSDs_Pgm.php) 
‡ Data extracted from table II only, in Cantero-Tellez 2017  






Pain was assessed using a variety of numerical scales (Table 4.1). Function was 
measured by various self-report outcomes except for two studies in which a 
performance measure, pinch grip strength, was used (Weiss et al., 2000, 2004). Pain and 
function outcomes were not reported beyond one year. Quality of life was not assessed 
in any of the studies, either at baseline or follow up.  
4.4.3 Risk of bias and quality assessment  
Five studies were judged to be at high or unclear risk of selection bias: one of four 
studies comparing splint with no splint (Arazpour et al., 2017) and five of eight studies 
comparing different types of splints (Cantero-Téllez et al., 2017; Cantero-Tellez et al., 
2018; McKee & Eason-Klatt, 2006; Weiss et al., 2000, 2004). All outcomes reported in 
this review were judged to be at high risk of detection bias primarily due to self-
reported outcomes being completed by unblinded participants. Risk of selective 
outcome reporting was judged unclear or high for seven studies because study 
protocols were neither registered a priori nor published (Arazpour et al., 2017; 
Cantero-Téllez et al., 2017; McKee & Eason-Klatt, 2006; Weiss et al., 2000, 2004), stated 
outcomes or time points were not reported (Hermann et al., 2014; Rannou et al., 2009), 
or splint materials were provided by industry with unclear risk of influence (McKee & 
Eason-Klatt, 2006).   
Risk of other bias was judged unclear or high in 10 studies relating to four main areas: 
short or no washout period in cross-over design trials (Sillem et al., 2011; van der Vegt 
et al., 2017; Weiss et al., 2000, 2004); potential for contamination between groups 
where participants in the control group were fitted with the intervention splint during 
assessment (Gomes Carreira et al., 2010); inconsistency in unit of allocation vs analysis 
(individual vs hand) (Hermann et al., 2014); and poor quality of data reporting or 
outcome ambiguity or both (Cantero-Téllez et al., 2017; Cantero-Tellez et al., 2018; 
McKee & Eason-Klatt, 2006; Weiss et al., 2000). The researchers’ judgements are 






Figure 4.2 Risk of bias graph: summary of each risk of bias item presented as percentages across 
all included studies.  
Further assessment of study quality identified that six studies did not state an intention-
to-treat analysis or did not state or did not meet sample size calculations (Arazpour et 
al., 2017; Cantero-Téllez et al., 2017; McKee & Eason-Klatt, 2006; van der Vegt et al., 
2017; Weiss et al., 2000, 2004). In seven of the twelve included studies it was unclear if 
co-interventions were avoided or similar (Arazpour et al., 2017; Becker et al., 2013; 
Hermann et al., 2014; McKee & Eason-Klatt, 2006; van der Vegt et al., 2017; Weiss et al., 
2000, 2004). Acceptable adherence to interventions was reported in five studies 
(Arazpour et al., 2017; Cantero-Tellez et al., 2018; Rannou et al., 2009; van der Vegt et 
al., 2017; Weiss et al., 2004) and variable adherence reported in two studies (Hermann 
et al., 2014; Sillem et al., 2011). Adherence was not reported in the remaining five 
studies. Participant drop-out was ≤15% in all but two studies (Becker et al., 2013; 
McKee & Eason-Klatt, 2006). 
4.4.4 Narrative synthesis 
Results of the individual studies are summarised in Table 4.2. In all studies splints were 
associated with a reduction in pain scores over the course of the study. In some studies, 
function worsened in the short-term (Arazpour et al., 2017; Rannou et al., 2009; Weiss 
et al., 2000, 2004) or remained unchanged (van der Vegt et al., 2017).  
Heterogeneity was present between studies in control over potential sources of bias 





measures used and the variations in intervention implementation. Other differences 
included time to follow-up and symptom severity (Table 4.1). Insufficient data were 
available to conduct subgroup analyses. 
No major adverse events were reported; one minor adverse event of skin irritation 






Table 4.2 Summary of results of included studies 
First 
author, 











Rigid CMC splint: -1.0 ± 1.99 
Control group: 0.11 ± 1.34 
Rigid CMC splint: 0.85 ± 20.20 
Control group: -4.11 ± 17.98 












Soft CMC/MCP splint: -0.81 ± 2.9 
Rigid CMC/MCP splint: -0.9 ± 2.2 
Soft CMC/MCP splint: - 2.5 ± 17.4 
Rigid CMC/MCP splint: -3.8 ± 13.2 
0.09 (-1.2, 1.4)  
 










Rigid CMC/MCP splint: -31 ± 1.8† 
Rigid CMC splint: -29 ± 1.8† 
Rigid CMC/MCP splint: -4.1 ± 0.8†  
Rigid CMC splint: -6.0 ± 0.8† 
-2.0 (-2.87, -1.13) 
 











Rigid CMC/MCP splint: -25.6 ± 1.7 
Rigid CMC splint: -25.0 ± 1.8 
Rigid CMC/MCPsplint: -10.3 ± 1.0 
Rigid CMC splint: -12.0 ± 1.0 
-0.6 (-1.35, 0.15)‡ 
 


















Rigid CMC/MCP splint: -2.0 ± 2.37 
Control group: -0.3 ± 2.36 
Rigid CMC/MCP splint: -2.2 ± 2.46 
Control group: 0.1 ± 2.44 
Rigid CMC/MCP splint: -7.3 ± 24.40 
Control group: -7.6 ± 23.43 
Rigid CMC/MCP splint: -10.5 ± 24.69 
Control group: -6.7 ± 22.65 
-1.7 (-3.17, -0.23)‡ 
 
-2.3 (-3.82, -0.78)‡ 
 












Soft CMC/MCP splint: -0.3 ± 2.56 
Control group: -0.2 ± 2.98 
Soft CMC/MCP splint: -0.2 ± 1.29§ 
Control group: -0.3 ± 1.26§  
-0.09 (-1.4, 1.2)  
 









Rigid CMC/MCP splint: -10.24  
± 12.47|| 
Rigid CMC splint: -12.99 ± 11.77|| 
Rigid CMC/MCP splint: -7.13 ± 23.34|| 
Rigid CMC splint: -18.45 ± 28.11|| 


















Rigid CMC/MCP splint: -10.1 ± 22.25 
Control group: -10.7 ± 22.38 
Rigid CMC/MCP splint: -22.2 ± 23.08 
Control group: -7.9 ± 23.48 
Rigid CMC/MCP splint: 1.3 ± 10.29 
Control group: -0.3 ± 10.29 
Rigid CMC/MCP splint: -1.9 ± 11.20 
Control group: 4.3 ± 11.53 
0.6 (-7.9, 9.1)  
 
-14.3 (-23.0, -5.2)  
 
1.6 (-2.3, 5.5) 
 










Soft CMC/MCP splint: -2.05 ± 9.54 
Rigid CMC splint: -5.69 ± 11.08 
Soft CMC/MCP splint: -2.69 ± 16.33 
Rigid CMC splint: -5.54 ± 17.37 
3.7 (0.68, 6.76) 
 


















Rigid CMC/MCP splint: -0.3 ± 2.97 
Semi-rigid CMC splint: -0.3 ± 2.83 
Rigid CMC/MCP splint: 0.0 ± 8.56 
Semi-rigid CMC splint: -0.9 ± 8.34 
0.0 (-1.05, 1.05)‡ 
 









Rigid CMC/MCP: -2.65 ± 2.88|| 
Rigid CMC splint: -2.27 ± 3.62|| 
Rigid CMC/MCP splint: 0.25 ± 1.67|| 
Rigid CMC splint: -0.07 ± 1.75|| 
-0.4 (-2.16, 1.40)‡ 
  









Soft CMC/MCP splint: -3.13 ± 2.91 
Rigid CMC splint: -1.83 ± 3.26 
Soft CMC/MCP splint: -0.3 ± 2.55 
Rigid CMC splint: 0.3 ± 2.48 
-1.3 (-3.01, 0.41)‡ 
 
0.0 (-1.39, 1.39)‡ 
CMC, carpometacarpal joint; MCP, metacarpophalangeal joint 
* Negative value indicates improvement   
† Data extracted from table II only, in Cantero-Tellez 2017  
‡ Calculated in RevMan 
§ Unpublished data 
|| Data extracted from graph 
 
4.4.5 Quantitative synthesis  
4.4.5.1 Effectiveness of splinting on pain and function 
Figure 4.3 presents the synthesis of the four studies reporting on the effectiveness of 
splints for pain and function. No significant effect was found for either outcome in the 
short-term (0-3 months); this result did not alter with sensitivity analyses (Figure 4.4). 
GRADE: Very low (serious risk of bias, very serious imprecision).  
Based on the overall pooled effect estimate from two studies totalling 137 participants, 
splinting was found to result in a statistically significant reduction in pain at medium-
term (3-12 months) compared to no splinting (SMD -0.7 [95% CI -1.0 to -0.35],  
p < .0001), representing a moderate to large effect size (Figure 4.3). GRADE: Low 
(serious risk of bias, serious imprecision).  
The overall pooled effect estimate, from two studies totalling 135 participants, also 
suggested that splinting resulted in a statistically significant improvement in function at 
medium-term (3-12 months), (-0.42 [-0.77 to -0.08], p = .02), representing a small to 
moderate effect size. GRADE: Low (serious risk of bias, serious imprecision).  






Figure 4.3 Forest plot: effectiveness of splint versus no splint for pain and function forest plot, at short-term (0-3 months) 






Figure 4.4 Forest plot: effectiveness of splint versus no splint for pain and function forest plot, at short-term (0-3 months) 





4.4.5.2 Effectiveness of different splint types on pain and function  
The effect estimate based on one study totalling 84 participants suggested that splints 
not including the MCP joint compared to splints including the MCP joint resulted in 
statistically significant improvement in function at medium-term (3-12 months)  
(1.68 [1.18 to 2.19]) (Figure 4.5). GRADE: very low (very serious risk of bias, very 
serious imprecision). 
All other comparisons showed no significant effect (Figure 4.6). GRADE: Very low (very 
serious risk of bias, very serious imprecision). Sensitivity analyses showed no 
significant effect for comparisons of splint type (GRADE: very low) (Figure 4.6).  
Predication intervals were calculated for comparison of effectiveness of splints in the 
short-term for pain (PI -4.30 to 3.94) and function (PI -1.72 to 1.92) (Figure 4.4). No 






Figure 4.5 Forest plot: effectiveness of soft versus rigid splint for pain and function at short-term 
(0-3 months), and MCP included versus MCP not included splint for pain and function at short-






Figure 4.6 Forest plot: effectiveness of soft versus rigid splint for pain and function, and MCP included versus MCP not included 






This systematic review examined the effectiveness of splinting for pain and function in 
thumb CMC OA and compared different splint materials and design. Meta-analysis of 
studies without selection bias found that splints cause a moderate to large reduction in 
pain and a small to moderate improvement in function in the medium-term  
(3-12 months) but not short-term (<3 months) (low quality of evidence). Meta-analysis 
of studies without selection bias also found no difference between rigid and soft splints 
or between splints including or not including the MCP joint (very low quality of 
evidence). The effect of splints on quality of life in people with thumb CMC OA is 
unknown. There was no evidence found that splints cause significant harm.  
Findings of a moderate to large effect for pain and a small to moderate effect for 
function in the medium-term (3-12 months) are comparable to those of a previous 
systematic review with meta-analysis by Kjeken et al. (Kjeken et al., 2011). However, 
this review differs from another previous systematic review with meta-analysis which 
concluded there was no significant effect of splinting on pain levels at ≥3 months 
(Bertozzi et al., 2015). These conflicting conclusions may be partly explained by the 
earlier Kjeken et al. review’s inclusion of one study with multiple co-interventions 
which did not meet inclusion criteria for this review.  
In contrast, this review found no effect of splinting for pain in the short-term  
(<3 months), concurring with findings in the earlier review (Bertozzi et al., 2015) but 
conflicting with the first review which found a significant small-to-moderate effect 
(Kjeken et al., 2011). This difference from Kjeken et al. may be explained by the 
inclusion in this review of a more recent study investigating a soft splint and reporting 
relatively poor adherence to splint wearing (Hermann et al., 2014). The finding of no 
significant difference between splint material or design concurs with that of a further 
previous systematic review (Aebischer, Elsig, & Taeymans, 2016).  
This systematic review provides a robust updated appraisal of the evidence for splinting 
in people with thumb CMC OA and examines characteristics of the study designs and 
splint interventions. Splinting is a promising non-invasive intervention for thumb CMC 





recommendations can be made for the benefits of splinting and the lack of harm in 
clinical practice.  
4.5.1 Study limitations 
The small number of original studies and the small sample size of each included study 
represent significant limitations of the present and previous reviews. Meta-analysis 
with such small sample sizes may be at risk of ‘small sample bias’ (Nuesch et al., 2010). 
In other words issues of lower methodological quality along with reporting biases 
combine to result in the reporting of larger effect sizes than those in larger trials 
(Nuesch et al., 2010). These issues are evident in the present review by the high rate of 
selective outcome reporting, the ubiquitous risk of detection and performance bias, and 
by the smaller effect sizes seen on sensitivity analysis. While publication bias is likely to 
be present to some extent it is not strongly suspected as most of the included studies 
are not, nor likely to be, industry-sponsored (Guyatt et al., 2011). The use of funnel plots 
was not warranted given the small number of included studies (Sterne et al., 2011). 
In the present study these methodological issues are also apparent in the statistical 
heterogeneity found in the comparison of splint versus no splint for pain (Figure 4.3, 
Figure 4.4) and substantially in comparisons between splint types (Figure 4.5) at the 
short-term. Although heterogeneity relating to risk of bias will tend to have 
overestimated the effect sizes, the impact of heterogeneity in other study parameters 
(outcome measures, intervention implementation and population characteristics), is 
underestimation.  
Prediction intervals calculated for the comparison of splint vs no splint outcomes at 
short-term indicate that it is probable that 95% of exchangeable studies in the future 
can be expected to produce effects within these intervals (PI -4.30 to 3.94) and (PI -1.72 
to 1.92), for pain and function, respectively, which both span the null (Figure 4.4). 
Clearly, further new studies are likely to add significantly to the current evidence base, 
if performed to a high standard using Cochrane supported methodology and following 
the PREPARE trial guidelines (Bandholm, Christensen, Thorborg, Treweek, & Henriksen, 
2017). Symptom type and severity may be potential subgroupings for future primary 





The study design best suited to provide further evidence for the effectiveness of splints 
is one which includes a control group and is randomised but without a cross-over 
design. Only three of the studies in this review included a control group (Gomes 
Carreira et al., 2010; Hermann et al., 2014; Rannou et al., 2009). The cross-over 
randomised-trial design was used by four of the studies in this review, with data from 
two included in sensitivity analysis in the comparisons of splint material (Sillem et al., 
2011) and splint design (Sillem et al., 2011; van der Vegt et al., 2017). The use of cross-
over design is problematic in studies of thumb CMC OA since it is a chronic condition; if 
splint interventions are to be worth-while they need to be effective over a prolonged 
period of follow-up. The cross-over designs included in this review required the 
treatment effect to be lost after a short washout period: 1-2 weeks. Furthermore, 
statistical checking of carry-over effect is considered imperfect (Nolan, Hambleton, & 
Dwan, 2016) and possible bias due to carry-over effect remains a concern. The inclusion 
of data from both periods in each of the two studies using cross-over design will tend to 
have under-estimated the overall treatment effect.   
Blinding of participants and clinicians to group allocation did not occur in any of the 
included studies. These are prevalent issues in trials of rehabilitation interventions 
(Fregni et al., 2010). The impact of not blinding participants is that the effect size of the 
intervention may be over-estimated, mainly due to non-specific placebo effect (Fregni et 
al., 2010). This issue is compounded by the subjective nature of the primary outcome 
measures, the physical characteristic of the intervention (Bannuru et al., 2015), 
therapist involvement in its delivery (Fregni et al., 2010), and the context of chronic 
condition and chronic pain (Felson et al., 2016). Study design elements which could 
have minimised risk of performance and detection bias were not applied in the included 
trials, in particular: blinding participants to the research hypothesis; ensuring equal 
treatment across groups, for example, number and duration of sessions, quantity and 
quality of participant materials; and cluster randomisation, for example, by therapist 
(Bandholm et al., 2017; Fitzgerald et al., 2015).  
The ability to detect an effect for splints or between types of splints may be enhanced by 
implementing standardised usual care across groups and employing strategies to 





were under-utilised in the studies included in this review. However, in most of the 
included studies participant drop-out was low, strengthening the statistical power and 
validity of study findings and suggesting that long-term follow up (> 1 year) is feasible. 
A core set of outcome domains for investigating interventions for hand OA has been 
recommended, that is, pain, physical function, HR-QoL, joint activity, and hand strength 
(Kloppenburg, Maheu, et al., 2015), but it was apparent from the multiple different 
outcomes measures used by studies in this review that there is no consensus about 
which specific tools are best suited. Furthermore, no studies included in the review 
reported HR-QoL and several of the measures used to assess function were ones which 
face criticism for being outmoded (Stamm et al., 2009). Outcomes that differentiate 
thumb CMC from hand OA are likely to better detect change where interventions target 
thumb CMC OA, but no gold standard is currently available.  
The studies included in this systematic review were lacking in demographic information 
about participant ethnicity, body mass index (BMI) and co-morbidity as well as 
additional disease characteristics. Imaging, where used, was poorly described. Entry 
criteria were highly variable, reflecting the lack of specific classification criteria for 
thumb CMC OA. Medication burden, emotional impact, and sense of self were not 
specifically considered, representing a limitation of the systematic review. 
4.5.2 Conclusions  
 The present review supports the conclusion that splinting has medium to large effects 
for pain and small to medium effects for function in the medium-term and further 
supports the conditional recommendation of international guidelines that splinting is an 
effective intervention for thumb CMC OA. Current evidence, however, derives from a 
small number of studies with small sample sizes and short periods of follow-up. Thus 
the overall quality of the existing evidence is low and it is not possible to draw firm 
conclusions as to the effectiveness of splinting as an intervention. Significant challenges 
for future studies are the lack of diagnostic criteria and the absence of a gold standard 
outcome measure for thumb CMC OA. Future research into the effectiveness of splinting 





usual care is standardised, study design is appropriate, and follow-up extends beyond 
one year.   
These recommendations are considered in the following chapter in the design and 
conduct of a feasibility study for a future clinical trial to investigate the effectiveness of 







Splinting for thumb CMC OA: A feasibility randomised 
controlled trial 
5.1 Introduction 
The study reported in this chapter sets out to determine the feasibility of study 
elements for a future fully-powered trial investigating the effectiveness of splinting for 
outcomes in people with thumb CMC OA. The chapter opens with an introduction and 
background that draws on previous chapters and concludes with a discussion of the 
results of the feasibility study.  
5.2 Background 
This chapter takes its direction from the patient experience of thumb CMC OA and the 
treatment targets and outcomes which were identified as of importance to this 
population. The chapter is also informed by the findings of the systematic review in 
Chapter 4 and the background literature outlined in Chapters 1 and 2.  
As discussed in Chapter 2, the multifactorial aetiology of thumb CMC OA is recognised: 
genetic factors, age, and likely, metabolic factors all play a role in the development and 
progression of the condition. However, the inherent instability of the first CMC joint is 
arguably the most important factor in the onset of OA at this location since, considering 
the demands associated with human hand functions, this instability places the joint at a 
critical disadvantage. Therefore, interventions that can address thumb CMC OA from an 
anatomical and biomechanical approach have a sound theoretical basis. The 
mechanisms of effect of splinting in this regard were outlined in Chapter 4. 
Furthermore, the role of biomechanical interventions such as splints has been 
highlighted as a key area of OA management that needs more research (NICE, 2014).  
The qualitative study described in Chapter 3, which investigated the perspectives of 
people with thumb CMC OA, found that pain was the main symptom of concern, 
particularly pain that interrupts sleep. Other key problems were: impaired power 





included in the FIHOA instrument, and not included in gender classifications; negative 
thoughts and feelings including the use and burden of medication; an altered sense of 
self related to ageing, and, quality of life. These problems serve as key treatment targets 
and should be evaluated for their candidacy as primary or secondary outcomes for 
investigating treatment effectiveness in thumb CMC OA. These findings collectively 
provide a clear direction from the patient perspective about what treatment targets and 
outcomes are important and meaningful for this population.  
The previous work in this thesis also gives direction on which interventions are 
indicated for people with thumb CMC OA. The findings reported in Chapter 3 indicated 
that people with thumb CMC OA desire management approaches that delay, reduce, or 
obviate the need for pharmacological or surgical interventions. In this regard, splinting 
has potential as an acceptable management approach. As outlined in Chapter 1, this 
patient preference accords with the lack of evidence for the effectiveness of 
pharmacological interventions, excepting topical NSAIDs (Kroon et al., 2018), and the 
less extensive surgical options (NICE, 2014; Thillemann et al., 2016).  
The qualitative work also identified a strong desire for information about the condition 
and its management. This accords with international guideline recommendations for 
hand OA conditions, i.e. education and advice for self-management as core components 
of treatment (Hochberg, 2011; NICE, 2014; Zhang et al., 2007). Chapter 1 highlighted 
that exercise is also part of international guideline recommendations although what 
constitutes an effective exercise programme for thumb CMC OA has yet to be 
determined (Hochberg, 2011; NICE, 2014; Osteras et al., 2017; Zhang et al., 2007). 
Exercise is also a non-surgical, non-pharmacological intervention that is likely to be 
acceptable to patients. Based on international guidelines therefore, exercise, education, 
and advice are the current best practice usual care with which a splint intervention 
must be compared. To this end, a feasibility study needs to include the development of a 
standardised package of best practice usual care, which includes the development of an 
exercise programme. Consultation with expert clinician stakeholders can help to deal 
with some of the unresolved questions around exercise prescription for thumb CMC OA. 
Furthermore, expert clinicians together with people with thumb CMC OA are uniquely 





world health service and personal life context. Therefore, stakeholder consultation and 
piloting should form part of defining a standardised best practice usual care package for 
a feasibility study.  
The decision about which splint should be investigated rests again on patient 
preference and previously cited literature. Results of the systematic review, reported in 
Chapter 4, found splints to be a safe intervention, even though adverse events were not 
routinely reported; however, only low-quality evidence supports their use, and only in 
the medium-term (3-12 months). Furthermore, splints in these studies were made from 
a variety of materials and designs, were prescribed with a wide range of wearing 
schedules and dosage, and had no consistent rationale for use. Currently there appears 
to be no difference between splint types although this is based on very low-quality 
evidence (Donnelly & Carswell, 2002; Kloppenburg, Maheu, et al., 2015).  
Of the many splinting solutions available, a soft neoprene splint available off–the-shelf 
and easily fitted, is a cheaper and more accessible option than other splints, and one 
often preferred by patients (Becker et al., 2013; Sillem et al., 2011). The systematic 
review in Chapter 4 found that no study comparing a soft, off-the shelf splint with a no-
splint control has been reported. Furthermore, clear dosage parameters for splint 
interventions have not yet been determined. Therefore, investigation is necessary into 
the effectiveness of a soft neoprene splint prescribed with clear dosage parameters and 
a well-described standardised best practice usual care package, compared with 
standardised best practice usual care package alone. Stakeholder consultation should 
also inform development of the splint intervention including dosage parameters.  
Randomised clinical trials are the gold standard in providing information about 
comparative effectiveness in health research because they can deliver unbiased head-
to-head evaluations of alternative treatment options (Holbrook, Kempen, Prusakowski, 
Altaweel, & Jabs, 2011; Portney, 2015). The cost of interventions, particularly clinicians’ 
time, and limited health services’ resource require that clinical trials produce results 
that can be generalised and applied in real-life settings (Patsopoulos, 2011). Therefore, 
it is preferable that the investigation of effectiveness versus efficacy, following a 





in an ideal or laboratory context (Patsopoulos, 2011). This has implications for the 
study design in terms of inclusion criteria (condition classification identifiable by 
practising clinicians); interventions that are deliverable and scalable for real world 
health services and accessible and achievable for real world patients; and outcomes that 
are relevant to patients’ concerns and practical for real world health service quality 
audit (Patsopoulos, 2011; Williams, Burden-Teh, & Nunn, 2015).    
In addition to centring on outcomes that are important and meaningful to patients, the 
primary endpoint of an RCT must also meet five key measurement criteria (Holbrook et 
al., 2011). Firstly, the outcome can be measured for all participants (Holbrook et al., 
2011). Secondly, the outcome has sound psychometric properties in terms of reliability, 
that is,  the degree to which test scores are free from measurement error (Donnelly & 
Carswell, 2002) and validity, that is, it measures what it claims to measure (Donnelly & 
Carswell, 2002; Portney, 2015). Thirdly, the outcome is responsive and can detect 
minimal change over time (Donnelly & Carswell, 2002; Holbrook et al., 2011; Portney, 
2015). Fourthly, the outcome has good utility in terms of acceptability of format, time 
required to complete and score, and ease of interpretation (Donnelly & Carswell, 2002). 
The fifth criterion is to be able to detect change that is clinically meaningful to 
participants: that is, a known minimal difference which signifies that a patient has 
improved, the minimal clinically important difference (MCID) (Holbrook et al., 2011; 
Jaeschke, Singer, & Guyatt, 1989; Losina, Ranstam, Collins, Schnitzer, & Katz, 2015; 
Portney, 2015; Wright, Cook, Baxter, Dockerty, & Abbott, 2011). While most studies 
reviewed in Chapter 4 included OARSI-recommended core outcomes of pain and 
physical function (Kloppenburg, Maheu, et al., 2015), there was no consensus about 
which instruments should be used, and no studies assessed QoL, joint activity, or 
number or ratio of OMERACT-OARSI responders, also recommended in OA trials 
(Fitzgerald et al., 2015; Kloppenburg, Maheu, et al., 2015). Determining which outcomes 
should serve as primary and secondary endpoints for a comparative effectiveness trial 
is a further goal to be achieved.  
Effectiveness trials require large sample sizes and are costly to conduct. In order, 
therefore, to conduct an effectiveness trial to a high standard with minimal research 





feasibility study (Abbott, 2014; Bandholm et al., 2017). This chapter describes the 
development and conduct of a study with the primary aim of determining the feasibility 
of conducting a future fully-powered RCT to compare soft splint and best practice usual 
care versus best practice usual care comparator intervention for thumb CMC OA.  
The primary objectives of this feasibility study were: 
1) Recruitment of 30 participants in a 4-month period;  
2) Retention >85% at 6 months;  
3) >90% of participants finding the interventions acceptable; and,  
4) Determination of the rate and type of adverse events.  
Part of the overall intent of the methods which follow was to develop a splint 
intervention and a standardised best practice usual care package, and to consider which 
clinical outcome measures satisfy the research needs outlined above. 
5.3 Methods 
The study was conducted according to the principles of good clinical practice, which 
protect the rights, safety, and well-being of study participants, in compliance with the 
Declaration of Helsinki. Consultation was completed with the University of Otago Ngāi 
Tahu Māori consultation committee (Appendix M), and received ethical approval from 
the New Zealand Northern B Health and Disability Ethics Committee Ref 18/NTB/240 
(Appendix N). 
5.3.1 Study design 
This study was designed as a pragmatic, assessor-blinded and partial participant-
blinded, 2-arm parallel-group feasibility RCT with randomisation stratified by hand 
dominance. The study was undertaken to establish the feasibility of conducting a full-
scale future trial designed to assess the superiority of a soft, prefabricated splint 
intervention vs no splint intervention at 4-weeks and 6-months follow-up.  
The study adhered to the SPIRIT 2013 Statement (Chan et al., 2013) which defines 
standard protocol items for clinical trials. The study was also informed by the CONSORT 





2016), the Medical Research Council Guidance for Developing and Evaluating Complex 
Interventions (Craig et al., 2008), the Template for Intervention Description and 
Replication (TIDieR) guide and checklist (Hoffmann et al., 2014), and the PRECIS-2 
toolkit (Loudon et al., 2015). A sample size of 30 participants was considered 
appropriate for a feasibility study. Samples of 24 to 30 participants have been 
recommended as meeting feasibility study aims (Julious, 2005; Lancaster, Dodd, & 
Williamson, 2004) and enabling estimates of the location of the mean and variability of 
parameters for future sample size calculations, when more robust data are unavailable 
(Abbott, 2014; Cook et al., 2018; Julious, 2005; Lancaster et al., 2004). 
This trial was registered with the Australian New Zealand Clinical Trials Registry 
(ANZCTR): ACTRN12618001639213.  
5.3.2 Setting 
The study was conducted in two health settings in two centres (Dunedin and 
Invercargill) in the South Island of New Zealand: a university-based school of 
physiotherapy and a public hospital outpatient department, respectively. A research 
administrator at the hosting research centre managed the recruitment process and 
provided administrative support for the study. To avoid any potential perception of 
coercion, the PhD researcher, a supervisor, and an advisor, who were all clinician 
employees of the local District Health Board, were not involved in gaining consent from 
potential participants.  
Three independent research assistants (RA), blinded to participants’ study group 
allocation, conducted the baseline, 4-week, and 6-month assessments (a practicing 
physiotherapist and two PhD students: one a trained kinesiologist, the other a trained 
physiotherapist). The assessors were trained according to an assessor manual 
(Appendix O). All assessments for each participant were made by the same assessor. 
Pre-enrolment clinical screening tests, conducted as part of the in-person eligibility 
screening, were carried out for participants at the Dunedin site by the PhD researcher 
and in Invercargill by the RA who was a practicing clinician. The PhD researcher, a 
registered hand therapist and physiotherapist with 17 years’ clinical experience, 






This study recruited those aged 40 years and over with symptomatic CMC OA who were 
either physician diagnosed or whose history suggested a diagnosis of thumb CMC OA; 
met stipulated minimum symptom severity: pain ≥4/10 and FIHOA score ≥6/30 
(recommended by OARSI clinical trials group for entry into OA clinical 
trials(Kloppenburg, Maheu, et al., 2015)); no other specific diagnosis; and fulfilled the 
inclusion criteria (Table 5.1). A more conservative approach was taken to selecting the 
age criteria compared to that of the qualitative study which used the criteria of 30 years, 
to add confidence that those included had the condition targeted by the intervention. A 
40-year minimum age is part of validated classification criteria for general OA (Hawker 
et al., 2008) and 40- or 45-years has tended to be selected for inclusion criteria in 
previous clinical trials conducted in people with thumb CMC OA (Gomes Carreira et al., 
2010; Rannou et al., 2009). Exclusion criteria are also listed in the table. Potential 
participants were screened initially by telephone and then in-person prior to baseline 
assessment, according to a screening schedule (Appendix P). The stipulated symptom 
severity thresholds were not advertised to potential participants to avoid inauthentic 
reporting of pain and function status (McAlindon et al., 2015). 
Since no specific clinical classification criteria for thumb CMC OA have currently been 
agreed, a method for identifying a history suggestive of hip and knee OA (Hawker et al., 
2008) was adapted for use in the thumb (Table 5.1), as was used in the qualitative study 
(Chapter 3). In addition, a clinical assessment adapted from the ACR criteria for 
generalised hand OA was performed (Altman et al., 1990). This followed an inclusive 
approach whereby one or more of four clinical tests were required to be positive. If an 
eligible participant presented with bi-lateral thumb pain, only the self-nominated 






Table 5.1 Inclusion and exclusion – Feasibility study 
Inclusion criteria Exclusion criteria 
• Aged 40+ years 
• Physician diagnosis of thumb CMC OA or 
answer “yes” to the question, “Have you 
experienced aching, discomfort, pain 
and/or stiffness in or around the joint at 
the base of either thumb on most days for 
at least 1 month (15 or more days of the 
month) during the past year?” and have no 
other specific diagnosis. 
• Minimum severity pain NRS 4/10 
• Minimum score FIHOA 6/30 
• One or more clinical sign(s) of 1st CMC joint 
involvement 
o Joint tenderness on palpation 
o Grind test 
o Pressure-shear test 
o ‘Step-off’ sign 
• Give written informed consent 
• Thumb non-symptomatic for the past 
month 
• Previous surgery of the symptomatic joint 
• Steroid injection in the past 6 months 
• Concurrent rheumatoid arthritis or any 
other significant inflammatory or 
autoimmune conditions affecting the hand 
such as scleroderma, systemic lupus 
erythematosus and psoriatic arthritis, or 
another kind of chronic pain syndrome or 
metabolic disorder, such as fibromyalgia, 
diabetic neuropathy, or gout. 
• Injury to thumb/wrist in past 6 months 
• Unable to comprehend instructions and 
outcome measure instruments in English. 
CMC, carpometacarpal joint; NRS, numeric rating scale; FIHOA, Functional Index for Hand Osteoarthritis. 
 
Participants were recruited between April and August 2019 from community and health 
settings, including secondary public health services in the two centres. Recruitment was 
by way of advertisement (Appendix Q) or clinician invitation (Appendix R). The 
recruitment strategy aimed to optimise the number of participants of Māori descent, 
following the same pathway outlined for the qualitative study in Chapter 3. Potential 
participants contacted the research administrator for a participant information sheet or 
downloaded this from the study website (Appendix S). A $20 petrol voucher reimbursed 
participants for their costs incurred in attending each of the three assessments; other 
benefits of involvement in the study included education and advice about thumb base 
OA. The consent process was completed by the study assessor, per the consent form 
(Appendix T).    
5.3.4 Intervention development 
The splint intervention and the standardised best practice usual care package were 





5.3.4.1 Literature review 
Based on findings of the systematic review reported in Chapter 5, the optimal duration 
and schedule for splint wearing is not currently known. The larger of the two studies 
included in the meta-analysis at the medium-term prescribed splint-wearing over-night 
for 12 months (Rannou et al., 2009), whereas the smaller study prescribed splint-
wearing in the day (Gomes Carreira et al., 2010). Other studies included in the 
systematic review described variable combinations of over-night or day-time wearing, 
or left wearing to participants. These showed positive but not significant results (Becker 
et al., 2013; Cantero-Téllez et al., 2017; Cantero-Tellez et al., 2018; Hermann et al., 2014; 
McKee & Eason-Klatt, 2006; Sillem et al., 2011; Weiss et al., 2000, 2004); in most cases 
the actual wear time was not reported. On the other hand, in the clinical literature, full-
time splint wearing in the initial treatment period (2- to 4-weeks) has been advocated 
by some United States authors for more than two decades (Colditz, 2000; Weiss & 
Falkenstein, 2005) although this has not been systematically investigated.  
Since a sufficient intervention dosage is needed to produce therapeutic effects, it is 
hypothesized, therefore, that insufficient intervention time may be a reason for the lack 
of short-term effect described in the previous literature. Prescription overnight in 
addition to daytime use is one way in which wearing time can be increased without 
interfering in daily activities. Therefore, stakeholder consultation was intended to 
achieve the highest dosage of splint wearing likely to be feasible and acceptable to 
patients and clinicians.  
Development of the standardised best practice usual care package was based on key 
recommendations from international guidelines for management of hand OA (Hochberg 
et al., 2012; NICE, 2014; Zhang et al., 2007), and informed by  best available evidence on 
exercise and joint protection in thumb CMC and hand OA (Dziedzic et al., 2015; Kjeken 
et al., 2013; O'Brien & Giveans, 2013; Scott, 2018; Shankland et al., 2017; Stamm et al., 
2002), expert opinion (Colditz, 2013; Taylor, 2000), and a clinical practice resource 
(Albrecht, 2015).  
Measures to optimise adherence to the splint intervention and standardised best 





aesthetically acceptable; advising how to successfully adapt activities without 
compromising the splint regime (O'Brien, 2012); establishing a trusting relationship by 
providing education and rationale for treatments (Smith-Forbes et al., 2016); catering 
for different learning styles (Harte & Law, 2017); and implementing a simple 
behavioural intervention (Cole, Robinson, Romero, & O'Brien, 2017). 
5.3.4.2 Stakeholder consultation 
From August to September 2018 the PhD researcher conducted stakeholder 
consultations with two focus groups (n=6, n=2) and a single one-to-one interview (n=1), 
which included experienced Hand Therapy New Zealand-registered hand therapists, 
both physiotherapists and occupational therapists, working in public and private 
practice settings in New Zealand. The consultation schedule included an introduction to 
the stakeholder discussion (Appendix U); a short presentation of the study and relevant 
literature (Appendix U.1); and a schedule of questions (Appendix U.2). Data were 
summarised under key points (Appendix U.3). The stakeholder process gave careful 
consideration to utility in a usual-care setting and identified the specific splint type and 
wearing schedule. Typical scenarios were outlined where a patient would be unable to 
wear the splint as instructed. These scenarios informed the instructions provided to 
participants concerning when not to wear the splint, or suggested potential solutions to 
issues with the splint. 
Written resources were compiled based on the literature reviews and stakeholder input 
for 1) the splint intervention and 2) the standardised best practice usual care. The 
written resources and instructions were pilot-tested with two lay people with thumb 
CMC OA. The splint intervention and best practice usual care package were acceptable; 
and changes were made to clarify concepts where necessary. 
5.3.5 The splint intervention  
Participants randomised to the intervention group were fitted with a soft neoprene 
hand-based splint (Procool T/R Splint Bound, @Therapy), issued a second (to have one 
to wash and one to wear) and instructed to wear a splint 20 hours out of 24 for 4 weeks. 





A simple behavioural intervention accompanied the splint prescription comprising 
dedicated time for skill acquisition and practice within the treatment session for 
donning and doffing the splint, providing feedback and encouragement, and fostering 
self-efficacy through problem-solving to incorporate the splint in everyday life (Cole et 
al., 2017). Minor modifications were made to the splint as required for optimal fitting 
while maintaining splint aesthetic and integrity: for example, shortening or altering the 
shape of the thumb exit space by cutting, or altering the length of the strap through the 
web space or wrist using NRX Strap (@Therapy) or OneStrap (Mitre10 Mega). The 
splint intervention procedure comprised a single face-to-face consultation, occurring 
immediately after delivery of the standardised package of best practice usual care, and 
took a maximum 20 minutes per participant. The written resource, a single-sided A4 
information sheet specific to the left (Figure 5.1) or right hand (Appendix V) was also 
provided. The 4-week time point marked the end of the intervention period. Thereafter, 
participants were invited to keep the splints that had been issued and to use them at 











5.3.6 The standardised best practice usual care package 
Both groups received a standardised package of recommended best-practice usual care. 
This was delivered by the PhD researcher at a single face-to-face consultation taking 
approximately 25 minutes. The package comprised verbal and written education about 
thumb CMC OA and joint care principles, simple hand exercises, and advice to increase 
general activity levels, for example, walking or pool (NICE, 2014), together with advice 
to continue with usual physician care. Also included was the written resource, a 2-sided 
A4 information sheet specific to the left (Figure 5.2 and Figure 5.3) or right hand 
(Appendix W), and additional verbal cues (Appendix W.1). The same behavioural 
approach was taken as for the splint intervention.  
Participants in either group who required assistance during the 4-week treatment 
period were able to contact the research administrator to ask the treating therapist to 
make an arranged call to the participant. If any issue could not be resolved by telephone 
consultation, a follow-up treatment session was arranged. Participants were not offered 
additional treatment after completion of the 4-week intervention period; participants 
randomised to the comparator intervention group were not offered the splint 
intervention on completion of the intervention as there was insufficient evidence to 
demonstrate that the intervention would be effective.  
At the end of the 4-week intervention period and following the 4-week follow-up 
assessment, the treating therapist counselled the participant regarding intervention 
received by the other group, reiterated that the treatment period was complete but to 
advise that, at the participant’s discretion, the best practice usual care or splint 

















5.3.7 Primary feasibility outcomes and criteria 
The following specific criteria were pre-determined to assess feasibility:  
5.3.7.1 Recruitment 
Recruitment was evaluated based on the number of participants recruited in 4 months. 
The number who responded to advertisements, the outcome of screening, and the 
number enrolled were recorded, by location, on an Excel spreadsheet and reviewed 
weekly by the research administrator and the researcher. The feasibility criterion was 
recruitment of 30 participants in a 4-month period. 
5.3.7.2 Retention 
Retention was defined as the number who completed assessments at the 4-week and  
6-month time points. The feasibility criterion was retention >85% at 6-months. 
5.3.7.3 Intervention acceptability 
Interviews were conducted by the researcher following the 4-week and 6-month 
assessments to obtain participants’ views on acceptability of the interventions and the 
assessment procedures, according to interview schedules (Appendix X, Appendix Y). 
The feasibility criterion was acceptability >90%. 
5.3.7.4 Notification of adverse events 
Participants were asked to notify the research administrator of any adverse events. 
These were forwarded to the study-treating therapist who addressed any concerns with 
the participants by telephone in the first instance and in person if necessary. Referral 
for further care could be made if required. All adverse events were recorded and, if 
significant, brought to the study-monitoring committee. Splinting is a low-risk 
intervention and few adverse events were anticipated. The feasibility criterion was no 
significant adverse events.  
5.3.8 Secondary outcomes – feasibility  
Secondary aims were to 1) confirm the time needed for study procedures to be 
undertaken by the assessor and clinician; 2) achieve intervention implementation in 
over 80% of prescribed instances (days of the week); 3) maintain satisfactory quality-





recruitment and randomisation; 5) explore the potential role of imaging (x-ray and 
ultrasound) in evaluating participant characteristics at baseline, and the feasibility of 
using imaging to identify a subgroup of participants who might be more responsive to 
treatment; 6) explore whether treatment outcomes are consistent with expectations 
based on previous literature.  
5.3.8.1 Intervention fidelity 
Adherence to either the splint or best practice usual care interventions, or both, was 
assessed by a daily log completed by the participants according to a template form 
specific to each group (Appendix Z, Appendix Z.1). Participants in the splint group 
recorded the number of hours the splint was worn and any reasons for not wearing the 
splint. Participants in both groups recorded exercises completed, any reasons for not 
completing exercises, any concerns or problems, and the advice followed. The clinical 
research administrator telephoned, texted, or emailed reminders (as preferred) on a 
weekly basis to remind participants to complete the daily log.  
5.3.8.2 Quality audit 
The quality of intervention delivery and outcome assessment was audited on two 
occasions each by the PhD primary supervisor using pre-defined quality audit tools 
based on those used in the U.K. Osteoarthritis Thumb Therapy (OTTER) trial [Adams, 
Personal Communication2] (Appendix AA, Appendix BB). The quality of the intervention 
delivery and outcome assessment was also monitored by the PhD researcher and in 
consultation with the assessors. 
5.3.8.3 Imaging 
Imaging at baseline was performed as recommended for studies investigating 
effectiveness of treatment for symptoms or disease status in hand OA (Hunter et al., 
2015). X-ray imaging was obtained for each participant to characterise, at baseline, the 
radiological involvement of the CMC joint, unless a recent good quality x-ray (< 6 
months) was available. A consultant orthopaedic surgeon interpreted the x-rays 
according to the OARSI-atlas (Altman & Gold, 2007) and the modified E-L grade (Eaton, 
Lane, Littler, & Keyser, 1984). The E-L stages were defined as follows: 1 – slight joint 
 





space widening, normal articular contours; 2 - mild JSN, spurs or debris ≤2mm, early 
erosion trapezium; 3 – marked JSN, spurs or debris ≥2mm, subchondral sclerosis; 4 - 
marked JSN and articular destruction, involving S-T joint (Eaton et al., 1984). The 
OARSI-atlas grades for individual features of osteophytes and JSN were defined as: 0 – 
normal; 1 – mild change; 2 – moderate change; 3 – severe change (Altman & Gold, 
2007). Scores were reported directly into an Excel spreadsheet according to a 
standardised reporting form (Appendix CC). A Professor of Radiology undertook a 
second independent interpretation and both readings were compared to assess inter-
rater reliability of the x-ray scores.   
Ultrasound imaging was performed in a convenience sample of seven participants at the 
Dunedin site. This was undertaken and interpreted independently by two consultant 
rheumatologists, experienced and trained in musculoskeletal ultrasound, according to a 
recommended scanning protocols and atlases (Hammer et al., 2011; Mathiessen et al., 
2013). Ultrasound was performed using a using a NextGen LOGIQ model e machine (GE 
Healthcare, Chicago, IL) with a 12L RS 4.2 – 13.0 MHz linear array transducer 
(optimized for power Doppler for each individual). Grey scale images were graded for 
osteophytes, and scored as follows: 0 – no osteophytes, i.e. a smooth cortical surface; 1 – 
small and distinct cortical protrusion(s) of the bony surface; 2 – larger protrusion(s) 
which may have broad base(s); 3 – very large protrusion(s) which may have very broad 
base(s) (Mathiessen et al., 2013). Grey scale and power Doppler images were 
interpreted for presence of joint fluid and vascularisation, and together graded for 
synovitis as follows: 0 – none; 1 – minor presence of ultrasonographic pathology; 2 – 
moderate presence of ultrasonographic pathology; 3 – major presence of 
ultrasonographic pathology (Hammer et al., 2011). Each participant was scanned by 
both clinicians and scoring reported on a standardised form (Appendix DD). After 
scanning the first three participants the two rheumatologists completed a consensus 
exercise conferring on scores that differed, repeating the ultrasound scanning, and 
coming to agreement about the scores.  
Clinicians involved in the acquisition, or reading, or both, of x-ray or ultrasound images 





5.3.9 Secondary outcomes – clinical outcomes 
Data were collected and analysed to investigate the impact of the splint versus no splint 
on pain, self-reported function, QoL, global rating of change (GROC), OMERACT-OARSI 
responder criteria, use of other treatments including medication, and physical 
performance variables (Table 5.2). The clinical assessments were chosen for their 
potential to be primary or secondary outcomes in a future full clinical trial. These 
measures were based on core outcome sets recommended for hand OA (Kloppenburg, 
Maheu, et al., 2015) and OA generally (Fitzgerald et al., 2015), and impact identified as 
important and meaningful to people with the condition, as outlined in Chapter 3. Due to 
the small sample size, these preliminary data were not collected in anticipation of 
reaching significance, but rather to identify areas of interest which may inform future 
studies. The data were also collected to inform, but not be the sole basis for, 
specification of an effect size for sample size calculation for a future full trial.  
Clinical assessments were collected at baseline, then at 4-weeks and 6-months 
according to pro-forma schedules of assessments (Appendix EE, Appendix EE.1, 
Appendix EE.2). These time points were chosen to provide 1) a time-frame relevant to 
the long-term nature of thumb CMC OA (6-months), and 2) short-term assessment  
(4-weeks) for participant retention and engagement, as well as assessing adverse 
events and evaluating the immediate impact of the intervention. 
5.3.9.1 Pain 
Pain on average and pain at night were rated on 11-point NRS, anchored by the 
statements, ‘No pain’, and ‘Extreme pain’ (Hawker, Mian, Kendzerska, & French, 2011) 
(Appendix FF). The definitions and time frame for recall were “…what your pain at the 
base of your thumb has usually been like on average during the past week” and “what 
your pain at the base of your thumb has usually been like at night during the past 
week”. A minimal detectable change (MDC) of 1.3 has been estimated for pain NRS, 
derived from a knee OA population (Alghadir, Anwer, Iqbal, & Iqbal, 2018). An MCID of 
2-points has been estimated, derived from cohorts with chronic conditions including OA 
(Farrar, Young Jr, LaMoreaux, Werth, & Poole, 2001; Hawker, Mian, et al., 2011). An 





Table 5.2 Secondary clinical outcome measures 
Assessment – secondary outcomes: Measurement scale: Time*: 
Pain numeric rating scale (NRS) for pain at base of thumb, 
on average in past week 
0 – 10  0, 4, 26 
Pain at night (NRS), on average in past week 0 – 10   0, 4, 26 
Functional Index for Hand Osteoarthritis (FIHOA) (10 
questions relating to function, rated 0-3; low score is 
better)  
0 – 30  0, 4, 26 
Additional Functional Questionnaire (AFQ)  0 – 3  0, 4, 26 
Quick Disability of the Arm, Hand and Shoulder 
(QuickDASH) (11-item questionnaire, rated 0-4; low score 
is better) (Aasheim & Finsen, 2014; Beaton, Wright, Katz, 
& Upper Extremity Collaborative, 2005)(Aasheim & 
Finsen, 2014; Beaton et al., 2005) 
0 – 100  0, 4, 26 
Global Rating of Change (GROC) -5 to +5 4, 26 
Patient-reported health status (EQ-5D-5L Index score and  
EQ-5D-5L VAS score) 
0.0 – 1.0  
0 – 100  
0, 4, 26 
NSAID Equivalent score (+/- other medications)  0, 4 
Other interventions sought (including surgery)  4, 26 
Power grip strength, dynamometer (best of three)  kilogram-force 0, 4, 26 
Pinch grip strength, dynamometer (best of three) kilogram-force 0, 4, 26 
Inter-digit distance (IDD) (length of 1st web space, ruler)  millimetres  0, 4, 26 
CMC joint palmar abduction (Pollexograph – purpose-built 
box with protractor printed on top)  
degrees 0, 4, 26 
Grip Ability Test (GAT) (test of functional performance, 
timed) 
seconds 0, 4, 26 
OMERACT-OARSI responder yes / no 4, 26 
EQ-5D-5L, EuroQuol 5-Dimension, 5-Level; VAS, visual analogue scale; NSAID, non-steroidal anti-
inflammatory; CMC, carpometacarpal; OMERACT-OARSI, Clinical Trials Response Criteria Initiative and 
Outcome Measures in Rheumatology and Osteoarthritis Research Society International. 
* 0 = baseline, 4 = 4-weeks, 26 = 26-weeks (6-months) 
 
5.3.9.2 Self-reported function 
Three self-report measures of function were used: the FIHOA, the QuickDASH, and an 
Additional Functional Questionnaire (AFQ).  
The FIHOA, validated in hand OA populations, contains 10 items relating to function, 
scored on 0-3 scale (total score 0 to 30, lower is better) (Dreiser, Maheu, & Guillou, 





functional measure recommended by the OARSI clinical trials group (Kloppenburg, 
Maheu, et al., 2015) and OMERACT hand OA working group (Kloppenburg, Boyesen, et 
al., 2015) and is freely available. As described in Chapters 1 and 3, the FIHOA has faults 
including clinician-centric development and lack of modern-day relevance, and it poorly 
represents the functional impact for people with thumb CMC OA. Therefore, the 
QuickDASH was chosen as an additional measure. No studies have previously defined a 
MCID for the FIHOA. An MDC has been calculated to be 5.6 points (Moe et al., 2010); 
although previous studies have claimed as MDC an arbitrarily determined 3 points, or 1 
scale point (a reported minimal potential detectable change (MPDC) (Bellamy, Carr, 
Dougados, Shea, & Wells, 2001)) for sample size calculation and interpretation of 
results (Damman et al., 2018; Deveza et al., 2017).  
The QuickDASH is widely used and recommended in the surgical setting for thumb CMC 
OA (Martou, Veltri, & Thoma, 2004; Wajon et al., 2015). The 11-item QuickDASH is a 
validated shortened version of the original 30-item DASH (Aasheim & Finsen, 2014; 
Beaton et al., 2005). The 30-item DASH has existing evidence for reliability in a range of 
populations (Beaton et al., 2005; Franchignoni et al., 2014; Sorensen, Howard, Tan, 
Ketchersid, & Calfee, 2013). It contains items relevant to the functional impact and 
participation restrictions experienced by people with thumb CMC OA (Chapter 3). 
Scores range from 0 to 100 where 0 = no disability and 100 = maximum disability 
(Beaton et al., 2005). In relation to the QuickDASH an MCID of 15 points has been 
suggested (Franchignoni et al., 2014; Sorensen et al., 2013). Smaller MCIDs of 7 to 8 
points have also been calculated but these lower values were derived using less robust 
methods, that is, based on a generous interpretation of using a 1-point change on  
7-point GROC scale for an anchor (Kazmers et al., 2020). Estimates of MDC for the 
QuickDASH range from 11.2 points to 13 points (Franchignoni et al., 2014; Mintken, 
Glynn, & Cleland, 2009; Sorensen et al., 2013). 
While the QuickDASH contains more items relevant to people with thumb CMC OA than 
the FIHOA, including impact on work, social interactions, and sleep interference 
(Chapter 3), the instrument is a region-specific rather than condition-specific measure 
and this may have implications for sensitivity to change in thumb CMC OA (Donnelly & 





example, the inclusion of paraesthesia is not directly relevant to the condition of thumb 
CMC OA.  
The third self-report measure of function was an additional set of 10 functional items 
based on findings from Chapter 3 These were formulated into an ‘Additional Functional 
Questionnaire’ (AFQ) for exploratory use and scored as per the FIHOA (Appendix GG).  
5.3.9.3 Health-related quality of life 
Health-related QoL was evaluated using the newer 5-Level EQ-5D-5L version of the EQ-
5D (Herdman et al., 2011; The EuroQol Group, 1990). The cumulative ‘health state’ 
which lists scores of each of the five levels was converted to an index value (van Reenen 
& Janssen, 2015) using the EQ-5D-5L Crosswalk Index Value Calculator, and the 
published value set from the United Kingdom (EuroQol Research Foundation, 2020; The 
EuroQol Group, 1990; van Hout et al., 2012) (0.0 to 1.0, higher is better). The EQ-5D-5L 
index score has an MDC of 0.03 to 0.12 derived from populations of people with 
diabetes (McClure, Sayah, Ohinmaa, & Johnson, 2018) and cancer (Pickard, Neary, & 
Cella, 2007). 
5.3.9.4 Global rating of change 
The global nature of the Global Rating of Change (GROC) scale is presumed to allow 
participants to focus their response to those things that matter the most to them 
(Kamper, Maher, & Mackay, 2009). Therefore, the self-reported pain and function 
instruments were supplemented with the 11-point GROC scale at 4-weeks and at  
6-months (Kamper et al., 2009). The question was formulated with respect to 
participants’ ‘thumb base problem’ (Appendix HH). An MDC of 0.45 points and MCID of 
2 points have been suggested for the 11-point GROC scale (Kamper et al., 2009). 
5.3.9.5 Responder criteria 
The OMERACT–OARSI responder criteria combine pain, function, and patients’ global 
assessment to provide a standardised assessment of whether a patient has responded to 
an intervention or not (Fitzgerald et al., 2015). This approach takes into account the 
patient perspective and is recommended for clinical trials in OA (Fitzgerald et al., 2015). 
Furthermore, since results are easy to interpret, findings are more likely to be 





important change set by this measure provides assurance that measured change is 
indeed meaningful (McGlothlin & Lewis, 2014; Pham et al., 2004). However, a limitation 
is that criteria were drawn from data and expert-clinician opinion based on studies of 
hip and knee OA only (Pham et al., 2004) and no criteria yet exist for hand OA 
conditions (Kloppenburg, Maheu, et al., 2015).  
Nevertheless, these responder criteria have been usefully employed across a wide range 
of OA trials and interventions, including in hand OA (Dziedzic et al., 2015; Hennig, 
Hæhre, et al., 2015; Osteras et al., 2014). Therefore, this measure is explored for its use 
in splinting for thumb CMC OA. Responders were defined as 1) improvement in pain or 
physical function ≥50% and an absolute change ≥20 on 0-100 scale; or 2) improvement 
≥20% and an absolute change ≥10 in at least two of the following three categories: pain, 
physical function, and GROC (Pham et al., 2004). 
5.3.9.6 Medication use 
Participants’ usual use of medication, including dosage of NSAIDs, where available, was 
self-reported by participants at the first and second assessments; change in medication 
use during the 4-week intervention period was recorded by participants in their daily 
log. Other pharmacological or surgical interventions were similarly recorded. Non-
steroidal anti-inflammatory drug use was transformed into an NSAID Equivalent Score 
based on comparable dosage parameters (Dougados et al., 2012; Dougados et al., 2011), 
assuming stable use for 7 days prior to baseline assessment.  
5.3.9.7 Physical performance 
Performance measures included the following: thumb palmar abduction ROM measured 
using the Pollexograph (de Kraker, Selles, Schreuders, Hovius, & Stam, 2009; de Kraker, 
Selles, Schreuders, Stam, & Hovius, 2009), as well as a novel modification of the inter-
metacarpal distance (de Kraker, Selles, Schreuders, Stam, et al., 2009; Murugkar, 
Brandsma, Anderson, Gurung, & Pun, 2004) – characterised as the ‘inter-digit distance’ 
(IDD) (Figure 5.4) – calculating the mean of three measures; maximum grip and pinch 
strength using dynamometers, recording the best of three attempts (Buhler, 2007; 
Mathiowetz, 1990); and the timed Grip Ability Test (GAT) functional performance test 





Measures of palmar abduction were selected because it has been hypothesised that 
increased first web space may be a mechanism of effect of splinting for thumb CMC OA 
(Rannou et al., 2009). Although this was not demonstrated in a previous study of night-
time splinting (Rannou et al., 2009), a more recent study of exercise in general hand OA 
did find a significant increase in first web space length in the intervention group 
compared associated with reduced pain (Osteras et al., 2014). Another study has used a 
measure of ‘hand span’ which measured the linear distance from tip of thumb to tip of 
little finger with the fingers fully-spread. This measure, similar to the IDD, was found to 
correlate significantly with improved self-reported function of a post-arthroplasty 
thumb CMC OA population even though most other physical measures recorded in the 
study, including strength, did not (MacDermid et al., 2007). For the present study, IDD 
landmarks were chosen for their proximity to the thumb CMC, easy identification and 
anecdotally, the PhD researcher has usefully employed them in clinical practice for over 
10 years.   
The Pollexograph is a portable 21 cm x 13 cm x 7 cm cardboard box upon which was 
printed a 180 degree reversible scale, constructed according to published specifications 
(de Kraker, Selles, Schreuders, Hovius, et al., 2009). Thumb palmar abduction is 
measured with the hand stabilised against the box and using a ruler to align skin 
markings identifying CMC motion to the degree attained on the scale. There is some 
evidence of reliability of the Pollexograph in healthy adults (de Kraker, Selles, 
Schreuders, Stam, et al., 2009), and it has shown superior reliability compared to a 
goniometer in assessment of hypoplastic thumbs (de Kraker, Selles, Schreuders, Hovius, 
et al., 2009). However, reliability has not been assessed in populations with thumb CMC 
OA.    
Previous estimates of MCID for grip strength are 6.0 KgF to 6.5 KgF (Benaim, Blaser, 
Leger, Vuistiner, & Luthi, 2019; Bohannon, 2019) derived from a 1-year post-distal 
radius fracture population (mean age 55 years) (Kim, Park, & Shin, 2014) and a study in 
adults with chronic musculoskeletal conditions (not including hand OA) (Benaim et al., 
2019). Markedly smaller MCIDs for grip strength, of 0.84 KgF to 1.12 KgF, have also 
been suggested (Villafañe, Valdes, Bertozzi, & Negrini, 2017). These values should be 





CMC OA, they were calculated using a distribution-based approach in a cross-sectional 
cohort matched with healthy controls. Although they may not be true MCIDs, these 
values may serve as interim MDCs. These same authors reported the only published 
values (also judged to be MDC rather than MCID, for the same reasons as above) for 
pinch strength, 0.23 KgF to 0.33 KgF (Villafañe et al., 2017),  
The GAT was chosen for use in this study for its brevity, low cost, and inclusion of tasks 
involving the thumb in gross grasp, power pinch, and fine pinch (Dellhag & Bjelle, 1995; 
Poole, 2011). It is a shortened version of Sollerman’s Grip Function Test (Dellhag & 
Bjelle, 1995). The three key functions in particular were identified as important from 
the patient perspective in the qualitative interviews in Chapter 3. Furthermore, in 
Chapter 2 these functions were reported as of significance anatomically in thumb CMC 
OA aetiology. The GAT has demonstrated excellent reliability, good internal consistency 
and discriminate validity, sensitivity to change, and an estimated MCID of 8 seconds in 
an RA population (Dellhag & Bjelle, 1995). Little literature exists for the GAT’s 
measurement properties in other populations, including CMC OA.  
All measures were described in detail in the Assessor Manual (Appendix O). Grip and 
pinch strength were measured using the same dynamometer and pinch grip meter, 







Figure 5.4 Active thumb palmar abduction inter-digit distance (IDD) measurement, 
measured from the intersection between the volar and dorsal skin creases on the 
radial aspect of the proximal interphalangeal joint of the index finger and where 
the thumbnail exists the nail bed (at the ulna border of the junction of the nail bed 
and the hyponychium) on the distal-ulna aspect of the thumb. 
5.3.10 Baseline characteristics 
Patient characteristic variables were collected at baseline (Table 5.3) using a tailored 
and pre-tested data collection form, slightly modified from the qualitative study 
questionnaire (Appendix II) 
5.3.11 Randomisation and allocation concealment 
The randomisation schedule was prepared by the research administrator using 
computerised sequence generation and allocations concealed in series of opaque 
envelopes according to three randomisation blocks (dominant vs nondominant vs 
ambidextrous), in block sizes of six. Following the consent process and baseline 
assessment, the next envelope in sequence in the relevant block was opened by the 







Table 5.3 Participant baseline characteristics 
Participant characteristic variable:  Measurement scale: 
Age years 
Sex male / female   
Ethnicity  
Descent  
Work status Full time / part time / not 
working / student / in the home / 
unemployed or seeking work / 
age retired / disability pension / 
sick leave 
Dominant hand Left / Right / Ambidextrous 
Hand with thumb CMC OA Left / Right / Both 
Thumb CMC OA diagnosed by health care provider?   Yes / No 
If yes, which health care provider?  GP, physio/hand therapy, 
rheumatologist, surgeon 
How long have you had your thumb CMC problem(s)? years 
Other joints with OA (besides your hands):  
Other medical conditions  (e.g. diabetes, heart problems) 
Current medications   
Current and previous treatments for thumb CMC 
problem 
Yes / No / When, for: topical 
cream (type); injections; physio 
(exercise, advice, splint); other 
Thumb MCP hyperextension at rest degrees 
Joint tenderness on palpation* Present / absent 
Grind test*  Positive / negative 
Pressure-shear test* Positive / negative 
‘Step-off’ sign* Present / absent 
BMI  
X-ray: standard PA view, OARSI-atlas grade for 




Ultrasound: grade for synovitis and osteophytes   0-3 semi-quantitative scale, and 
dichotomous “Present / Not 
present” 
CMC, carpometacarpal joint; OA, osteoarthritis; MCP, metacarpophalangeal joint; BMI, Body Mass 
Index; PA, posterior-anterior; OARSI, Osteoarthritis Research Society International; JSN, joint space 
narrowing.  







It was not possible to fully blind the participants or the treating clinicians to group 
allocation due to the nature of the study intervention. However, to provide partial 
blinding, the study hypothesis was not revealed to participants until after their 4-week 
follow-up visit. Information provided to participants at recruitment explained that the 
nature of the treatments offered to the other trial group would be concealed from them 
until after the 4-week follow-up, in order that their perceptions about the intervention 
did not influence the study findings at this time point. Instruction was given to the 
treating therapist, assessors, and all health professionals and administration staff 
involved in participants’ care to keep this information concealed until after the 4-week 
follow-up. Outcome assessors were not involved in participant care and were blinded to 
group allocation. Participants’ splints were removed prior to follow-up assessments and 
participants were instructed not to disclose information about their treatment to 
maintain assessor blinding.  
Data were analysed by the researcher, who was also the study clinician. The researcher 
was not blinded to participant group allocation. 
5.3.13 Data analysis 
Planned data analysis of primary outcomes was documented a priori, published in a 
protocol paper in an academic journal, and adhered to.   
Data analysis comprised descriptive analysis of the primary and secondary feasibility 
outcomes and appraisal against the feasibility criteria. Baseline and adherence-related 
participant characteristics were presented using descriptive statistics: mean, SD, 95% 
CI for scale and ordinal self-reported outcomes data, and case number and percentage 
for nominal data. 
To examine individual variation in treatment response across time, modified Brinley 
plots (Blampied, 2017) were used to show change in the dependent variables 
considered as candidates for primary outcome in a future full trial (pain on average 
NRS, pain at night NRS, FIHOA, and QuickDASH). Each individual participant’s scores on 
the same dependent variable at different time points were plotted on a scatter plot 





close to the diagonal (45°) represented no change. Parallel lines depicting the minimal 
reliable change, that is change beyond measurement error or MDC (Lin et al., 2009; 
Portney, 2015) and MCID, where available, aided interpretation of the reliability and 
clinical importance of individual improvement or deterioration (Blampied, 2017). The 
proportion for whom change in the dependent variable exceeded MDC or MCID was 
calculated for each group at each time-point. This approach takes the individual as the 
unit of analysis, enhancing the ecological validity of the construct (Asenlof, Denison, & 
Lindberg, 2006). 
Within-group differences in secondary outcome measures (scale and ordinal data) at 
different time points were described using paired t-tests and between-group differences 
using independent sample t-tests; both were compared to available MDC and MCID, to 
further inform selection of outcome measures for a future full-size trial. The number 
and ratio of responders were presented for each group (Fitzgerald et al., 2015). Inter-
rater reliability of imaging scores was assessed using Cohen’s Kappa.  
All data were entered into Excel spreadsheets along with a full data dictionary, and 
checked by an independent assistant. Data were then imported into IPM SPSS Statistics 
version 25.0 for analyses. Advanced statistical analyses, including hypothesis testing 
were not undertaken due to the small sample size and the study’s primary aim of testing 
feasibility. Patient-reported outcomes were treated as scale data while imaging scores 
were treated as nominal data. Analysis followed the intention-to-treat principle. 
Complete case analysis was applied where more than one item was missing for an 
outcome or the outcome was missing in entirety. A missing item on the QuickDASH was 
dealt with by adjusting the calculation as per instrument instructions (Beaton et al., 
2005). The FIHOA has no prescribed rules for missing items so the approach taken was 
to compute the mean based on the number of items completed.  
5.4 Results 
Recruitment took place between April and August 2019 and data collection from April 
2019 to March 2020. Recruitment ceased once the target of 30 eligible participants was 





participant allocated to the splint group withdrew prior to implementation of the 
intervention. 
Of note, in the early phase of recruitment four potential participants recruited and 
randomised in error resulted in an additional four baseline assessments completed 
including x-rays; these were also three of the seven who underwent ultrasound imaging. 
The allocation error was due to misinterpretation of inclusion criteria whereby a score 
of 6 or more on the AFQ was incorrectly understood to have met the inclusion criteria 
for functional outcome when the FIHOA score had not reached 6/30. Although clinical 
baseline measures of these four participants were not included in the data presented as 
part of the present study, their imaging data are included but only for the purpose of 
evaluating inter-rater reliability of the x-ray scoring method. The three potential 
participants randomised in error for whom ultrasound data were available were those 
in whom the ultrasound imaging consensus process was undertaken; therefore, these 







Figure 5.5 Participant flow diagram 
5.4.1 Baseline characteristics 
Just under two-thirds of participants were female, mean age 66.9 (SD 10.2) years, and 
just over two-thirds were in paid employment part- or full-time. The two groups were 
similar in most baseline characteristics including number of dominant hands enrolled 







Table 5.4 Baseline characteristics of study participants by group 
Variables 
Splint group Comparator group 
N=15 N=15 
N (%) or mean (SD) N (%) or mean (SD) 
Recruitment, N (%)   
 Centre 1 10 (66.7) 7 (46.7) 
 Centre 2 5 (33.3) 8 (53.3) 
Age (years) 68.33 (11.88) 65.40 (8.28) 
Sex, female (%) 6 (40) 13 (86.7) 
Descent   
 NZ/other European (%) 13 (86.7) 14 (93.3) 
 NZ Māori (%) 1 (6.7) 1 (6.7) 
 Missing 1 (6.7) - 
Paid employment   
 Full or part-time (%) 12 (80) 9 (60) 
 Age-retired (%) 3 (20) 5 (33.3) 
Dominant hand enrolled (%) 8 (53.3) 9 (60) 
Clinician diagnosed thumb CMC OA (%) 6 (40) 10 (66.7) 
Duration of symptoms (years) 5.47 (7.11) 6.31 (9.93) 
Other joint involvement (%) 15 (100) 11 (73.3) 
 Contralateral thumb CMC (%) 8 (53.3) 9 (60) 
 Other finger joint(s) (%) 5 (33.3) 2 (13.3) 
 Other hand joints (wrist) (%) - 1 (6.7) 
 Knee(s) (%) 5 (33.3) 3 (20) 
 Hip(s) (%) 1 (6.7) 4 (26.7) 
 Spine (neck or lower back) (%) 3 (20) 1 (6.7) 
 Feet or ankle(s) (%) 1 (6.7) 2 (13.3) 
 Shoulder(s) (%) 2 (13.3) - 
Co-morbidities 6 (40) 8 (53.3) 
 Diabetes or pre-diabetes 3 (20) 2 (13.3) 
 Heart condition 1 (6.7) - 
 High blood pressure - 3 (20.0) 
 Epilepsy - 1 (6.7) 
 Low back pain or spinal pathology 1 (6.7) 1 (6.7) 
 Migraines - 1 (6.7) 






Splint group Comparator group 
N=15 N=15 
N (%) or mean (SD) N (%) or mean (SD) 
 Thyroid - 1 (6.7) 
 Cancer 1 (6.7) 1 (6.7) 
 Sleep apnoea - 1 (6.7) 
 Asthma 1 (6.7) - 
Medications for pain relief   
 Paracetamol (%) 3 (20) 5 (33.3) 
 NSAID (%) 6 (26.7)* 3 (20) 
  NSAID Equivalent score 31.91 (65.08)* 23.35 (52.18) 
 Codeine (%) 2 (13.3) 1 (6.7) 
 Other pain relief (%) - 1 (6.7) 
Positive clinical tests   
 Step-off appearance (%) 15 (100) 13 (86.7) 
 Tender on palpation (%) 14 (93.3) 15 (100) 
 Grind test (%) 11 (73.3) 12 (80) 
 Pressure-shear test (%) 13 (86.7) 12 (85.7)* 
BMI 27.3 (5.00) 29.8 (7.90) 
MCP hyperextension   
 At rest (deg) 2.5 (10.03) 6.1 (8.46) 
 Active (deg) 15.5 (12.26) 13.1 (7.89) 
Pain on average (0-10) 5.7 (1.58) 5.8 (1.48) 
Pain on average at night (0-10) 5.3 (2.34) 5.2 (2.76) 
FIHOA (0-30) 12.2 (5.79) 10.3 (4.23) 
Additional Functional Questionnaire (0-
30) 
11.7 (5.28) 10.7 (4.13) 
QuickDASH (0-100) 32.8 (15.57) 33.9 (16.60) 
EQ-5D-5L Index score (0.0-1.0) 0.682 (0.169) 0.656 (0.169) 
EQ-5D VAS (0-100) 81.47 (13.56) 82.67 (10.18) 
Pollexograph 43.5 (10.53) 45.8 (8.59) 
Inter-digit distance (mm) 101.3 (18.18) 95.2 (17.60) 
Grip Ability Test (seconds) 22.3 (9.36) 17.6 (5.73) 
Grip strength dynamometer    
 Contralateral (KgF) 32.1 (11.62) 24.7 (8.66)* 
 Study hand (KgF) 30.2 (11.41) 21.9 (6.88)* 






Splint group Comparator group 
N=15 N=15 
N (%) or mean (SD) N (%) or mean (SD) 
 Contralateral (KgF) 6.7 (2.44) 6.6 (1.92) 
 Study hand (KgF) 6.2 (2.32) 5.5 (1.73) 
NZ, New Zealand; CMC, carpometacarpal joint; NSAID, non-steroidal anti-inflammatory; BMI, Body 
Mass Index; MCP, metacarpophalangeal joint; FIHOA, Functional Index for Hand Osteoarthritis; 
QuickDASH, Quick Disabilities of the Arm, Shoulder, and Hand Questionnaire; EQ-5D-5L, EuroQuol 5-
Dimension, 5-Level; VAS, visual analogue scale; KgF, kilogram-force. 
* N=14 due to one missing item 
 
The intervention group had a higher proportion of male and employed, and fewer with 
clinician-diagnosed CMC1 OA. This group also had a higher proportion with other joint 
involvement, greater grip strength, and less MCP hyperextension at rest compared with 
the comparator intervention group. The GAT was 4.7 seconds faster in the comparator 
intervention group. The NSAID Equivalent score was also higher in the comparator 
intervention group than in the splint group.  
The baseline measures for the withdrawn participant in the splint group did not differ 
from those of the remaining participants.   
X-ray scoring predominantly classified disease as mild or moderate, i.e. OARSI or Eaton 
grades 2 or 3. Four to six participants were classified as having early OA, i.e. Eaton grade 
1. A similar number were classified to have severe OA (Table 5.5).  
Four of the 30 study participants underwent US imaging, two from the comparator 
intervention group and two from splint group. Synovitis was visualised in two 
participants of the two in the comparator intervention group and in one participant of 
the two in the splint group (Table 5.5). Examples of grading for synovitis on ultrasound 
imaging are presented in Figure 5.6. Structural changes were also identified on 
ultrasound imaging in three of four participants. Examples of grading for osteophytes 





Table 5.5 Baseline imaging scores of study participants by group 
Variable 
Splint group Comparator group 
N=15 N=15 
N (%) or mean (SD) N (%) or mean (SD) 
X-ray imaging scores Reader 1 Reader 2 Reader 1 Reader 2 
 Eaton-Littler (1-4)     
  Grade 1 4 (26.7) 2 (13.3) 1 (6.7) 1 (6.7) 
  Grade 2 3 (20) 6 (40) 6 (40) 7 (46.7) 
  Grade 3 6 (40) 6 (35.7) 5 (33.3) 6 (40) 
  Grade 4 2 (13.3) 1 (6.7) 3 (20) 1 (6.7) 
 OARSI Osteophyte (0-3)     
  Grade 0 3 (20) 4 (26.7) 0 (0) 2 (13.3) 
  Grade 1 3 (20) 5 (33.3) 7 (46.7) 8 (53.3) 
  Grade 2 5 (33.3) 4 (26.7) 4 (26.7) 3 (20) 
  Grade 3 4 (26.7) 2 (13.3) 4 (26.7) 2 (13.3) 
 OARSI JSN (0-3)     
  Grade 0 1 (6.7) 2 (13.3) 0 (0) 1 (6.7) 
  Grade 1 5 (33.3) 8 (53.3) 7 (46.7) 8 (53.3) 
  Grade 2 5 (33.3) 5 (33.3) 3 (20.0) 5 (33.3) 
  Grade 3 4 (26.7) 0 (0) 5 (33.3) 1 (6.7) 
Ultrasound imaging scores (N=2) (N=2) 
 Osteophyte score (0-3)     
  Grade 0 1 (50) 1 (50) 0 (0) 0 (0) 
  Grade 1 1 (50) 0 (0) 0 (0) 0 (0) 
  Grade 2 0 (0) 1 (50) 1 (50) 2 (100) 
  Grade 3 0 (0) 0 (0) 1 (50) 0 (0) 
 Synovitis score (0-3)     
  Grade 0 2 (100) 1 (50) 0 (0)  0 (0) 
  Grade 1 0 (0) 0 (0) 0 (0) 1 (50) 
  Grade 2 0 (0) 1 (50) 1 (50) 0 (0) 
  Grade 3 0 (0) 0 (0) 1 (50) 1 (50) 
 Dichotomous      
  Osteophytes present 1 (50) 1 (50) 2 (100) 2 (100) 
  Synovitis present 1 (50) 1 (50) 2 (100) 2 (100) 






   
Figure 5.6 Ultrasound images of the thumb CMC joint with examples of synovitis grade (power 
Doppler and greyscale). Tz, trapezium; MC1, first metacarpal. 
 
   
Figure 5.7 Ultrasound images of the thumb CMC joint with examples of osteophyte grade. Tz, 
trapezium; MC1, first metacarpal. 
5.4.2 Primary feasibility outcomes 
5.4.2.1 Recruitment-related feasibility  
Of the 112 people who responded to advertisements and invitations, 66 were screened 
by telephone of whom 44 potential participants were booked for screening in-person 
(one did not attend) before recruiting the targeted 30 participants (Figure 5.5). The 30 
enrolled participants represented 45.5% of those screened by telephone and 68.2% of 
those screened in-person. Reasons for ineligibility at in-person screening were: FIHOA 
score < 6/30 (N=8); pain NRS score < 4/10 (N=6), or previous clinician-prescribed 
splint treatment (late declaration, N=1). No potential participants declined to be 
randomised.  
Grade 0 Grade 1 Grade 3 









5.4.2.2 Retention-related feasibility 
Retention was 96.7% for all outcomes at 4 weeks; 96.7% and 93.3% at 6 months for 
self-report and physical outcomes respectively. The single withdrawal occurred prior to 
commencing the intervention due to misunderstanding in the location of the treatment 
session and was unavailable to rebook. Retention-related feasibility outcomes are 
summarised in Table 5.6. 
5.4.2.3 Intervention-related feasibility: acceptability 
The splint intervention was acceptable to all participants who received this 
intervention, although some reported issues requiring them to remove the splint for a 
time, either due to minor adverse events (Table 5.6) reported below, or incompatibility 
with daily tasks. Recommendations for modifications to overcome some of the barriers 
to routine splint wearing were made and are reported in the final table of this results 
section.  
The standardised best practice usual care package was acceptable to all participants. 
While some discomfort was experienced doing some of the exercises, most participants 
found this acceptable: for example, an excerpt from a participant’s daily log during 
intervention week 1: "discomfort after exercises for an hour. Thumb feeling great!!". In 
some instances other activities interacted with the exercises creating more discomfort; 
for example, another participant at intervention week 4: “the more I do exercises the 
worse my thumb area feels”…, “when thumb not used a lot e.g. no work [then] exercises are 
easier”. The same participant ended with the following final comment, “Thanks for 
giving me this opportunity. To get some relief and better understanding of this condition.”.  
5.4.2.4 Intervention-related feasibility: adverse events 
No serious adverse events were recorded. 13 minor adverse events occurred, 5 splint-
related and 7 exercise-related (Table 5.6). One prompted a participant to contact the 
researcher for advice on exercise modification. None required health service input. The 
types and rates of minor adverse events resulting from the splint intervention, as 
recorded from post-assessment interview data, were: a welt with skin intact (N=1 
[7.1%]), a welt resulting in open wound (N=1 [7.1%]), and pain related to wearing the 





3 days until the skin healed and then resumed splint wearing with no further problems. 
The pain associated with splint wearing was transient. Pain was relieved by removing 
the splint for 1 or 2 days and the participants then continued to wear the splint.  








N (%) or 
mean 
(SD) 
N (%) or 
mean 
(SD) 
1. Number of participants recruited 
in 4-month period 
15* 15 
N=30  
2. Retention at 6 months 14 (93.3) 15 (100) 96.7% 
3. Found intervention acceptable 14 (100) 15 (100) 
100%  
Found assessments acceptable 14 (100) 15 (100) 
4. Rate of adverse events    
 Major adverse events 0 (0) 0 (0) 
Splint-related N=5 
Exercise-related N=6 
Adverse events were 
transient   
 Splint-related minor adverse 
events 
5 (35.7) - 
  Skin irritation (welt) 
requiring splint removal 
2 (14.3) - 
   Broken skin 1 (7.1) - 
  Pain requiring splint 
removal up to 1 day 
3 (21.4) - 
 Exercise-related minor adverse 
events 
2 (14.3) 5 (33.3) 
  Pain requiring exercise 
cessation on one or more 
occasion 
2 (14.3) 5 (33.3) 
   Exercise 1 - 1 (6.7) 
   Exercise 2 1 (7.1) 1 (6.7) 
   Exercise 3 1 (7.1) 2 (13.3) 
   Exercise 4 2 (14.3) 4 (26.7) 
   Exercise 5 1 (7.1) 4 (26.7)  
   Exercise 6 1 (7.1) 4 (26.7) 






As reported by participants in their daily logs and in mid-way interviews, the exercises 
caused minor or moderate discomfort in some instances and participants altered 
performance or stopped for some time as required. Exercise 4, active palmar abduction, 
caused discomfort most frequently; an alternate technique for carrying out this exercise 
is suggested for addition to the exercise instructions in the final table of this section. 
There were no withdrawals or dropouts due to adverse events.  
5.4.3 Secondary outcomes – feasibility 
The secondary feasibility outcomes are presented in Table 5.7. 
5.4.3.1 Assessor-related feasibility: time and quality 
The time required to undertake the in-person screening and baseline assessment was 
confirmed to be 45 minutes’ maximum, and for follow-up assessments 30 minutes’ 
maximum.  
Observations from the quality audits and PhD researcher’s reflections are summarised 
in Table 5.7. The missing self-report outcome items were primarily attributed to 
incomplete checking for missed items by the assessors; these were few.  
Observations regarding study procedures made by the assessors, the researcher, and 
participants included difficulty with consistency for the GAT, i.e. whether the clip went 
on the envelope or in the envelope, lack of clarity about whether grip strength 
assessments should be carried out ‘through pain’ or ‘to pain’, uncertainty about elbow 
position for grip and pinch strength assessments, uncertainty about which fingers 
should be involved with the pinch strength test, and failure to record which assessor a 
participant was assessed by. One set of baseline grip strength data was missing due to 
faulty equipment; the equipment was replaced as soon as identified and before the next 
participant was assessed.  
5.4.3.2 Clinician-related feasibility: time and quality 
The clinician time required for the intervention session was confirmed to be 25-45 
minutes, the session taking 15-20 minutes longer in the splint intervention group than 
in the comparator intervention group. Three follow-up phone calls were conducted, two 





intervention or to provide advice on exercise modification. Follow-up phone calls lasted 
a maximum of 10 minutes each. A fourth telephone call led to one additional 20 
minutes’ clinic session to modify the splint intervention; the Velcro strap had failed and 
required some maintenance. Therefore, one in five of splint group participants and one 
in 15 comparator intervention participants required additional clinician time of 10-30 
minutes.  
The information resource with exercise instructions together with the verbal prompt 
sheet were effective in achieving consistent delivery of the standardised best practice 
usual care package. Quality-control audit of the interventions carried out on two 
occasions, one in-person and one recorded with the participant’s consent, identified full 
compliance with protocols for the delivery of the splint intervention and the 
standardised best practice usual care package.  
5.4.3.3 Intervention-related feasibility: fidelity 
On average the splint intervention was adhered to fully on 68.4% of days during the  
4-week intervention period (Table 5.7). On average across participants, splints were 
worn 94.4% of the total hours prescribed, equivalent to an average of 18.9 hours per 
day. However, some participants wore their splints for more than the prescribed 20 
hours per day. Therefore, these higher values do not accurately reflect average dosage 
across participants. The first measure, i.e. the proportion of instances on which splints 
were worn as prescribed, is the key outcome relating to the fidelity of the splint 
intervention.   
The best practice usual care exercise intervention was completed on ≥80% of days for 
all exercises on all weeks for both groups (Table 5.7). No significant differences were 
seen in adherence to exercises between groups. Advice was followed in the splint group 
















N (%) or 
mean 
(SD) 




1. Time (minutes)     
Assessor baseline 45 45 - 
Satisfactory  Assessor follow-up 30  30 - 
Clinician intervention 45 30 - 
2. Intervention fidelity      
 
Number of days per week 
splint worn (0-7) 
   
68.4% of 
instances  
  Week 1 4.9 (2.1) - - 
  Week 2 5.6 (2.1) - - 
  Week 3 4.7 (2.8) - - 
  Week 4 4.2 (3.1) - - 
  Total  4.8 (2.6) - - 
 
Number of hours per day 
splint worn (0-24) 
   
94.4% of total 
hours prescribed  
 
Splint worn for 
longer than the 
prescribed time in 
some instances.  
  Week 1 19.1 (2.8) - - 
  Week 2 19.4 (4.4) - - 
  Week 3 19.4 (4.3) - - 
  Week 4 17.7 (4.4) - - 
  Total 18.9 (3.4) - - 
 
Number of days per week 
exercises completed (0-7) 
   





 Week 1 6.3 (0.5) 6.0 (1.4) -0.3 (-1.1, 
0.5) 
 
 Week 2 6.2 (1.0) 6.6 (0.7) 0.4 (-0.3, 
1.0) 
 
 Week 3 6.6 (0.6) 6.7 (0.8) 0.1 (-0.4, -
1.3) 
 
 Week 4 6.0 (0.7) 5.6 (1.3) -0.4 (-1.3, 
0.4) 
 
















N (%) or 
mean 
(SD) 





















2 (14.3) 3 (20) 
 
  Use thumb in ‘C’ shape 0 (0) 1 (6.7)  
  
Mindful when gripping 
(alter thumb posture or 
direction of pull, use 
whole hand)  
1 (7.1) 4 (26.7) 
 
  Heat 0 (0) 2 (13.3)  
  Use both hands 0 (0) 4 (26.7)  
  Use large pen 0 (0) 1 (6.7)  
  Use sharper knives 0 (0) 1 (6.7)  
  
Modified handles for 
better grip (pot handles, 
gear stick knob) 
0 (0) 1 (6.7) 
 




0 (0) 1 (6.7) 
 
  
Use fingers more than 
thumb in pinch 
0 (0) 2 (13.3) 
 
 
  Use larger joints 1 (7.1) 1 (6.7)  
  
Not specified (ticked OR 
state ‘followed advice’) 
3 (21.4) 3 (20) 
 
  Total 5 (35.7) 10 (66.7)  
 





Other exercise, e.g. pool, 
tennis, golf  
5 (35.7) - 
 Food preparation or eating 6 (42.9) - 
 
Wet tasks, e.g. dishes, 
washing 















N (%) or 
mean 
(SD) 




 Toilet  2 (14.3) - 
 
Work requirements, e.g. 
patient contact, hand hygiene, 
gloves 
5 (35.7) - 
 
Incompatible with tasks, e.g. 
computer, sewing 
1 (7.1) - 
 Aesthetic reason 1 (7.1) - 
 
To avoid splint getting dirty, 
e.g. painting, garden, outdoor 
chores, pets  
7 (50) - 
 Driving (%) 2 (14.3) - 
 
Forgot to put splint on, or left 
it somewhere 
7 (50) - 
 
 For rest or ‘time out’ 4 (28.6) - 
 Too hot 1 (7.1) - 
 Too tight/web strap too short 1 (7.1) - 
 Got bored with it 1 (7.1) - 
 
Reasons for non-adherence to 
exercises 
  
 Family events 0 (0) 1 (6.7) 
 Difficulty with motivation 0 (0) 1 (6.7) 
3. Quality-control audit  
• Reasons for missing data: 
o Assessor checking incomplete  
o Faulty equipment x1 
o Participant unable to travel x1 
• Corrections for GAT, grip, and pinch strength 
assessments.  
• Assessor name and signature added  




4. Recruitment and randomisation  
• Achieved:  
o Dominant hands equal between groups 
o Māori N=6.7% 
o Not previously sought care N=46.7% 
• Issues: 

















N (%) or 
mean 
(SD) 




• Randomisation in error N=4  
• Reasons for exclusions: 
o FIHOA score < 6/30 (N=8) 
o Pain NRS score < 4/10 (N=6) 
o Previous clinician-prescribed splint 
treatment (late declaration) (N=1) 
5. Imaging (x-ray and ultrasound)   
• X-ray imaging 
o Referral and image accessing 100% 
o Inter-rater reliability k = 0.34 to 0.41  
• Ultrasound imaging 
o Time per participant: 15 minutes  
o Inter-rater reliability  
▪ Scores (N=4): k = 0.33  
▪ Dichotomous (N=4): k = 1.0 
Inter-rater reliability for 
scores: borderline 
 




6. Clinical outcomes were explored  
• Low rate of missing data 
• MCID surpassed for pain at night NRS in splint 
group at 4-weeks and 6-months.   
• All other outcomes saw positive within-group 
change with the following exceptions: 
o FIHOA, Pollexograph, GAT no change at 4-
weeks in comparator group. 
o AFQ, Pollexograph, IDD, GAT no change at 6-
months in comparator group 
o EQ-5D-5L VAS negative change at 6-months 
in splint and comparator group 
o EQ-5D-5L VAS negative change at 6-months 
in comparator group 
Pain NRS, including pain at 
night, is a promising primary 
outcome  
 
GAT, Grip Ability Test; FIHOA, Functional Index for Hand Osteoarthritis; NRS, numeric rating scale; 
MCID, minimal clinically important difference; AFQ, Additional Functional Questionnaire; IDD, inter-
digit distance; EQ-5D-5L, Euroquol 5-Dimension, 5-Level; VAS, visual analogue scale. 
 
5.4.3.4 Recruitment and randomisation-related feasibility 
The recruitment strategy was successful in that those who might not otherwise seek 
care, that is, those with no health-care provider diagnosis, constituted 46.7% of those 





descent achieved partial success with one person of Māori descent recruited from each 
centre, i.e. a study proportion of 6.7%, just over the population proportion in the 
primary centre (6.2%), but lower than that in the secondary centre (13.3%) or 
nationally (16.5%) (Statistics New Zealand, 2013). Randomisation was successful in 
allocating similar number of dominant-involved hands to each group (Table 5.4, 
 Table 5.7).  
5.4.3.5 Secondary outcomes – feasibility of baseline imaging 
Inter-rater reliability for x-ray and ultrasound imaging scores for the two readers for 
each modality are given in Table 5.8. Inter-rater reliability was k 0.34 to 0.41 for x-ray 
reading (n=30 and n=34). The Eaton-Littler had slightly higher Kappa values than 
OARSI atlas items. For ultrasound image reading (n=4) ks = 0.33 were computed for 
both the osteophyte and the synovitis scores. Dichotomous scores for presence or 
absence of osteophytes and of synovitis, had perfect reliability (k = 1.00).  
Table 5.8 Inter-rater reliability for imaging scores 
Score 
X-ray imaging score Kappa (N=30) Kappa (N=34) 
 Eaton-Littler (1-4) 0.41 0.40 
 OARSI Osteophyte (0-3) 0.38 0.38 
 OARSI JSN (0-3) 0.34 0.39 
Ultrasound imaging scores Kappa (N=4) 
 Osteophyte score (0-3) 0.33 
 Synovitis score (0-3) 0.33 
 Osteophyte dichotomous (0,1) 1.00 
 Synovitis dichotomous (0,1) 1.00 
OARSI, Osteoarthritis Research Society International [x-ray imaging 







5.4.4 Secondary outcomes – clinical outcomes 
Clinical outcomes were collected at the three time points as planned. Individual 
outcomes are reported in Figure 5.8, Figure 5.9, Figure 5.10, Figure 5.11. Within and 
between group means are reported in Table 5.9 and Table 5.10. Overall, there was a low 
rate of missing data.  
5.4.4.1 Clinical outcomes of individual participants 
For pain on average NRS, 7 of 15 participants (47%) in the comparator group and 8 of 
14 participants (57%) in the splint group improved reliably and clinically at 4-weeks 
(Figure 5.8). Two in the comparator group and one in the splint group deteriorated. At 
6-months, 7 of 15 (47%) in the comparator group and 7 of 13 (54%) in the splint group 
were improved reliably and clinically and two in each group deteriorated.  
For pain at night NRS, 7 of 15 (47%) in the comparator group and 10 of 14 (71%) in the 
splint group improved reliably and clinically at 4-weeks (Figure 5.9). One participant in 
the comparator group and two in the splint group deteriorated. At 6-months, 6 of 15 
(40%) in the comparator group and 6 of 13 (46%) in the splint group improved while 
two in the comparator group and one in the splint group deteriorated.  
For the FIHOA, no participants in the comparator group were improved at 4-weeks 
while 2 of 14 participants (14%) in the splint group improved reliably (Figure 5.10). At 
6-months, 2 of 15 participants (13%) in the comparator group and 4 of 14 participants 
(29%) in the splint group were reliably improved. No participants in either group 
showed reliable deterioration at either time point.  
The QuickDASH outcome saw reliable but not clinically important improvement in 2 of 
15 participants (13%) in the comparator group at 4-weeks (Figure 5.11). In the splint 
group, 4 of 14 participants (29%) saw improvement, 2 (14%) of which were clinically 
important. No participants in either group showed deterioration at this time-point. At  
6-months, 4 of 14 (29%) in the comparator group and 3 of 13 (23%) in the splint group 






   
   
Figure 5.8 Modified Brinley plots depicting individual change in scores for pain on average 
numeric rating scale (NRS) by group for baseline to 4-weeks and baseline to 6-months. Data 
points to the right of the small-dashed line (MDC boundaries of 1.33) represent those who 
showed reliable improvement. Data points to the right of the long-dashed line (MCID boundaries 
of 2.0) represent those who showed clinically important improvement. Note that larger data 
points represent two individual values.  
  
 











   
   
Figure 5.9 Modified Brinley plots depicting individual change in scores for pain at night numeric 
rating scale (NRS) by group for baseline to 4-weeks and baseline to 6-months. Data points to the 
right of the small-dashed line (MDC boundaries of 1.33) represent those who showed reliable 
improvement. Data points to the right of the long-dashed line (MCID boundaries of 2.0) represent 
those who showed clinically important improvement. Note that larger data points represent two 


















   
Figure 5.10 Modified Brinley plots depicting individual change in scores for Functional Index of 
Hand Osteoarthritis (FIHOA) questionnaire by group for baseline to 4-weeks and baseline to 6-
months. Data points to the right of the small-dashed line (MDC boundaries of 5.6) represent 


















   
Figure 5.11 Modified Brinley plots depicting individual change in scores for Quick Disabilities of 
the Arm, Hand, and Shoulder (DASH) questionnaire by group for baseline to 4-weeks and 
baseline to 6-months. Data points to the right of the small-dashed line (MDC boundaries of 11.2) 
represent those who showed reliable improvement. Data points to the right of the long-dashed 















5.4.4.2 Clinical outcomes and descriptive statistics within- and between groups  
At baseline in the splint group one participant was missing data for descent, one was 
missing one item on the QuickDASH, and one was missing grip strength. At 4-week 
follow-up in the splint group one participant was missing one item on the FIHOA, one 
was missing one item on the QuickDASH, one was missing one item on the Additional 
Functional Questionnaire, and one was missing the EQ-5D index score. At 6-months 
follow-up two participants, one in each group, were missing full QuickDASH outcome; a 
further three participants, two in the splint group and one in the comparator 
intervention group, were missing one item each on the QuickDASH; and one participant 
in the comparator group was missing physical measures due to a rural domicile and not 
having time to travel the distance to attend the final assessment.. 
5.4.4.2.1 Descriptive statistics for clinical outcomes at 4 weeks 
Pain on average at night in the past week NRS (0-10) showed reduction in both groups 
between baseline and 4-weeks with CIs of neither including the null (Table 5.9). 
Between group difference of -1.1 (95% CI -3.34 to 1.09) appeared to favour splinting. 
However, the CI for this difference included the null and the CIs for within-group change 
overlapped substantially (-4.8 to -1.17 and -3.33 to -0.07 for splint and comparator 
groups, respectively).  
Pain on average in the past week NRS, not specifically at night, also reduced in both 
groups, but to a lesser extent and with a smaller apparent between-group difference, 
again with a wide CI that included the null (-0.6 [-2.48 to 1.16]). GROC score recorded 
+1.2 (SD 1.3) on an 11-point scale in the splint group and +0.5 (1.63) in the comparator 
intervention group, with an apparent between-group difference which also had a wide 
CI that included the null 0.7 (-0.51 to 1.81). Self-report functional measures (FIHOA, 
AFQ, and QuickDASH) showed apparent but not substantial positive change in the splint 
group and less improvement or none at all in the comparator group, all with wide CIs 
that included the null. QoL measured by the EQ-5D-5L index score appeared to change 
marginally in a positive direction in both groups, as did the EQ-5D-5L VAS scale score; 





Palmar abduction ROM measured on the Pollexograph increased by 9.3 (0.80 to 17.82) 
degrees in the splint group compared to no  apparent change in the comparator 
intervention group (0.2 [-3.75 to 4.06]), with a between-group difference of  
9.2 (0.45 to 17.86). The positive change in Pollexograph ROM demonstrated in the splint 
group although still with a wide CI, excluded the null and overlapped only modestly 
with that of the comparator group; the CI for the between-group difference also 
excluded the null. Inter-digit distance also showed apparent increase in the splint group 
greater than that in the comparator group but with a smaller between-group difference 
of 3.3 (-2.68, 9.25) millimetres and a wider CI that included the null. The GAT showed 
apparent positive change of -2.9 (-6.91 to 1.13) seconds in the splint group against  
-0.3 (-3.28 to 2.79) seconds in the comparator group, although the splint group had a 
higher baseline time by over 5 seconds. The CIs were wide for both groups and 
overlapped substantially. Grip strength measures showed small apparent positive 
change over time of 2.0 (-0.33 to 4.33) KgF in the splint group and 1.5 (-1.48 to 4.41) 
KgF in the comparator group, both with wide CIs which included the null. Pinch strength 
showed smaller apparent change (Table 5.9).  
No participants required new medication prescription or proceeded to joint injection or 
surgery. According to OMERACT-OARSI responder criteria, at 4-weeks there were nine 






Table 5.9 Clinical outcomes: Comparison of change within and between groups at 4-weeks 
Variable 
Splint group∞ Comparator group Between group difference∞ 
Baseline 
mean (SD) Follow-up 
Change (95% CI) 
or (%) 
Baseline 
mean (SD) Follow-up 
Change (95% CI) 
or (%) t Difference 
Pain on average NRS 5.5 (1.50) 3.9 (1.90) -1.6 (-2.91,  
-0.31) 
5.8 (1.48) 4.9 (2.00) -1.0 (-2.33, 0.39) -0.73 -0.6 (-2.44, 1.16) 
Pain on average at night NRS 5.2 (2.42) 2.4 (1.86) -2.8 (-4.48,  
-1.17)  
5.2 (2.76) 3.5 (2.56) -1.7 (-3.33,  
-0.07) 
-1.04 -1.1 (-3.34, 1.09) 
GROC - 1.2 (1.31) - - 0.5 (1.63) - 1.23 0.7 (-0.51, 1.81) 
FIHOA  12.2 (5.79) 10.4 (5.39) -1.9 (-4.27, 0.56)   10.3 (4.23) 10.3 (4.04) 0.0 (-1.69, 1.69) -1.37 -1.9 (-4.63, 0.92) 
Additional Functional 
Questionnaire 
11.7 (5.28) 10.3 (4.68) -1.4 (-3.03, 0.17) 10.7 (4.13) 10.5 (4.82) -0.2 (-2.84, 2.44)  -0.84 -1.2 (-4.23, 1.77) 










-2.4 (-6.36, 1.51) -0.84 -2.9 (-9.82, 4.11) 












-0.473 -0.03 (-0.180, 0.112) 




2.5 (-2.76, 7.83)* 82.7 
(10.18) 
83.4 (7.18) 0.7 (-4.59, 6.06) 0.52 1.8 (-5.39, 9.00)* 











9.3 (0.80, 17.82) 45.8 (8.59) 46.0 
(11.36) 
0.2 (-3.75, 4.06) 2.16 9.2 (0.45, 17.86) 








1.3 (-3.50, 6.12) 1.13 3.3 (-2.68, 9.25) 
Grip ability test 23.1 (9.16) 20.2 (8.09) -2.9 (-6.91, 1.13) 17.6 (5.73) 17.3 (5.80) -0.3 (-3.28, 2.79) -1.14 -2.7 (-7.40, 2.11) 




2.0 (-0.33, 4.33)* 21.9(6.88) 23.4 (8.99) 1.5 (-1.48, 4.41) 0.30 0.5 (-3.13, 4.19)* 






Splint group∞ Comparator group Between group difference∞ 
Baseline 
mean (SD) Follow-up 
Change (95% CI) 
or (%) 
Baseline 
mean (SD) Follow-up 
Change (95% CI) 
or (%) t Difference 
OMERACT-OARSI responders 
N (%) 
- - 9 (64.3) - - 4 (26.7) -  
NRS, numeric rating scale; GROC, Global Rating of Change; FIHOA, Functional Index for Hand Osteoarthritis; QuickDASH, Quick Disabilities of the Arm, Shoulder, 
and Hand questionnaire; EQ-5D-5L, EuroQuol 5-Dimension, 5-Level; NSAID, non-steroidal anti-inflammatory; OMERACT-OARSI, OMERACT-OARSI, Clinical Trials 
Response Criteria Initiative and Outcome Measures in Rheumatology and Osteoarthritis Research Society International.  
∞ N=14 for all splint group baseline and follow up data, unless otherwise indicated. This table represents those data available for full case analyses for each of the 
follow up time points.  





5.4.4.2.2 Descriptive statistics for clinical outcomes at 6 months 
At 6-months from baseline, pain on average at night NRS showed apparent positive 
change in both the splint group and the comparator group (Table 5.10). While the splint 
group appeared to show greater change (-2.2 [-4.00 to 0.31] and -1.4 [-3.15 to 0.42] for 
splint and comparator group, respectively), CIs for both groups were wide, included the 
null, and overlapped substantially. The CI for the between-group difference of  
-0.8 (-3.24 to 1.66) was also wide and included the null.  
Pain on average NRS also showed apparent positive change in both groups but with no 
apparent difference between groups (-0.0 [-2.41 to 2.39]). The CIs for change over time 
were again wide and included the null (Table 5.10). The GROC score saw apparent small 
positive change over time in both groups with no apparent between-group difference. 
The FIHOA score also showed apparent positive change of -3.1 (-5.53 to 0.62) and  
-0.9 (-3.33 to 1.47) points in the splint and comparator group respectively, but with 
wide CIs that included the null and overlapped substantially. An apparent between-
group difference of -2.1 (-5.41 to 1.14) also had a wide CI and included the null. The 
QuickDASH showed apparent positive change at 6-months in both groups, again with 
wide CIs that included the null and substantially overlapped. An apparent between 
group difference that appeared to favour the comparator intervention of  
2.3 (-5.84, 10.55) had a wide CI that crossed the null.  
The EQ-5D-5L Index score showed apparent positive change over time in the 
comparator group but apparent negative change in the splint group, both with wide CIs 
that crossed the null; CIs overlapped substantially. The EQ-5D-5L VAS scale scores 
showed apparent decline in both groups, by -4.5 (-12.45 to 3.45) in the splint group and 
-4.5 (-13.90 to 4.97) in the usual care group. With an outlier removed from the splint 
group, the EQ-5D-5L Index score was calculated to be unchanged from that at baseline 
(0.01 [-0.140 to 0.167]) while the VAS scale score still showed apparent negative change 
but to a lesser extent (-3.3 [-11.50 to 4.89]). 
Palmar abduction again showed apparent positive change on both measures in the 
splint group, and not in the comparator group, although at this time the CI for change in 





(Table 5.10). While CIs for change over the time in the splint group were wide, they 
overlapped with those of the comparator group only modestly. Between group 
differences on both measures appeared to favour the splint group, of  
5.4 (-3.02 to 13.73) degrees for the Pollexograph and 5.6 (-1.06 to 12. 25) mm for the 
IDD, but with CIs that were wide and included the null. 
 Grip and pinch strength showed apparent small positive change in both groups while 
the GAT greater apparent change in the splint group. The number of OMERACT-OARSI 
responders was similar between the two groups, N=6 (46.2%) in the splint group and 





Table 5.10 Clinical outcomes: Comparison of change within and between groups at 6-months 
Variable 
Splint group∞ Comparator group Between group difference∞  
Baseline 
mean (SD) Follow-up 
Change (95% CI) 
or (%) 
Baseline 
mean (SD) Follow-up 
Change (95% CI) 
or (%) t Difference 
Pain on average NRS 5.6 (1.55)* 4.0 (2.38)* -1.6 (-3.48, 0.33)* 5.8 (1.48) 4.3 (2.43) -1.6 (-3.24, 0.10) -0.01 -0.0 (-2.41, 2.39) 
Pain on average at night NRS 5.2 (2.52)* 3.1 (2.29)* -2.2 (-4.00,  
-0.31)* 
5.2 (2.76) 3.8 (2.91) -1.4 (-3.15, 0.42) -0.66 -0.8 (-3.24, 1.66)  
GROC - 0.9 (1.9) - - 0.8 (1.9) - 0.17 0.1 (-1.6, 1.4) 
FIHOA  12.2 (5.79) 9.1 (7.63) -3.1 (-5.53,  
-0.62)  
10.3 (4.23) 9.3 (3.71) -0.9 (-3.33, 1.47) -1.34 -2.1 (-5.41, 1.14) 
Additional Functional 
Questionnaire 
11.7 (5.28) 10.0  
(7.00) 
-1.7 (-3.27, 0.15) 10.7 (4.13) 10.5 (5.45) -0.3 (-2.26, 1.72) -1.22 -1.5 (-3.89, 0.99) 












0.59 2.3 (-5.84, 10.55) 








0.73 (.189) 0.07 (-0.003, 
0.152) 
-1.20 -0.01 (-0.266, 0.070) 

















-0.2 (-4.07, 3.65)** 1.32 5.4 (-3.02, 13.73) 








-0.7 (-5.70, 4.32)** 1.73 5.6 (-1.06, 12.25) 
Grip ability test 23.1 (9.16) 18.6 
(10.73) 




0.4 (-2.85, 3.56)** -1.22 -4.8 (-0.06, 9.74) 








2.1 (-0.97, 5.26)** -0.12 -0.2 (-3.87, 3.43) 
Pinch strength 6.2 (2.41) 6.3 (2.87) 0.1 (-0.95, 1.23) 5.5** 
(1.79)** 






Splint group∞ Comparator group Between group difference∞  
Baseline 
mean (SD) Follow-up 
Change (95% CI) 
or (%) 
Baseline 
mean (SD) Follow-up 
Change (95% CI) 
or (%) t Difference 
OMERACT-OARSI responders 
N (%) 
- - 6* (46.1 %) - - 6 (40.0) -  
NRS, numeric rating scale; GROC, Global Rating of Change; FIHOA, Functional Index for Hand Osteoarthritis; QuickDASH, Quick Disabilities of the Arm, Shoulder, 
and Hand questionnaire; EQ-5D-5L, EuroQuol 5-Dimension, 5-Level; NSAID, non-steroidal anti-inflammatory; OMERACT-OARSI, OMERACT-OARSI, Clinical Trials 
Response Criteria Initiative and Outcome Measures in Rheumatology and Osteoarthritis Research Society International. 
∞ N=14 for all splint group baseline and follow up data, unless otherwise indicated. This table represents those data available for full case analyses for each of the 
follow up time points.  
* N=13  





5.4.4.3 Clinical outcomes by group in relation to reliable and clinically important 
change  
The apparent direction of change in each variable at each time point and in relation to 
known MDC or MCID or both, is presented in Table 5.11.  
In both the splint and the comparator groups, at both time points, an MDC of 1.3 for pain 
NRS was exceeded by the apparent positive change in both pain NRS and pain at night 
NRS. MCID of 2-points for pain NRS was surpassed by apparent positive change in pain 
at night NRS in the splint group of both -2.8 (-4.48 to -1.17) at 4-weeks and  
-2.2 (-4.00 to -0.31) at 6-months.  
The apparent positive but negligible change in the splint group shown by FIHOA, 
QuickDASH, and AFQ, did not exceed known estimates of MCID or MDC. In the 
comparator intervention group, findings were similar although no change was seen in 
the FIHOA at 4-weeks, or in the AFQ at 6-months. 
Apparent positive change in grip strength in both groups at both time points exceeded 
smaller previous estimates of MDC values (0.8 KgF to 1.1 KgF) but not MCID (6.0 KgF to 
6.5 KgF). Smaller previous estimates of MDC for pinch strength (0.2 KgF to 0.3 KgF) 
were surpassed by both groups at 4-weeks but not at 6-months.  






Table 5.11 Direction of change in clinical outcomes at 4-weeks and 6-months in relation to 
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EQ-5D-5L VAS  
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NSAID Equivalence Score 
 

















Grip ability test# 
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+, positive change; –, negative change; MDC, known minimal detectable change exceeded; MCID, 
minimal clinically important change exceeded; NC, no change; NA, not available; NK, no known MDC or 
MCID; NRS, numeric rating scale; GROC, Global Rating of Change; FIHOA, Functional Index for Hand 
Osteoarthritis; QuickDASH, Quick Disabilities of the Arm, Shoulder, and Hand questionnaire; EQ-5D-
5L, EuroQuol 5-Dimension, 5-Level; NSAID, non-steroidal anti-inflammatory. 






5.5 Discussion                                                                     
This study investigated the feasibility of study elements with a view to conducting a 
future full RCT to evaluate the effectiveness of splinting for thumb CMC OA. The study 
found that the described protocol is feasible and identified some modifications that will 
optimise the conduct of the full-size study. A summary of the feasibility criteria and 
recommendations for a future full trial are given in Table 5.12. 
5.5.1 Principal findings 
All primary outcomes surpassed the a priori feasibility criteria for feasibility. The study 
RCT protocol was found to be feasible for recruitment, retention, intervention 
acceptability, and safety. Five participants experienced splint-related problems and 
seven experienced exercise-related concerns. These were minor short-lived events; 
their frequency can be interpreted as acceptable. In addition, the factors causing these 
events are modifiable and can be addressed in a future trial.  
The secondary feasibility outcomes were met except for the fidelity of the splint 
intervention which reached less than the targeted 80% of instances. Measures were 
identified which could lead to this target being achieved and are outlined in Table 5.12. 
The remaining five secondary outcomes were met. The time required for study 
procedures was feasible. Quality-control audit of the intervention and assessments was 
satisfactory and suggested areas for improvement. Randomisation stratification was 
successful in evenly allocating enrolled participants by their dominant hand. Clinical 
outcomes were successfully collected with few missing items and could be explored to 
ascertain whether treatment effects and outcomes are consistent with expectations 
based on previous literature. Baseline imaging was feasible with respect to time and 
process but demonstrated borderline inter-rater reliability. Measures were identified 






Table 5.12 Summary table of feasibility criteria and recommendations for full trial 
Criteria Feasibility 
criteria met? 
Recommendations for full-scale trial 
Primary feasibility criteria 
1. Recruitment of 
30 participants 
in a 4-month 
period 
Yes No change needed  
2. Retention >85% 
at 6 months 
Yes No change needed 
3. >90% find the 
intervention 
acceptable 
Yes No change needed 
4. Rate of adverse 
events 
Yes Splint-related adverse events can be avoided by: 1) 
instruction not to exceed the prescribed splint-wearing 
time, 2) splint removal for short periods at regular 
intervals (e.g. 4-hrly in the day), 3) address splint 
design modifications with manufacturer – lengthen web 
space strap, remove binding against 2nd metacarpal, add 
lining to 1st web space. 
Exercise-related adverse events can be reduced by 
reminding participants to contact the researcher should 
an exercise cause unacceptable pain on two or more 
consecutive days and by offering alternative techniques 
for the exercises. Modification is recommended for 
Exercise 4 (active palmar abduction): e.g. place the palm 
flat on a table or other firm surface and allow the thumb 
to palmar abduct by dropping vertically over the edge. 
Advice regarding exercise discomfort generally should 
be that some discomfort is acceptable.  
Secondary feasibility criteria 
1. Time required 
for assessor and 
clinician 
confirmed 
Yes No change needed 
2. Intervention 
implementation 





 Splint No In addition to the recommendations for splint 
intervention modifications above, a tentative 
recommendation is to reduce the splint-wearing fidelity 
threshold to 16 hours /24 hours in 80% of instances. 
This would allow those who need to remove the splint 
for work purposes to meet intervention fidelity; and 







Recommendations for full-scale trial 
Provision of a third splint would allow use of one 
outdoors for dirty tasks, one indoors or ‘clean’, and one 
to wash.  
 Exercises Yes An alternative technique for Exercise 4, and advice 
regarding exercise discomfort generally, is suggested 
above. The remaining content and format can remain 
unchanged.  
 Advice and 
education 
No The daily log should be modified to provide more space 
for the specific advice given to be recorded and for the 
participant to record which advice was followed and 
when. 
Additional instruction should be provided to the 






Yes For assessments: recap on assessor training after first 
assessment and then 2-weekly; revise assessor manual 
and training to clarify GAT and grip and pinch strength 
assessments; test equipment prior to assessment; more 
robust checking of missing data by assessors and direct 
audit by researcher of  
data- checking for first 4 assessments for each assessor 
(prior to participant leaving the premises).   
Interventions: more than one clinician will be required 
for a large-scale trial. Clinician training should be 
provided and regular audit of intervention 
implementation. 





Yes Additional strategies are required for targeted 
recruitment of participants of Māori descent – 
recommendations are made in Chapter 6. 
Enrolment error can be obviated by a two-person check 
system for the first 10 enrolments to confirm inclusion 
criteria are adhered to and any inconsistencies clarified.   
Stratification by hand dominance is feasible in a future 
full RCT.  
Removal of the stipulated FIHOA score ≥6/10 for study 
entry is recommended; discussed in later section.  





joint status at 
baseline 
Yes, if cost 





X-ray imaging: recommend pre-reading training and 
two readers confer for consensus score. 
Ultrasound imaging: dichotomous outcomes can be 
used. Pre-reading training and consensus approach 











Yes Pain NRS appears to be a suitable primary outcome.  
Other measures have potential as secondary outcomes; 
however, additional information of measurement 
properties in thumb CMC OA is required, including 
reliability (palmar abduction measures, GAT, grip and 
pinch strength, MCID (FIHOA). Exploration of the 
decline in EQ-5D-5L scores at 6-months is needed to 
understand the role of this measure.   
Measures to enhance assessment of medication use 
include: request participants to bring a full list of their 
medications to assessments; complete a 1-week daily 
log of medication use prior to the baseline assessment. 
NRS, numeric rating scale; FIHOA, Functional Index for Hand Osteoarthritis; CMC, carpometacarpal 
joint; GAT, Grip Ability Test; MCID, minimal clinically important difference; EQ-5D-5L, EuroQuol 5-
Dimension, 5-Level. 
 
5.5.2 Discussion of findings in relation to feasibility and previous literature 
5.5.2.1 Recruitment and randomisation 
Several differences in baseline characteristics between the groups appeared to be 
associated with the higher number of males in the splint group, that is: higher grip 
strength and higher employment status. Although these between-group differences 
occurred by chance, such differences create potential for confounding if characteristics 
are associated with differences in treatment response. Female sex has been identified as 
one of several predictors of success in responses to physical therapy intervention in 
knee OA (Chapple, 2012) and has shown a similar association in studies of topical 
NSAIDs for hand OA (Persson et al., 2020). However, neither sex, age, post-menopausal 
stage, BMI, radiographic stage, nor duration of symptoms has been established as a 
predictor of disease progression or treatment response in hand OA (Barthel, Peniston, 
Clark, Gold, & Altman, 2010; Bijsterbosch, Watt, et al., 2011; Botha-Scheepers et al., 
2009; Haugen et al., 2011; Kwok, Plevier, Rosendaal, Huizinga, & Kloppenburg, 2013; 
Marshall et al., 2013; Persson et al., 2020); furthermore, no data exists specifically for 
thumb CMC OA. Firm evidence for the influence of hand dominance on degree of impact 
was found by the qualitative study in Chapter 3. This study has shown stratification by 





The systematic review reported in Chapter 4 found that study populations in previous 
studies have included generally only 10-20% male, compared to the 37% enrolled in the 
present study. One reason for this is likely due to the success of the present study in 
recruiting those who might not otherwise seek care – who are commonly men (Yousaf, 
Grunfeld, & Hunter, 2015).  
In considering feasibility outcomes for recruitment, the rates of success in achieving 
recruitment response, screening (telephonic and in-person), and in identifying 
eligibility were similar to those in previous general OA studies: for example, Gignac 
screened n=224 to include 90 participants (with and without OA) in a qualitative study 
(Gignac et al., 2006). The present study, screening 66 to enrol 30 participants, 
performed well, given that its inclusion criteria were tighter than Gignac’s study and its 
demands on participants were higher in terms of the number of assessments, 
commitment to the interventions, and duration of follow-up. No potential participants 
declined to participate or voiced concern about being randomised to a no-splint 
comparator intervention group in an RCT. Many reported that they were pleased to 
have received any care and happy to support research into the condition.  
The strategy used in this study to recruit participants of Māori descent was less 
successful than expected. Additional steps for a future study are outlined in Chapter 6.  
5.5.2.2 Intervention implementation findings 
Overall, the splint intervention package developed in this study was implemented with 
a high level of success and some modifications were identified to ensure fidelity criteria 
can be met in a future full trial. Adherence to the standardised best practice usual care 
exercises in this study exceeded the fidelity criteria of 80% of prescribed instances. This 
a high rate of adherence. Poor adherence is a common weakness of exercise 
interventions for chronic musculoskeletal conditions including OA, and is considered a 
major reason for lack of effectiveness in research and clinical practice (Jordan, Holden, 
Mason, & Foster, 2010).  
Since no previous studies of splinting for thumb CMC OA have included a best practice 
standardised usual care package, this is the first study to do so. However, only two-





group reported adherence to the advice component of the standardised best practice 
usual care. It may be that participants did not follow the advice, or it may be that they 
just did not report it. Daily reporting of the exercises completed, and in the splint group, 
the hours the splint was worn, may have detracted from reporting on the advice 
followed; this may also explain the discrepancy in advice followed between groups. A 
recommendation for a full trial is to modify the daily log for a stronger emphasis on 
reporting of the advice followed. Alternative approaches to monitoring adherence are 
discussed in the study strengths and weaknesses section below.  
A positive response occurred in participants receiving best practice usual care 
comparator intervention and so, if this is used for future studies it may necessitate a 
large sample size since the differences between groups will have to significantly exceed 
the beneficial effects of the comparator intervention.  
In summary, the standardised best practice usual care package developed in this study 
is fit for use in a future full trial with some modifications to Exercise 4 (active palmar 
abduction). Furthermore, the package, with recommended modifications, may also have 
a role in usual clinical practice.  
5.5.2.3 Imaging findings 
To enable better evaluation of participant characteristics at baseline, the feasibility of  
x-ray and ultrasound imaging was evaluated, with a view to exploring their potential 
ability to predict a subgroup of participants who might be more responsive to 
treatment. Process and timing were found to be feasible for the imaging measures. 
Inter-rater reliability of the x-ray scoring was borderline but comparable to previous 
reports for Eaton-Littler score (k = 0.11 to 0.56) (Berger et al., 2014) and OARSI Atlas 
JSN (k = 0.48) (Gossec et al., 2008). Additional measures, namely, pre-study training and 
a consensus approach to reaching a final score, are likely to provide a satisfactory level 
of reliability for x-ray scoring to be used in intended future analyses.  
The ultrasound imaging in the present study served as a pilot for a full study protocol. A 
consensus approach was taken for the first three scans. Preliminary computations 
indicated border-line inter-rater reliability for semi-quantitative scoring but excellent 





number of participants (n=4) means this data is purely exploratory. Previous 
investigation of ultrasound inter-rater reliability in hand OA (including thumb CMC), 
has found high agreement for osteophytes (k ≥0.91) for both semi-quantitative scale 
and dichotomous response (Mathiessen et al., 2013). Inter-rater reliability for both 
detecting synovitis and use of power Doppler in the same cohort has also been found to 
be high (k = 0.74 and >0.93 respectively) (Mathiessen et al., 2016). Therefore, ahead of a 
future full trial, further work is warranted to refine the protocol and reader training.  
If baseline imaging, x-ray or ultrasound, proves able to provide robust characterisations 
of participants’ joint status, a linear regression model could be used to examine the 
association between imaging findings and treatment outcomes. For example, whether 
change in pain intensity in response to the splint intervention can be predicted for 
subgroups with higher grade structural change or presence of synovitis at baseline. Sub-
group analysis would require careful preparation as part of the study statistical plan 
and sample size computation (Losina et al., 2015; Moher et al., 2010). This is 
particularly important as synovitis is increasingly recognized as an important correlate 
of pain in OA (Bacon et al., 2020). 
5.5.2.4 Clinical findings 
Secondary clinical outcomes were collected to explore whether treatment outcomes and 
effects were consistent with expectations based on previous literature.  
On an individual participant basis, pain on average NRS and pain at night NRS saw 
reliable and clinically meaningful improvement in around half participants in both 
groups at 4-weeks which was largely maintained at 6-months. Of note, at 4-weeks a 
substantially greater proportion in the splint group (71%) improved on pain at night 
NRS compared to that in the comparator group (47%). In contrast, functional PROs saw 
only a small proportion who reliably and clinically improved in either group at 4-weeks, 
increasing to around one quarter at 6-months. Few participants deteriorated on any of 
the four outcomes.  
Due to the small sample size group-level clinical findings represent preliminary 
indicative data only and do not have sufficient statistical power to assess significance. 





change over time and between-group difference, being wide, frequently overlapping, 
and in the majority of group-comparison CIs including null, indicate a low level of 
confidence that this suggested change actually occurred.  
5.5.2.4.1 Pain 
At 4-weeks (short-term) the mean between-group differences in pain in the present 
study were similar to findings in previous larger studies at low risk of selection bias 
(Chapter 4) (Table 5.13). However, at 6-months (medium-term) mean between-group 
differences were lower, or absent. The standardised best practice usual care may have 
contributed to positive change in both groups; while this may explain the 
aforementioned observation, earlier apparent positive change seen in the splint group 
could be attributed to the splint intervention. Given the wide CIs of the between-group 
difference which included the null, along with the wide and overlapping CIs of the 
change over time, the confidence with which the observed change might be said to 
suggest actual change is low.  
The positive change over time at both individual participant and group level appeared 
to be maintained in both groups at 6-months with minimal deterioration towards the 
baseline. The overall apparent improvement in pain seen with standardized best 
practice usual care alone might signal that there is little room for other interventions to 
prove their additional benefit. 
Alternate explanations for the observed change are that the improvement was a result 
of participants’ knowledge of their being observed in the context of a clinical study, i.e. 
the Hawthorne effect (Portney, 2015), or that change reflected the natural fluctuations 
in the disease state. In studies of knee OA two thirds of patients report pain that 
remains the same or improves while one third report deterioration (National 
Collaborating Centre for Chronic Conditions Corporate, 2008). However, studies suggest 
that the natural trajectory of hand OA is less likely to be associated with improvement 
in pain over time, with approximately half of patients having stable pain or improving, 
while the other half deteriorates (Bijsterbosch, Watt, et al., 2011; Botha-Scheepers et al., 





Table 5.13 Comparison of change in pain outcomes between previous studies at low risk of selection bias (Chapter 4) and the present feasibility study 
 Study N Variable 






















40 Pain past week 
splint off NRS (0-10) 
-2.0  
± 2.37 
-0.3 ± 2.36 -1.7 (-3.17, -0.23) -2.2  
± 2.46 
0.1 ± 2.44* -2.3 (-3.82, -0.78) 
Hermann 
2014 
59 Pain – NRS (0-10) -0.3 ± 2.56 -0.2 ± 2.98 -0.1 (-1.4, 1.2) - - - 






0.6 (-7.9, 9.1)** -22.2  
± 23.08 
-7.9 ± 23.48 -14.3 (-23.0, -5.2)  
Feasibility 
study  
 30 Pain average past 
week NRS (0-10) 
-1.6 ± 2.25 -0.1 ± 2.46 -0.6 (-2.44, 1.16) -1.6 ± 3.14 -1.6 ± 3.02 -0.0 (-2.41, 2.39) 
 30 Pain at night 
average past week 
NRS (0-10) 
-2.8 ± 2.88  -1.7 ± 2.94 -1.1 (-3.34, 1.09) -2.2 ± 3.06 -1.4 ± 3.21 -0.8 (-3.24, 1.66) 
NRS, numeric rating scale; VAS, visual analogue scale. 
* Negative change within group 





5.5.2.4.2 Self-reported function 
In common with previous studies investigating splinting for thumb CMC OA, the 
feasibility study did not show great change in functional scores, frequently failing to 
meet previous estimates of MCID. This could be a result either of problems with the 
outcome measures, such as lack of available MCID and none developed specifically for 
CMC OA or, potentially but unlikely, no actual change in function. 
The between-group differences in the present study were slightly larger in the short-
term but smaller in the medium-term compared to findings from previous larger studies 
at low risk of selection bias (Table 5.14).  
An important finding in the present study was that the self-report functional outcomes 
in the present study (FIHOA and QuickDASH) showed minimal change, consistent with 
previous studies in thumb CMC OA (Table 5.14). There are several possibilities for why 
this may have occurred, including that current measures are not sensitive enough for 
thumb CMC OA, the sample size was too small to be able to detect any true change that 
may have occurred, resulting in type II error, or that there truly was no change in 
function to be observed.  
On the latter, the domain of function was also assessed by performance measures in the 
present study which, as discussed in the section below, changed positively but not 
substantially. The FIHOA correlates moderately with a comprehensive test of hand 
function performance (Stamm et al., 2007) but its relationship with the GAT is 
unknown. In RA populations the longer DASH, and another questionnaire similar to, but 
longer than the FIHOA – the Duruoz Hand Index – as well as the HAQ, have been shown 
to correlate moderately with the GAT (Bircan, 2014). However, these data are not 
available for hand OA populations. Grip strength has been shown to have weaker 
correlation with self-report function than tests of hand function performance (Stamm et 
al., 2007). Unfortunately, due to insufficient sample size in the present study, it is not 






Table 5.14 Comparison of change in self-report function outcomes between previous studies at low risk of selection bias (Chapter 4) and the present 
feasibility study 
 Study N Variable 
Short-term (0-3 months) Medium-term (3-12 months) 
Splint 
group (SD 
or 95% CI) 
Comparator 
group (SD 






or 95% CI) 
Comparator 
group (SD 
or 95% CI) 
Between group 


















3.8 (-18.48, 10.88)** 
Hermann 
2014 
59  AUSCAN function 
subscale (0-5) 
-0.2 ± 1.29 -0.3 ± 1.26 0.06 (-0.7, 0.8)** - - - 










-6.3 (-10.9, 1.7) 
Feasibility 
study  
 30  FIHOA -1.9 ± 4.17 0.0 ± 3.54 -1.9 (-4.63, 0.92) -3.1 
±04.26 
-0.9 ± 4.33 -2.1 (-5.41, 1.14) 
 30  AFQ -1.4 ± 2.77 -0.2 ± 4.77  -1.2 (-4.23, 1.77) -1.7 ± 
 2.70 
-0.3 ± 3.59 -1.5 (-3.89, 0.99) 
 30  QuickDASH -5.3 ± 
10.89 
-2.4 ± 7.11 -2.9 (-9.82, 4.11) -4.0 ± 
10.89 
-6.3 ± 9.73 -2.3 (-10.55, 5.84) 
DASH, Disabilities of the Arm, Shoulder, and Hand questionnaire; AUSCAN, Australian-Canadian Hand Osteoarthritis Index; FIHOA, Functional Index for Hand 
Osteoarthritis; AFQ, Additional Functional Questionnaire  
* Negative change within group 




All things considered, it is reasonable to surmise that current functional outcomes are 
not adequate for thumb CMC OA because while positive changes in pain were noted, 
existing self-assessment outcome measures noted in previous and the present studies 
report limited change in function.  Although future data may enable the establishment 
of an MCID for FIHOA and thus help to understand better the utility and sensitivity of 
this measure, it seems increasingly clear that other measures also need to be explored 
or developed to identify a valid and responsive instrument for thumb CMC OA. This is 
further discussed in Chapter 6. 
5.5.2.4.3 Health-related quality of life 
While MDC for this outcome was exceeded by positive change for both groups at  
4-weeks and in the comparator group at 6-months values unexpectedly showed 
apparent negative change at 6-months in the splint group. Furthermore, the EQ-5D-5L 
VAS score showed apparent negative change in both groups at 6-months, suggesting a 
decline in health-related QoL. Wide and overlapping CIs for change over time and the 
inclusion of null in CIs of between-group comparison indicates a low level of confidence 
that this observed change suggests actual change.  
The apparent negative change in the splint group was explored for a single outlier for 
whom a marked reduction in EQ-5D5L- scores at 6-months was due to substantial co-
morbidities. Despite exclusion of this outlier value, a secondary analysis still showed 
return to baseline for the index score at 6-months and apparent decline below baseline 
of the VAS scale score. It is unclear why this occurred when generally positive apparent 
change was seen in most other parameters. If reflecting actual decline, this inconsistent 
finding may be an aberration given the small sample study population, or the role of 
other health or life events may have a significant bearing. If real, consideration would 
need to be given to how a decline in HR-QoL can be understood in a full study or how 
change in QoL specific to thumb CMC OA status can be measured. This is explored 
further in Chapter 6. Quality of life has not been assessed in previous studies of splint 
effectiveness but the significant impact on people’s emotional, mental, and spiritual 
well-being indicates that QoL is an essential outcome in investigating the effectiveness 




5.5.2.4.4 Global rating of change 
The MDC was exceeded by positive change in both groups at both time points, indicating 
that, in general, participants’ in both groups perceived positive overall change. 
However, this did not reach the threshold for clinically meaningful change.     
5.5.2.4.5 Responder criteria 
The relatively high proportion of responders in the splint group (n = 9 [64.3%]) 
compared to comparator group (n = 4 [26.7%]) at 4-weeks in the present study, along 
with evidence from previous fully-powered trials in hand OA, makes OMERACT-OARSI 
responder criteria a promising candidate for a robust and responsive outcome measure 
to assess effectiveness of splint interventions for thumb CMC OA.  
Significant findings in previous studies include, for example, 33% for joint protection 
group vs 21% for no joint protection as part of self-management for hand OA (Dziedzic 
et al., 2015); and, for exercises versus no exercises for hand OA, 43.2% vs 5.9% (Hennig, 
Hæhre, et al., 2015) and 46% vs 16% (Osteras et al., 2014). The present and previous 
studies indicate that detecting a significant and meaningful difference using current 
responder criteria is feasible. Therefore, work is worth carrying out to determine 
criteria relevant to hand OA and, by extension, thumb CMC OA.  
5.5.2.4.6 Medication use 
Self-report medication use showed a surprisingly low rate of use at baseline by most 
participants. This may reflect both the inclusion of a relatively high proportion of 
participants, nearly half, who had not previously sought care for their thumb CMC OA 
problem, and the desire expressed in the qualitative study to avoid medication use 
where possible. Three previous studies included in the systematic review reported 
simple dichotomous outcomes (yes/no) of participants’ medication use on study entry 
and found half (Sillem et al., 2011; van der Vegt et al., 2017) to three-quarters (Rannou 
et al., 2009) were using medication. Only one of these studies reported medication type 
and assessed medication use over the course of a splint intervention, although no 
analysis of this data was made (Rannou et al., 2009). 
The calculation of quantitative measure of NSAID use in the present study is a novel 




robust evaluation of this important outcome. A suggested MCID of 24 points, calculated 
in a population with axial spondyloarthritis (Dougados et al., 2012; Dougados et al., 
2014), was not met in the present study. However, this MCID might not be relevant to 
thumb CMC OA given the low baseline scores in the present study. Interestingly, low use 
of NSAIDs has also been reported in a previous similar southern New Zealand cohort of 
lower limb large joint OA (Stebbings, Gray, Schneiders, & Sansom, 2017) – this may be a 
local difference for New Zealand.   
5.5.2.4.7 Thumb palmar abduction range of motion 
Thumb palmar abduction ROM appeared to changed positively in the splint group while 
the comparator intervention group saw little or no apparent change at both time points. 
While CIs were wide for these measures, they only modestly overlapped for change over 
time, and for Pollexograph at 4-weeks excluded the null for between-group comparison. 
Thus, a low to moderate level of confidence can be had that this observed change 
suggest actual change. No MDC or MCID values are available for these measures. 
Furthermore, the IDD is a novel adaptation of another method and requires evidence of 
its validity and reliability.  
Notably, the splint group demonstrated a marked increase in first web space length on 
measures of both Pollexograph palmar abduction and IDD at 4-weeks and the increase 
was maintained, to a lesser extent, at 6-months. This contrasts with an earlier study 
which showed no significant change in first web space length with night-time splint 
wearing over a 12-month period (Rannou et al., 2009). Since the present study used a 
different splint worn at a higher dosage, different measurement methods, and included 
best practice usual care, any or all of these may explain the difference between these 
two studies. The change in thumb palmar abduction in the splint group but not the 
comparator intervention group in the present study supports the hypothesis that the 
splint intervention may have a specific effect on thumb palmar abduction. Whether this 
could form a useful outcome measure is worthy of further study.  
5.5.2.4.8 Grip and pinch strength 
The small yet positive change in both grip and pinch strength is interesting given that 




also contrasts with a previous large RCT which found strength decreased, although not 
significantly, following 12 months of night-time splint wearing (Rannou et al., 2009). 
5.5.2.4.9 Grip ability test 
In this study, the speed of performance on the GAT improved in the splint group at  
4-weeks and even more so at 6-months but not at all in the comparator intervention 
group. Notably, the baseline speed was around 20% slower in the splint group than the 
comparator group, leaving much greater room for improvement in the splint group; this 
may explain the greater change in the splint group. Adjustment for baseline 
performance could address this in a future trial.  
The GAT shows promise in detecting improvement in physical functioning in response 
to a splint intervention. Further research to determine its measurement properties is 
indicated.  
5.5.3 Strengths and limitations 
The strengths of this study included blinding of participants to the study hypothesis, a 
high dosage of splint intervention, best practice usual care, high adherence to exercise, 
exploration of outcome measures important to patients, analysis of individual-level 
data, and inclusion of a representative study population for all of whom thumb CMC OA 
has an impact. These strengths have resulted in findings that can effectively inform a 
future full trial and so produce high quality findings that are translatable to practical 
real-world settings.  
A major strength of this study, in addition to the blinding of study assessors, was the 
blinding of participants to the study hypothesis until after the 4-week follow-up, 
something not previously reported in studies of splinting for thumb CMC OA. Together, 
these measures reduce the risk of performance and detection bias, and so reduce the 
likelihood of over-estimating intervention benefit due to non-specific placebo effect 
(Fregni et al., 2010), thereby increasing the validity of the results. However, the success 
of the measures taken to blind participants to both the study hypothesis and the 
opposite group intervention, and to blind assessors to group allocation, was not 
assessed. Evaluating the effectiveness of blinding measures should be built into a future 




and at interim periods with assessors. Furthermore, statistician blinding can help to 
minimise researcher bias; a researcher blinded to group allocation should perform the 
statistical analysis in a future trial.   
Participant knowledge of their group allocation at the 6-month follow-up increases the 
risk of performance bias and, for self-reported measures, detection bias at this time 
point. Any new studies should be reviewed in planning for a future trial, as this might 
permit longer-term participant blinding if uncertainty in longer-term outcomes persists.  
Additional strengths of the study included successful recruitment strategy, enrolment, 
and retention. The low participant attrition rate minimised the issue of missing data. 
Those data that were missing tended to be items not completed due to inadequate 
checking rather than due to any characteristics specific to participants or the outcomes 
themselves, i.e. ‘missing completely at random’ (Lodder, 2014). The single participant 
who withdrew did so due to participant characteristic-related factors, namely, work-
related time commitments, and thus can be defined as ‘missing at random’ (Lodder, 
2014). No data were missing due to factors related to the outcomes themselves 
(‘missing not at random’) (Lodder, 2014). Therefore, the multiple imputations method 
would be a robust option for dealing with missing data in a future full study that retains 
statistical power and adherence to the intention-to-treat principle while mitigating to a 
good extent against loss of validity (Lodder, 2014; Losina et al., 2015). 
There were also little missing data from self-report diaries, following reminders to 
complete diaries, and high intervention implementation. The splint-wearing schedule 
was prescribed at a dosage much higher than in previous studies; the present study has 
shown that such higher dosage is feasible and acceptable to participants. It has also 
shown, for both splint intervention and the standardised best practice usual care 
package, that clearly described dosage parameters with similar treatments, time, and 
attention between groups can be implemented in an RCT design. Evaluation of 
intervention fidelity could be further strengthened by assessing participants’ correct 




Limitations of the present study include the relatively short length of the follow-up 
period; assessment at varying times of day; a lack of evaluation of ongoing self-
management; reliance on paper methods for screening, informed consent, outcome 
measures, and fidelity evaluation; a lack of assessment of the success of blinding 
participants and assessors; a lack of blinding of statistical analysis; the absence of some 
demographic measures.  
Thumb CMC OA is a long-term condition; although follow up occurred at 6-months post-
implementation of intervention, long-term evaluation is required to assess whether 
interventions are effective over longer time periods (Kloppenburg, Maheu, et al., 2015). 
Follow-up at 12- and 24-months is recommended (Kloppenburg, Maheu, et al., 2015), 
and should be included in a future large trial. Retention rates in the present study 
substantiate the findings of the systematic review in Chapter 4 that longer follow-up is 
likely to be feasible. Evaluation of self-regulated continued splint use or exercise 
performance beyond the active intervention period should be undertaken for the longer 
time periods, for example, at 6- and 12-months. The present study’s success in 
evaluating intervention implementation suggests that a similar but more sporadic 
assessment of ongoing self-management is feasible.  
Reliance on paper methods for many elements in the present study is a limitation 
contributing to researcher burden and cost. Although the use of digital methods to 
support recruitment, screening, outcome collection, automation of reminders, and 
intervention implementation may reduce this reliance, the consequent reduction in 
researcher contact and relationship may come at the cost of increased missing data and 
lower adherence to intervention prescriptions. Furthermore, age, ethnicity, 
employment status, and hearing and vision ability may limit study participation for 
vulnerable or deprived groups, such as Māori and the very elderly, if the study were to 
go completely digital. Digital sensors could be an alternate option for monitoring splint 
wearing adherence with low participant burden but are still at the development stage 
for appendicular devices (Davies et al., 2020). No standardised approach exists for 
measuring adherence to complex interventions in clinical trials (Davies et al., 2020; 
Graham et al., 2016). A simple descriptive approach suited to the context has been 




measuring device use in rehabilitation intervention trials has been found to be accurate 
compared to electronic monitoring including in older adults (Jeffrey et al., 2012), 
although the method appears less valid for other interventions such as walking 
frequency (Frost, McClurg, Brady, & Williams, 2016). Given the low cost, simplicity, and 
suitability for devices, a simple logbook is recommended for measuring adherence to 
thumb splint wearing in a future full trial. 
To eliminate unnecessary travel and researcher time for potential but ineligible 
participants, digital methods to assess remotely baseline eligibility could be used, e.g. to 
screen demographic, health, and self-report measures. Video consultation might 
overcome the issue of self-report measures designed to be interviewer-administered, 
e.g. the FIHOA (Dziedzic, Thomas, & Hay, 2005). Developing a specific self-administered 
questionnaire would also be helpful for distance or electronic administering, making the 
FIHOA even less fit for purpose now and in future. 
Although assessments in the present study were generally conducted between 11am 
and 4pm they were not booked at consistent times for each participant. Pain, dexterity, 
and stiffness in hand OA are known to fluctuate according to daily rhythms with the 
optimal time being mid-afternoon (Bellamy, Sothern, Campbell, & Buchanan, 2002). 
Depending on the time of day assessments took place, results could have under- or 
overestimated change in these outcomes. A future full trial should either ensure 
assessments occur at consistent times for each participant or use symptom diaries at 
specific points during the day. Additional baseline characteristics of marital status, 
living circumstances, and education level are recommended for intervention trials in 
hand OA (Kloppenburg, Maheu, et al., 2015) and should be collected in a future full-size 
trial. It would be feasible to add these to the demographic questionnaire as assessments 
were not time-pressured and participants identified no concerns about questionnaire 
burden. Robust methods of checking for data completeness at time of assessment was a 
further area identified as potentially improving a future study.  
5.6 Conclusion  
The present study provides necessary data to assess the feasibility and to inform the 




intervention for thumb CMC OA. Findings from such a full trial can inform health 
funding policy on the provision of orthotic devices for people with thumb CMC OA and 
assist clinicians to be better informed when recommending an appropriate intervention 
for their patients. The conduct of a future full trial has been shown to be feasible. A 
subsequent RCT investigating the effectiveness of a soft off-the shelf splint for managing 
thumb CMC OA should be undertaken using the current protocol. Analysis of the 
feasibility data suggested a number of protocol adaptations.  
This feasibility study represents the final empirical work of this thesis. The final 
discussion chapter, drawing together the findings of the present study in relation to the 
findings of the earlier systematic review and qualitative study, reviews each in the 
context of the thesis as a whole and makes recommendations for future research and for 




   
General discussion 
6.1 Background 
Thumb CMC OA is a common, disabling condition and, from the patient perspective, 
little has been known about its unique impact. Usually it has been studied as part of the 
more general condition of hand OA and has received far less attention than lower limb 
large joint OA. Consequently, thumb CMC OA has been significantly under-investigated. 
Although international guidelines recommend splinting as a non-surgical, non-
pharmacological treatment option for CMC OA, evidence supporting this is sparse and 
inconsistent. The resultant lack of understanding about which outcomes and treatment 
targets are of importance to patients has contributed to gaps in outcome measurement, 
intervention design and, therefore, evidence for practice.  
This thesis set out to address these gaps in the research field by exploring the impact of 
thumb CMC OA from the perspective of people living with the condition and by 
investigating the effectiveness of splinting interventions for improving outcomes of 
importance for people with thumb CMC OA. A pragmatic, shared post-positivist and 
constructivist approach informed the research methodology. Thus, the research 
involved both qualitative and quantitative methods.  
In the pragmatic qualitative study in Chapter 3, 30 participants took part in individual 
interviews and solicited diaries. Data were analysed by thematic analysis using a 
primarily inductive approach. The Health Impact Model was employed to aid 
interpretation of results.  
In the systematic review in Chapter 4, existing evidence, that is, from published studies 
up to 17 March 2018, was investigated using narrative- and meta-analysis to determine 
the effectiveness of splinting for improving pain, function, and HR-QoL in people with 




Informed by these initial studies, a feasibility study in Chapter 5 was conducted to 
investigate a proposed protocol for a future fully-powered RCT to investigate the 
effectiveness of a soft splint intervention.  
6.2 Overview of thesis findings 
An overview of the thesis findings and directions for future research are outlined in 
Figure 6.1  
 




The qualitative study found that thumb CMC OA has a profound impact, largely 
associated with pain, on many aspects of a person’s health and well-being. Five main 
themes representing five inter-related levels of health impact were identified: negative 
experience of symptoms, functional limitations, restricted social activities and roles, 
negative thoughts and feelings, and altered sense of self. Impact was influenced by 
dominant hand involvement; cold climate; people’s financial, social and societal 
support; and attitudes to thumb CMC OA. Areas of impact which inform treatment goals 
and important measurable outcomes were identified, as well as areas requiring 
targeting of health resources. Pain, including pain at night, was a major concern. There 
was a strong desire for provision of high-quality information about self-management as 
well as effective non-surgical, non-pharmacological treatment options. Self-report 
composite functional questionnaires, currently recommended to measure functional 
limitations in people with thumb CMC OA, were concluded to be inadequate. 
The systematic review included twelve studies (n=1353 participants), four comparing a 
splint to control and eight to another splint. All evidence for splinting was of low quality. 
Sensitivity analyses demonstrated that in the medium-term (3-12 months) splints cause 
a moderate-to-large reduction in pain (SMD -0.7 [95% CI -1.04, -0.35], < 0.0001) and 
small-to-moderate improvement in function (SMD -0.42 [-0.77, -0.08], p = 0.02). No 
effect exists in the short-term. The review identified variability in self-reported 
outcomes, case definitions, and rationale for splinting; low and variable splint dosage; 
lack of standardised usual care; unassessed QoL; and inappropriate study designs. A 
need for further high-quality research was clearly established.  
The RCT design of the feasibility study was found to be achievable with some 
modifications. All primary outcomes surpassed the a priori thresholds for feasibility. 
Thirty participants were enrolled; 29 (96.7%) completed the assessment at 4 weeks. 
Preliminary indicative data suggest that a positive effect of splinting for pain on average 
and pain at night may exist in the short-term and for pain at night in the medium-term. 
The changes in pain – recording both pain on average in the past week and pain on 
average at night in the past week using NRS – indicated that these measures are 




In the following sections of this final chapter key findings of the overall thesis are 
discussed and their implications for clinical practice and research outlined. These 
include the significant impact of pain and pain at night; the relationship between pain 
and physical limitations; the challenges of assessing function; the broader impact of 
thumb CMC OA; factors that modify impact; and the effectiveness and prescription of 
splinting. A brief update of literature since the systematic review is then given, and gaps 
in thumb CMC OA outcome responsiveness literature outlined. Next, the strengths and 
weaknesses of the overall body of work are reviewed and recommendations for future 
research are made. The final section draws overall conclusions.  
6.3 The significant impact of pain and pain at night 
6.3.1 Pain, and pain at night are key outcomes and treatment targets 
The qualitative study of Chapter 3 identified that pain, including pain at night, was the 
major problem experienced by people with thumb CMC OA. This finding, concurring 
with the work of previous authors who have explored the impact of hip and knee OA 
(Hawker et al., 2008; Parmelee, Tighe, & Dautovich, 2015; Woolhead, Gooberman-Hill, 
Dieppe, & Hawker, 2010), including the pain experience, now extends this knowledge to 
include thumb CMC OA specifically. Pain, constant rather than intermittent or 
unpredictable, was of greater concern to participants with thumb CMC OA in contrast to 
those with hip and knee OA (Hawker et al., 2008). This finding aligns with and extends 
previous reports of pain impact in hand OA (Marshall et al., 2009) although pain on 
activity was identified as a more prevalent problem in the cohort among whom the 
AUSCAN outcome instrument was developed (Bellamy, Campbell, et al., 2002). From the 
perspective of people with thumb CMC OA, pain and pain at night are key treatment 
targets and outcomes. From a surgeon’s perspective, pain is also seen as the primary 
reason for surgery for thumb CMC OA and its relief the most important outcome 
(Martou et al., 2004).  
6.3.2 Pain at night an important clinical feature 
An important and novel finding of this thesis in both the qualitative and feasibility 
studies is the presence of pain at night as a major problem for participants who had a 
range of disease stages. While sleep disturbance has been reported for around  




Pettersen et al., 2019), pain at night has not previously been established as a prominent 
feature of thumb CMC OA other than as a symptom that may be present ‘in the later 
stages’ (Burkholder, 2000). Although ‘pain at rest’ is mentioned in some clinical texts 
(Valdes, Algar, & Weston McGee, 2020), pain at night associated with thumb CMC OA is 
not generally common in the literature, and clinical texts often describe thumb CMC OA 
pain as primarily mechanical and associated with demanding, repetitive manual tasks 
(da Silva & Woolf, 2010).  
Pain that occurs at night in hip and knee OA is associated with fatigue, distress, and 
worse pain levels (Hawker et al., 2008; Parmelee et al., 2015; Woolhead et al., 2010) and 
this is also likely to be the case in thumb CMC OA. Reducing pain that disturbs sleep may 
also relieve pain-related emotional distress (Parmelee et al., 2015). 
6.3.3 The relationship between pain and inflammation 
Osteoarthritis pain that occurs at night or interrupts sleep has been described as 
suggestive of an active inflammatory process (Sellam & Berenbaum, 2010). 
Furthermore, the importance of inflammation in OA pathogenesis and symptomatology 
is being increasingly recognised (Bacon et al., 2020), including in thumb CMC OA (Oo et 
al., 2019). However, there is no empirical evidence yet for a relationship between pain 
at night in the thumb CMC and inflammation in the joint; it would be salutary to 
understand this further. Whether signs of inflammation can predict response to 
treatments such as splints is also a question to be answered. Some preliminary steps 
were taken in this thesis to assess the feasibility of incorporating ultrasound evaluation 
into an RCT and this would appear achievable.  
6.3.4 The pain experience 
Pain experienced with an osteoarthritic joint may be associated with 
pathophysiological, molecular, or structural damage but the severity of anatomical joint 
disease is known to be only weakly related to that of the clinical problem (Dieppe & 
Lohmander, 2005). A recent study investigating the psychological aspects of pain from 
thumb CMC OA using cross-sectional survey methods found that 47% of variation in 
pain levels could be explained by psychological factors including illness distress, pain 




by x-ray scores (Hoogendam et al., 2019). Negative illness perceptions have also been 
associated with short- and long-term disability in hand OA (Damman et al., 2018).  
The extent to which psychological factors play a role in outcomes of hand and upper 
limb disease and injury is poorly understood however; previous studies attempting to 
explain this relationship suffer from methodological flaws, for example, cross-sectional 
study design and an unbalanced focus on negative psychological traits (MacDermid, 
Valdes, Szekeres, Naughton, & Algar, 2018). It is postulated though that the broader 
impact of thumb CMC OA, as identified in the qualitative study in this thesis, exerts a 
complex interactional effect on the pain experience of people with this condition. This 
effect includes anger and frustration about restrictions in life roles, distress about the 
future, anxiety about continuing independent and in work, loss of enjoyment, negative 
mood, ‘dispiritedness’, and altered sense of self.  
6.3.5 Pain assessment 
The measurement of pain is complex and the variety of instruments and operational 
definitions identified in the systematic review present a challenge to making valid 
comparisons across studies. In hip and knee OA the Western Ontario and McMaster 
Universities Arthritis Index (WOMAC) has become a standardised way of assessing pain 
and functional loss (Woolacott, Corbett, & Rice, 2012). For all its faults, including fee for 
use, multiple versions and scoring, the WOMAC has played a significant role in allowing 
more robust synthesis of findings across studies (Copsey et al., 2019; Woolacott et al., 
2012). Future research in thumb CMC OA should aim to decrease diversity in the 
outcome measures used, for pain particularly.  
The nuanced experience of pain has also been recognised and is poorly reflected by a 
single number recorded on a scale (Portney, 2015). Based on findings in this thesis, the 
pain profile in thumb CMC OA appears to be different to that in hip and knee OA. For 
example, although dimensions of impact on mood, sleep, and quality of life in the newly 
developed Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP) (Hawker, 
Mian, et al., 2011) will be highly pertinent, the dimension of unpredictability may not be 
so relevant. Adaptation of the ICOAP for hand and thumb CMC OA has been 




this thesis. The development of a pain question (NRS) that seeks to measure the 
constancy of pain with for example, present all the time at one anchor and present none 
of the time as the other anchor, which may incidentally measure night pain, may be a 
more sensitive measure in people with thumb CMC OA.  
Pain and pain at night are significant impacts of thumb CMC OA that should serve as key 
treatment targets and outcomes in clinical studies. Pain at night is not commonly 
described as a symptom in this population but was present for most participants in the 
work of this thesis, including those in early or mid-stage disease. A consistent measure 
of pain in hand and thumb CMC OA is needed. Pain at night is a symptom deserving of 
more attention in thumb CMC OA.   
6.4 The relationship between thumb CMC OA pain and physical limitations 
The qualitative study in Chapter 3 found that physical symptoms experienced by people 
with thumb CMC OA, including loss of strength and dexterity, were often associated 
with pain.  
The prominent role of pain in reducing strength and motor control in thumb CMC OA is 
suggested by a recent study employing an experimental model of thumb CMC joint pain. 
In this study, investigators injected hypertonic saline into the dorsal-radial ligament of 
human volunteers and isotonic saline on the contralateral hand, demonstrating a 
greater increase in pain and a concomitant between-group difference of 50% reduction 
in tip pinch strength compared to baseline (Ooishi et al., 2019). Furthermore, surface 
electromyography revealed significantly reduced activity of the APB and FDI muscles 
while activity of the EPL remained unchanged (Ooishi et al., 2019). The differentially 
greater experimental CMC joint pain induced by the hypertonic saline was hypothesised 
to reduce tip pinch strength via mechanical provocation of sensitised joint tissues 
causing inhibition of motor recruitment. Additionally, the loss of balanced dynamic 
control was hypothesised to increase joint point contact forces, provoking further pain 
(Ooishi et al., 2019). Such mechanisms are likely to be at play in thumb CMC OA.  
Variability in hand dexterity in OA has previously been observed to follow fluctuations 




Sothern, et al., 2002). In the qualitative study in this thesis participants identified 
problems such as dropping things, loss of grip, reduced dexterity, and perceived loss of 
power with pinch and grasp. These may be the consequences of pain-inhibited 
sensorimotor functioning rather than loss of strength per se. Moreover, in general hand 
OA, a reduction in pain has been correlated with improved function (Barthel et al., 
2010). While limitations in physical function are an important impact for people with 
thumb CMC OA, many of these limitations are influenced by pain. Since reducing pain 
has potential to increase hand strength and function, pain is the primary treatment 
target and outcome of interest. The relationship between pain, function, and strength in 
thumb CMC OA is also an area worthy of further research.  
6.5 The diversity of functional limitations 
6.5.1 The diversity of impact 
The qualitative study in Chapter 3 highlighted the impact of thumb CMC OA on a 
remarkably diverse range of functional activities. This reflects and underscores the 
importance of the thumb and, in particular, its basal joint in every-day human life. 
However, this diversity presents a challenge to capturing the functional domain 
adequately.  
In the feasibility study self-report functional measures showed a lack of change in the 
feasibility study and only small effect sizes in the previous studies included in the 
systematic review. The lack of change in function seen in thumb CMC OA is in contrast 
to the lower limb OA where, in the short-term, improvements in functional outcomes 
are greater than those seen in pain (Fransen et al., 2015). Based on the work of this 
thesis and previous literature, a possible reason for this contrast is that lower limb 
function is primarily ambulatory, against the remarkable variation in upper limb, 
especially hand and thumb, function. It is, therefore, more challenging to capture the full 
breadth of impact in the upper limb with a single standardised instrument. An 
alternative explanation is that splinting has no effect at all on function in people with 
thumb CMC OA, in which case no change would be measured even if thumb CMC OA-




6.5.2 Assessing self-reported function 
Both functional limitations and participation in life roles are important outcomes for 
people with thumb CMC OA. Currently, the FIHOA is the only freely available self-report 
functional outcome recommended by the OARSI clinical trials group recommendations 
for hand and, by extension, thumb CMC OA (Kloppenburg, Maheu, et al., 2015). The 
FIHOA was developed in the early 1990s using clinician-derived items (Dreiser et al., 
1995). Several participants in the present qualitative study, both men and women 
identified some items as inappropriate. In particular, the item “For women: can you 
sew? For men: can you use a screwdriver?”. These issues have also been identified by 
previous authors (Stamm et al., 2006). Furthermore, the appraisal of findings from the 
qualitative study found that a range of impact and potential outcome items important to 
people with thumb CMC OA were missing from the FIHOA, including household tasks, 
tasks involving impact or vibration, work roles, and interacting with children or 
grandchildren, among others.  
For the feasibility work in this thesis the QuickDASH was considered a good alternative 
to the FIHOA; it is valid, reliable, and has known MCID (Beaton et al., 2005; 
Franchignoni et al., 2014; Sorensen et al., 2013; Wong, Fung, Chu, & Chan, 2007). 
However, the ability of the QuickDASH to detect change in the feasibility study appeared 
no better than that of the FIHOA. The Additional Functional Questionnaire based on 
findings in Chapter 3 also showed little change but was not a robustly devised 
instrument.  
In summary, these findings support previous work which concluded that the currently 
recommended functional measures for hand OA are lacking in specific relevance to 
thumb CMC OA (Kloppenburg, Maheu, et al., 2015; Stamm et al., 2009). This is an area 
urgently requiring further research; the inclusion of patient perspectives will be critical 
to its success. 
6.5.3 Instrument development 
It would be challenging to develop an instrument to measure patient-reported function 
specifically for thumb CMC OA. Nevertheless, the qualitative work conducted in this 




framework for a new or modified instrument (Bredart, Marrel, Abetz-Webb, Lasch, & 
Acquadro, 2014). A subsequent step would be to conduct cognitive interviews to 
confirm the concepts selected after which a framework could be elaborated to develop 
items that assess the key identified concepts, thus establishing face- and content validity 
(Bredart et al., 2014). The process of building construct validity, i.e. providing the 
evidence to support or refute the theoretical framework, could then commence 
(Portney, 2015). This could use a factor analysis approach which analyses scores for 
factors’  fit with the theoretical premise of the instrument and can assess for internal 
consistency and removal of redundant items (Portney, 2015). Finally, the instrument’s 
ability to detect change would need to be assessed, including testing for reliability, floor 
and ceiling effects, and responsiveness to change (Portney, 2015). 
Alternative directions to assessment of self-reported function include person-specific 
measures such as the Patient-specific Functional Scale (PSFS), or computer adaptive 
testing (CAT) such as the dynamic Patient Reported Outcomes Measurement 
Information System (PROMIS). In contrast to region- or condition-specific measures, 
patient-specific measures such as the PSFS can be used in diverse client populations and 
can allow for those items of greatest relevance to the patient to be measured (Donnelly 
& Carswell, 2002). The PSFS has been found to have good reliability and content validity 
in thumb CMC OA cohorts although concurrent validity (against the DASH/Quick DASH 
and grip strength) is low-to-moderate (Rosengren & Brodin, 2013; Wright et al., 2017). 
This instrument also shows good ability to detect change in the hand OA population 
(Hennig, Haehre, et al., 2015). However, longstanding debate exists about the validity of 
using person-specific instruments in cross-participant group-level evaluation, a purpose 
for which they were not designed (Donnelly & Carswell, 2002; Kyte et al., 2015).  
The dynamic PROMIS employs item response theory to establish item difficulty 
estimates which, when used to select questions in a CAT situation, can increase 
measurement precision and accuracy (Lehman et al., 2011). The flexibility of this 
system is more likely to capture the diversity of functional limitations than currently 
available region- and condition-specific instruments (Lehman et al., 2011). The PROMIS 
physical function upper limb sub-domain appears to be able to detect differences 




construct validity when evaluated against the DASH and QuickDASH (Beleckas, Gerull, 
Wright, Guattery, & Calfee, 2019). However, limitations include the level of 
technological capability required to reliably administered the CAT version and the need 
for additional validation testing (Makhni et al., 2017). Responsiveness to change is also 
yet to be explored in hand conditions (Brodke, Saltzman, & Brodke, 2016). 
In summary, currently available measures are not satisfactory and their adaptation or 
the development of a new self-report outcome measure for thumb CMC OA is 
warranted. Findings from this thesis can contribute to future work. More robust, 
relevant, easy to use instruments are required to assess functional outcomes before 
splinting effectiveness for function can be determined. 
6.6 Impact beyond physical limitations  
The qualitative study in Chapter 3 revealed that people with thumb CMC OA experience 
a range of impact beyond that of hand-specific symptoms and function, including 
negative emotions, altered sense of self related to negative perceptions of ageing, 
reduced activity levels, and medication burden. These data highlight the broader patient 
experience of thumb CMC OA which is fundamental in determining suitable outcomes to 
evaluate the effectiveness of interventions and to assist clinicians to meet their patients’ 
needs and expectations (Carr, 1999; Hawker, Gignac, et al., 2011; MacDermid, 2005; 
Wylde, Hewlett, Learmonth, & Cavendish, 2006).  
Negative emotions experienced by participants included anger and frustration relating 
to pain and restrictions in work and life roles. Another negative impact was concern 
about the future. Maintaining independence was a common concern and has been 
reported in previous studies of hand OA (Hill et al., 2010); this is unsurprising given the 
central role of the hand and thumb in daily activities. Such negative mental and 
emotional impacts are important treatment targets in thumb CMC OA, while they are 
likely to contribute to the pain experience and are distressing on their own merits, they 
can also respond to a variety of interventions.  
Participants described an altered sense of self, related to a negative perception of their 




qualitative work among older people in the United Kingdom that one’s dignity can be 
jeopardised in older age, compared with other age groups, by being associated with loss 
of identity and loss of value (Woolhead et al., 2010). In New Zealand about 20% of 
adults aged 50 years or over reported as having felt invisible because of their age and 
around one third are concerned about becoming a burden on family, even though only 
8% of younger people see them in this way (Ministry of Social Development, 2016). In 
the World Values Survey, 60% of respondents thought that older people were not 
respected and the lowest levels of respect were found in high income countries (Officer 
et al., 2016). Ageing in this period of neoliberalism which emphasises qualities of 
individualism and independence can be a fraught experience (Rubinstein & de 
Medeiros, 2015). This wider context is liable to be an important factor in the impact of 
thumb CMC OA experienced by patients.   
Another negative impact experienced by participants in the qualitative study was 
reduced general activity levels. This has potential to contribute not only to a decline in a 
person’s general health but also to co-morbidities including mental health (Callahan & 
Ambrose, 2015; Kim, 2019). Therefore, maintenance of general activity to avoid decline 
in overall health is another important target for intervention in those with thumb CMC 
OA.  
Participants in the qualitative study wished, wherever possible, to avoid surgery and 
the burden of medication, especially in the presence of multi-morbidities. This 
compares with more mixed views found among cohorts of people with hip and knee OA 
for whom surgery is often seen as a more mainstream and available option (Papandony 
et al., 2017).  
Along with the impacts of pain and physical limitations described in the previous 
sections, these data portray in detail the less tangible and less easily measured costs 
borne by individuals with thumb CMC OA. 
6.6.1 Assessing the broader impact 
The findings of the qualitative study in Chapter 3 support those authors who now 
encourage a holistic approach in clinical trials of OA, i.e. monitoring the health of the 




However, it is unclear whether the measures available can do this justice (Lundgren-
Nilsson et al., 2018; Michon et al., 2011).  
Health-related QoL measures such as the EQ-5D-5L capture aspects of emotional and 
spiritual well-being, as well as perceived physical health status. Notably, however, one 
of the EQ-5D-5L questions relates to mobility, which is less likely to reflect isolated OA 
thumb-related QoL, and this forms one fifth of the measure. Its generic scope might 
account for the negative change seen in the EQ-5D-5L in the feasibility study at  
6-months, compared with the positive change seen in all other measures, i.e. by 
reflecting change in factors not directly related to thumb CMC OA. Other widely used 
HR-QoL instruments, such as the SF-36, have a similar emphasis on the lower limb. 
Suitable measures for assessing wider well-being in thumb CMC and hand OA is another 
area for further research.  
In contrast to previous findings in OA of hand joints generally (Hill et al., 2010; Stamm 
et al., 2009) participants in the qualitative study were minimally concerned about the 
aesthetic impact of their condition. This concurs with a previous U.K. study in which 
aesthetic appearance was of lesser concern for thumb CMC than nodal or erosive hand 
OA (Marshall et al., 2013). While assessment of aesthetic distress is advocated for 
general hand OA (Michon et al., 2011; Stamm et al., 2009), this domain need not form 
part of the outcome repertoire for thumb CMC OA.   
6.6.2 Management approaches  
Management of persistent pain and its attendant social, emotional, and spiritual 
impacts, requires an holistic approach (Allen et al., 2016; Lundgren-Nilsson et al., 2018). 
This requirement has been identified by both patients and physicians in primary care of 
generalised OA (Rosemann et al., 2006). A range of complementary therapies including 
Yoga and Tai Chi can be ways in which to support a more holistic approach to OA 
management and are recommended by international guidelines (Bannuru et al., 2019); 
however, the reasons or justifications for seeking complementary therapies are diverse 
and health professionals may not be well informed (Kim et al., 2020). Nevertheless, 
alleviation of OA pain can positively affect coping strategies, sleep, and mood, which 




approaches are likely to be of benefit in addressing the broader impact experienced by 
people with thumb CMC OA. 
Given the negative impact of thumb CMC OA on sense of self and quality of life reported 
in the qualitative study, consideration of the impact of splint use on these aspects is also 
necessary when investigating splinting as an intervention. Few studies have reported 
the personal experience of splint wearing generally and only one study could be located 
that specifically explores the experience of splint wearing for thumb CMC OA (Gruschke, 
Reinders-Messelink, van der Vegt, & van der Sluis, 2019). This study found that, for two 
types of rigid splint, central phenomena of splint wearing experience were stabilizer, 
tool, healer, preventer, and nuisance; these were related to participants’ understanding 
of the disease process and splint mechanism of effect (Gruschke et al., 2019). Thus, 
optimisation of splint wearing experience should include explanation of thumb CMC OA 
and the proposed mechanism of effect. The inclusion of these aspects in the best 
practice usual care intervention in the feasibility study may have contributed to the high 
levels of adherence and acceptability found in this study. Patient choice in splint types 
based on lifestyle, priorities, and personal beliefs may deliver an optimal splint 
experience (McKee & Rivard, 2004; McKee & Rivard, 2011) although evidence for 
achieving goals such as less pain and improved function is necessary for informed 
shared decision making (Towle & Godolphin, 1999). Limited narrative accounts suggest 
that successful patient-centred application of orthotic devices including for thumb CMC 
OA can make positive contributions to individual’s lives (McKee & Rivard, 2004; McKee 
& Rivard, 2011). Further research that explores the impact of splint wearing on sense of 
self or quality of life in thumb CMC OA would be valuable to better inform the process of 
splint prescription in both research and clinical settings. 
6.7 Impact-modifying factors  
The work of the qualitative study also provides some insights into the ways individual 
and environmental factors interact to mitigate or amplify the impact of thumb CMC OA. 
Many of these factors are modifiable. This has implications for research, clinical 




6.7.1 Personal factors 
At a personal level, the impact of thumb CMC OA was found to be greater where the 
dominant hand was involved. Therefore, in a research setting and depending on a 
study’s objective studies should stratify group allocation by hand dominance or adjust 
analyses where any baseline between-group differences are identified.  
Other person-level modifiers which alleviated the impact included self-efficacy, social 
supports, and religious faith; those which amplified impact included cold weather and 
lack of good information about the condition. Interventions that can alter or harness 
these, for example, to improve self-efficacy or provide quality information, are likely to 
have a positive effect. 
6.7.2 Education 
Findings of the qualitative work in this thesis indicate that information and education 
are highly valued and sought after by patients. Provision of quality information and 
education to explain a condition and its symptoms is a key intervention and a core 
recommendation of international guidelines for hand and thumb CMC OA (Bannuru et 
al., 2019; Kloppenburg et al., 2019; Kolasinski et al., 2020; NICE, 2014). Education can 
have powerful positive effects. For example, the ‘Explain pain’ approach for persisting 
or complex pain uses a range of educational interventions to increase patients’ 
understanding of the biological processes known to underpin pain as a mechanism to 
reduce pain itself (Moseley & Butler, 2015). Approaches that increase understanding, 
dispel myths, and allay fears are promoted for hip and knee OA (Darlow et al., 2020; 
O'Brien, Chapple, Baldwin, & Larmer, 2019). A conceptual model of thumb CMC OA that 
aids understanding, relieves fear and anxiety, and informs how CMC joint health can be 
influenced positively is likely to be well received. This could be developed by integrating 
current scientific knowledge from Chapters 1 and 2 and incorporating patients’ 
perspectives (Chapter 3) alongside clinician stakeholders’ views gathered as part of the 
feasibility study (Chapter 5) to produce a biopsychosocially-informed paper or digital 
resource. This could then be evaluated using a mixed-methods approach involving 
survey and focus groups with patients and clinicians, such as that undertaken for a 




6.7.3 Barriers to care 
Impact was influenced by barriers to accessing care. Participants experienced barriers 
for several reasons: 1) attitudes of participants or their health provider towards thumb 
CMC OA and older age; 2) clinical uncertainty about the effectiveness of treatments for 
thumb CMC OA; and 3) financial or geographical barriers. 
6.7.3.1 Attitudinal barriers 
Attribution of thumb CMC OA to older age, by participants or their health providers, was 
a frequent experience of participants in the qualitative study. This presents a barrier to 
accessing care for thumb CMC OA because symptoms are often minimised or ignored. 
Health worker prejudice towards older patients is a recognised phenomenon that 
influences decision making and impedes equitable quality and quantity of care for older 
people (Wyman, Shiovitz-Ezra, & Bengel, 2018), including those with OA (Gignac et al., 
2006). Age-related biases and assumptions held by adults themselves are also a known 
phenomenon that can influence interactions with health services (Gignac et al., 2006; 
Wyman et al., 2018). While thumb CMC OA is more prevalent in older age, well-
informed clinicians and patients are able, nevertheless, to make a difference to 
outcomes and the impact experienced; stronger evidence for treatment effectiveness 
will help this.  
6.7.3.2 Clinical uncertainty 
Clinical uncertainty was evident in the qualitative study on the part of both participants 
and participants’ reports of their interactions with clinicians. Lack of clarity about 
which treatments work or do not work leads to people either to avoid seeking care or to 
seek inappropriate care (Ackerman, Livingston, & Osborne, 2016; Runciman et al., 
2012). This has been previously identified as a barrier to care in hand OA (Hill et al., 
2011). A scarcity of research, particularly concerning peripheral joint OA such as the 
thumb CMC and hand, contributes to this problem (Hunter & Bierma-Zeinstra, 2019). 
The use of non-pharmacological, non-surgical treatments, including physiotherapy and 
occupational therapy, among people with hand OA and OA at other joints, is surprisingly 
low internationally (Dziedzic et al., 2007; Dziedzic & Allen, 2018; Gravas et al., 2019; 
Iversen et al., 2018; Runciman et al., 2012). For example, in Australia about 40% only of 




interventions being recommended as best practice first-line management (Hunter & 
Bierma-Zeinstra, 2019; Kloppenburg et al., 2019; Kolasinski et al., 2020; NICE, 2014). 
No data could be located for New Zealand. Whilst New Zealand expert clinician 
stakeholders nominated the type of advice, education, and exercises that they would 
offer a patient thumb CMC OA as part of the best practice usual care development for 
the feasibility study, findings from the qualitative study indicate that, unfortunately, 
such care is not yet ‘usual’ in New Zealand.  
6.7.3.3 Cost barriers 
Findings from the qualitative study indicated that some participants were prevented 
from accessing care by an inability to pay for health services. In the New Zealand 
healthcare system access to care for thumb CMC joint OA and OA at other joints is 
under-resourced (Baldwin, Briggs, Bagg, & Larmer, 2017), a situation common to many 
countries (Ackerman et al., 2016; Choojaturo, Sindhu, Utriyaprasit, & Viwatwongkasem, 
2019). Although New Zealand has a universal secondary-level public health system, 
primary care general practice is accessed on a subsidised user-pays basis (Goodyear-
Smith & Ashton, 2019) and most allied health OA-related primary care services have no 
subsidy. Therefore, both primary care and second tier services can be out of reach for 
those unable to pay (Jatrana & Crampton, 2020). Changes to health policy, funding, and 
provider arrangements that enable subsidised or universal access to care are likely to 
improve outcomes for people with CMC OA.   
Knowledge of the personal, social, and societal factors that modify the impact of thumb 
CMC OA to enable better understanding of variations in presentations or treatment 
effect is a target for health resourcing and changes in health worker education and 
health policy. The work of this thesis, along with ongoing and future research, will 
increase awareness of the significant impact of OA, including thumb CMC OA, and 
contribute to stronger evidence that will reduce clinical uncertainty, inform health 





6.7.4 Potential models for implementing best practice care 
The implementation of best practice care as usual care in New Zealand and elsewhere 
requires urgent attention. Modes of delivery such as telehealth or mixed media 
approaches may help to overcome cost and geographical barriers and make care more 
directly accessible to patients.  
Implementation of best practice care for peripheral joint OA generally in primary care 
has been investigated in the in the Model Consultation (MOSAICS) study (Dziedzic et al., 
2018). In this cluster RCT a well-developed package of care was provided to 
participants in the intervention group including an enhanced GP consultation, 
education, advice, pain management, an OA self-management guidebook, and practice 
nurse follow-ups. Although the intervention resulted in statistically significant higher 
uptake of best practice care, the primary clinical outcome of SF-12 physical component 
score was not significantly improved. A small but significant reduction in NSAID use was 
observed. Possible reasons for the lack of expected benefit included patient or clinician 
beliefs limiting access to nurse follow-ups, the time frame of 6-months being too short 
to see benefit in the chronic condition, complexity requiring more specialist input, and 
insufficient uptake of self-management or exercise intensity or both (Dziedzic et al., 
2018). It was concluded that the optimal combination of strategies for implementing 
best practice care for OA was yet to be discovered. Of note, the study had no severity 
threshold entry criteria and mean pain scores for the hand at study entry were low, 
around 2.9 on an 11-point scale. This may have resulted in a potential floor effect for 
participants with primarily hand OA. Furthermore, the 54-page self-management 
guidebook was lengthy and relatively generic. Possibly, a more focused approach e.g., 
for each joint or tailored to the patient, may have had a greater impact particularly 
where the thumb CMC joint is concerned. 
A number of OA management programmes (OAMPs) have had their implementation 
evaluated in various countries (Eyles et al., 2019). Overall, understanding of the optimal 
approach to implementation of OAMPs remains in its infancy. An international survey 
and prioritization exercise generated five top issues recommended for urgent attention: 
1) guidelines for implementing OAMPs to enhance consistency of delivery and 




care professionals (HCPs); 3) develop and evaluate implementation of novel models of 
OAMPs; 4) develop and evaluate core skill sets and resources for HCPs; and 5) develop a 
framework for enhancing quality of care provided by OAMPs (Eyles et al., 2019).  
Telehealth (remote synchronous or asynchronous patient care including by telephone, 
video conference, and online materials) is an example of a novel OAMP model. Multi-
media telehealth interventions for knee OA have shown a good level of acceptability 
among both patients (Lawford et al., 2020) and clinicians when well supported 
(Lawford et al., 2021), and positive outcomes (Hinman et al., 2020). It is postulated a 
blended model with options for in-person in addition to telehealth may meet the needs 
of the widest range of patients (Hinman et al., 2020). A process evaluation with 
programme coordinators involved in leading the Australian secondary-care referred 
Osteoarthritis Chronic Care Programme identified telehealth as a potential key 
facilitator for improved implementation by overcoming space and geographical 
barriers, particularly if primary care input were to be expanded (Eyles et al., 2020).  
A preliminary evaluation of telehealth assessment and management of hand 
impairments and function deficits by occupational therapists concluded that telehealth 
has potential as a successful model of service delivery that can facilitate implementation 
of best practice care for a range of hand conditions (Worboys, Brassington, Ward, & 
Cornwell, 2018). Brief review of the literature reveals that an OAMP model for thumb 
CMC OA that includes telehealth has not yet been developed or evaluated; this is a key 
area for future research.  
6.8 Splinting effectiveness and prescription 
The systematic review reported in Chapter 4 found that splinting has a moderate-to-
large effect in the medium-term but not in the short-term; but both findings were of low 
quality.  
The feasibility study in this thesis aimed to implement splint wearing at the highest 
dosage possible and acceptable. Following consultation with New Zealand expert hand 
therapists, this was tested for 20 hours of 24, including while sleeping. In contrast to 




effect at short-term as well as medium-term. This is encouraging and may be a result of 
the high splint dosage or the overnight wearing, or both. Importantly, this study 
demonstrated that splint wearing at a higher dose than reported in previous controlled 
trials is feasible and acceptable to patients.  
The lack of withdrawals or dropouts in the feasibility study concurs with the finding of 
the systematic review of Chapter 4 and is encouraging for future studies. It provides 
further support to the existing evidence that there is no significant harm associated 
with splint interventions. This, together with the high level of acceptability, is an 
important point for both research and clinical practice since thumb CMC OA is a long-
term condition and interventions that can be used frequently, for long or short periods 
without harm, are of high importance for optimising participants’ overall health and 
QoL.    
The mechanisms by which splint interventions influence first CMC joint alignment, 
motor patterns, synovial inflammation, or pain modulation and whether these are 
related to changes in patient symptoms are all areas requiring further research. A range 
of technologies now exist with which living tissues (and the impact of interventions) can 
be investigated, including biomechanical, EMG, and imaging methods.  
Splinting has good indication in all respects, and good potential to address patients’ pain 
concerns and meet patients’ desires for non-pharmacological, non-surgical 
interventions for symptomatic thumb CMC OA. Further investigation of both the efficacy 
and the effectiveness of splinting is merited.  
6.9 Literature update on the effectiveness of splinting for thumb CMC OA 
Since the systematic review in this thesis was undertaken, a large multi-centre RCT has 
been completed investigating the effectiveness and efficacy of active vs placebo thumb 
splints, in addition to an 8-week self-management programme, for participants with 
symptomatic thumb CMC OA (Adams et al., 2020). The OTTER study was conducted 
across 17 U.K. National Health Service (NHS) localities and enrolled 349 patients 
randomised in 1:1:1 ratio. Loss to follow-up was 16% at the primary endpoint of  




clinically or statistically significant differences between the intervention groups: active 
splint vs placebo splint MD -0.4 (95% CI -1.4 to 0.6 p=0.41); active splint vs. self-
management -0.5 (-1.4 to 0.4 p=0.26); placebo splint vs. self-management  
-0.1 (-1.0 to 0.8 p=0.78). This result of no effect for splinting in the short-term concurs 
with the findings of the systematic review in this thesis. Furthermore, although some 
imprecision may persist, this was a large, well-conducted study with low risk of most 
biases and thus would be likely to increase the GRADE rating of the finding to a 
moderate quality and reduce the likelihood that any future study would change the 
conclusion.  
However, several aspects of the study interventions require further consideration. First, 
the splint intervention involved some variability; a decision tool was used to determine 
whether a participant was fitted with a soft, off-the-shelf neoprene splint, or a custom-
made rigid thermoplastic splint (Adams et al., 2019). If more targeted intervention is 
more beneficial, this variability could have increased the effect or it could have reduced 
the effect if only one splint is more beneficial, or if the decision tool was imperfect to 
begin with. Second, splints were prescribed to be worn for approximately 6 hours in the 
day and wearing at night was discouraged (Adams et al., 2019). This dosage may not 
have been high enough to produce an effect, particularly if wearing a splint at night is a 
key factor, although this is not yet established. Third, the self-management programme 
was standardised, developed, and based on best practice comprising education, advice, 
and exercises (Adams et al., 2019). This represents a well-designed comparator; 
however, it is also likely to have reduced the effect size detectable for the splint. While 
including standardised usual care is a necessary development, it does make 
investigating interventions for thumb CMC OA more challenging, particularly when the 
effect size of a given ‘usual care’ remains unknown.  
In summary, in any future trial, sufficient dosage of a splint intervention is likely to be a 
key factor in its effectiveness for improving pain in thumb CMC OA, and the addition of 
best practice usual care to both the intervention and comparator groups raises the floor 
and increases the difficulty of detecting a difference between groups. The protocol 
outlined in the feasibility study in this thesis involves a substantially higher splint dose 




response to low splint dose such as that in the OTTER study is compared to medium or 
high splint dose such as that described in the feasibility study. The purpose of this type 
of study would be to estimate the response compared to dose given to analyse the 
efficacy of the intervention (Portney, 2015). Findings could further refine the future 
trial design or further inform whether to proceed with a full trial or both. Knowledge of 
the effect size of best practice usual care would aid in design of a future trial; however, it 
is unrealistic that this will ever be possible to study.  
An additional consideration regarding the OTTER study is the choice of primary 
outcome: the AUSCAN hand pain scale. This instrument places little emphasis on pain at 
night with one question asking about ‘pain at rest’ while the other four relate to pain on 
activities. Therefore, this measure may have lacked sensitivity for thumb CMC OA pain 
and so failed to detect actual change that may have occurred. Evaluation of splinting 
using pain, and pain at night, on NRS, as described by the feasibility study may be a 
more appropriate primary outcome.  
6.10 Treatment responsiveness 
Although most outcomes in the feasibility study demonstrated positive change, all 
require determination of what represents meaningful change in a thumb CMC OA 
population. The paucity of robust evidence of MCID for grip and pinch strength is 
particularly surprising, especially given that these measures are widely used as proxies 
for general health status in the older population (Bohannon, 2019), in which hand and 
thumb CMC OA are common. The GAT and the measures of thumb palmar abduction 
(IDD and Pollexograph) also require determination of validity or MDC, or both. 
Importantly, MCIDs are not absolutes; rather, they differ for different populations and 
contexts. 
The MCID of outcomes can be established by interpreting the outcome’s change 
(Portney, 2015). This can be done using one of two general approaches: distribution- or 
anchor-based (Portney, 2015; Wright et al., 2011). However, each method has its 
weaknesses. The distribution-based approach uses statistical methods and probability 
sampling (Portney, 2015); the major short-coming of these is that, because the 




detectable change beyond random error, rather than the MCID (Wright et al., 2011). By 
way of contrast, in anchor-based approaches scores are fixed to a reference standard, 
for example, a question that asks the patient about the level of change since a point in 
time, such as the GROC provides.  
A strength of the anchor-based approach is that the external anchor takes into account 
an understanding of the patient’s perspective of change (Wright, Hannon, Hegedus, & 
Kavchak, 2012). A limitation of this approach is the intrinsic weaknesses of the GROC 
which may suffer from recall bias (Portney, 2015; Schmitt & Abbott, 2015; Wright et al., 
2011) and uncertainty about what represents meaningful change on this primary 
measure for a given population and context (Terwee et al., 2010; Wright et al., 2012; 
Wright et al., 2011). Nevertheless, it is recommended that MCID be based primarily on 
anchor-based methods. Therefore, this would be an appropriate method to follow for 
determining MCID for outcomes in thumb CMC OA. It has also been recommended that 
MCID should exceed the MDC values, and should not rely on one study or one method 
only (Terwee et al., 2010). A more nuanced approach can be achieved by determining 
MCIDs relevant to participant demographic details such as baseline severity (Wright et 
al., 2012).  
6.11 Overall strengths and weaknesses of the thesis  
6.11.1 Strengths 
The strengths of this thesis derive from the pragmatic methodologies used to 
investigate the research questions, which entailed practical real-world perspectives, 
resulting in knowledge that translates directly to the needs of patients, clinicians, health 
services, researchers, and funders.  
The qualitative study in this thesis is the first investigation into the unique impact of 
thumb CMC OA from the patient perspective using interview methods. The pragmatic 
qualitative methods brought to light the significant and far-reaching impact of thumb 
CMC OA for patients, an impact which extends beyond that of physical impairments and 
symptom presentation. As an initial consequence, clinicians will be better informed in 
their management of the condition; beyond this, health services, researchers, and 




the problem of thumb CMC OA. Furthermore, patients themselves can expect to find 
benefit from a greater shared understanding of their condition.  
The use of qualitative methods ensured inclusion of patient perspectives in a robust 
way and enabled important insights to be incorporated into the feasibility study early in 
the research process. The input from stakeholders through focus group and individual 
interviews and including their clinical practice experience, together with the daily 
professional practice of the PhD researcher, increases the likelihood that future study 
findings will be successfully translated into clinical practice. 
The pragmatic approach to the qualitative study prompted responses relevant to the 
clinical presentation and preferred treatment options, as well as identifying barriers to 
potentially successful interventions. Findings from the study help to explain variation in 
thumb CMC OA presentation and response to treatments in clinical practice and 
research, for example, through consideration being given to the presence of other 
stressors in peoples’ lives and the impact on emotional well-being and general health. 
Furthermore, the qualitative study generated rich information that will inform the 
future development and refinement of outcome instruments and indicates areas where, 
for example, educational interventions may have benefit and may be worth the 
investment of further research and health service resources.   
The use of systematic review methods enabled a nuanced appraisal of available 
evidence as well as the potential pitfalls and difficulties of examining the questions of 
the benefits of splinting in thumb CMC OA and the difficulties of defining outcomes. The 
systematic review concluded that splinting is a promising non-invasive intervention for 
thumb CMC OA, and that the evidence supports the conditional recommendations made 
for the benefits of splinting. 
The methods of the feasibility study overcame several of the limitations identified in the 
previous studies of splinting for thumb CMC OA. Blinding participants to group 
allocation, providing similar or equal quantities and quality of participant materials and 
researcher contact time across groups, all reduce the likelihood of an effect size being 




al., 2015; Fregni et al., 2010). This has not been achieved in any of the previous studies 
reported in Chapter 4. Novel methods also included using ultrasound to explore its role 
in characterising structural changes and inflammation, trialling the IDD, a modified 
method of measuring palmar abduction, and using a quantitative score of NSAID use.  
The pragmatic orientation of the feasibility study, including the clinically applicable 
inclusion criteria and outcome measures, and the acceptability of the interventions to 
clinicians and patients will make findings of a future full RCT translatable to a broad 
range of clinical settings and patient presentations.  
Another strength of this thesis were the steps embedded in both the qualitative study 
and the feasibility trial to increase the recruitment of Māori participants. These included 
early consultation with Māori research advisors; the targeting of populations with a 
higher proportion of Māori, for example, adding the second centre; including people 
who might not otherwise seek care; consulting with service providers where possible 
about how to promote the study and to enable appropriate locations for study activities; 
and extending the recruitment time to implement strategies specifically aimed at 
recruiting Māori participants. In both studies the recruitment of participants of Māori 
descent in proportions that matched or exceeded the percentage in the local population 
is a positive outcome and is also an improvement on the low rates of recruitment of 
indigenous populations in much arthritis research (O'Brien et al., 2020; Strait et al., 
2019). The recruitment approach taken in this thesis is recommended as a small step 
towards addressing inequities in health care. 
However, Māori remained a small proportion of the total study populations. Steps to 
improve future recruitment include more extensive consultation with representatives,  
(Health Research Council of New Zealand, 2010; National Ethics Advisory Council, 
2020); seeking advice from Māori health research units, such as the Ngai Tahu Māori 
Health Research Unit in Dunedin (Health Research Council of New Zealand, 2010). In 
addition, there are other actions that have demonstrated success previously and could 
be incorporated in a future trial, namely, extending further the recruitment of Māori 
participants, e.g. by 6 months after non-Māori recruitment has ended; employing Māori 




greater use of whakawhanaungatanga (the process of establishing relationships, 
relating well to others) (Dyall et al., 2013; Selak et al., 2013).  
In summary, the methodological strengths of the work in this thesis are likely to make 
significant contributions to achieving high quality and accessible non-surgical, non-
pharmacological care that supports health and well-being for all people with thumb 
CMC OA. 
6.11.2 Weaknesses 
Limitations of the work in this thesis relate to the limitations of qualitative research 
generally, the need for validated classification criteria for thumb CMC OA, and the need 
for longer timeframes for follow-up.  
While valuable for generating rich understandings, the findings of the qualitative work 
in this thesis are not generalisable to all people with thumb CMC OA. A different 
researcher will bring different perspectives, experiences, and relationships, and may 
generate different data and make alternate interpretations (Creswell, 2014; Padgett, 
2012). This is a limitation applicable to the qualitative work in this thesis. However, the 
thesis introduction made clear the intent of the researcher, an experienced clinician and 
training clinician-researcher, to approach the work from a combined constructivist and 
post-positivist perspective. Furthermore, the development and conduct of the methods 
for collecting and interpreting interview data are robustly reported in Chapter 3. 
Therefore, where findings from the qualitative work are appropriate they can be 
applied with confidence.  
Alternate methods that could also serve the research aims include focus group 
interviews. A strength of focus groups is the scope that they give for participants to 
discuss, explore, and compare their experiences, a process which enables clarifications 
of participants’ views (Padgett, 2012). Although focus group data can be influenced by 
group norms and participants may be less likely to disclose personal accounts of health 
impacts (Padgett, 2012), focus groups may help in working through the complexity of 
the impact on function for further understanding of this domain, and in a co-design 
approach to treatment and health service development. Interview methods proved a 




The inclusion criteria used in the qualitative and feasibility studies seemed successful in 
identifying people with thumb CMC in the community but require validation. The use of 
validated classification criteria is recommended for entry into OA clinical trials 
(Fitzgerald et al., 2015). The feasibility study in Chapter 5 built on the clinical 
classification criteria used in the qualitative study in Chapter 3; these criteria could be 
investigated further for wider use in thumb CMC OA studies and clinical practice.  
The feasibility study included follow-up at 6-months but because thumb CMC OA is a 
long-term condition with long-term outcomes, follow-up >12 months is desirable in 
order to delineate the success of therapeutic approaches (Kloppenburg, Maheu, et al., 
2015). Furthermore, acquiring additional interview or questionnaire data, e.g. at  
4-weeks and 6-months, may reveal more about whether splint-wearing continues under 
participants’ own volition and more about what enables splint-wearing or what sets up 
barriers. 
6.12 Recommendations for future research  
This thesis has focused on the impact of thumb CMC OA from the perspective of people 
with the condition, and on the effectiveness of splinting based on existing evidence. 
When findings from these two threads of inquiry established that the lack of high-
quality studies investigating splinting constitutes a gap in the current evidence, a 
feasibility study for a full RCT was designed, informed by the first two studies, to 
address this problem. The findings of this third study indicate that a full RCT is feasible; 
recommendations for a full trial are outlined below.  
Several other areas requiring further investigation were also outlined in the sections 
above. These include developing or identifying a consistent measure of pain; the 
development of outcome instruments for self-reported function and HR-QoL in thumb 
CMC OA; developing a clinical definition of the condition; refining splinting and best 
practice usual care interventions; developing and evaluating implementation for best 
practice care; a dose-ranging study to estimate intervention efficacy; establishing 
validity for IDD, Pollexograph, and GAT in thumb CMC OA; providing estimates of MCID 
for outcomes in thumb CMC OA that account for the patient perspective; and refining 




aspects could occur as smaller studies nested within a larger trial, the conduct of a full 
RCT should be preceded by exploration of splint dose effect and optimisation of 
outcome measures. The detail of these additional studies is for future consideration. The 
purpose of this section is to put forward a design for a future fully-powered RCT based 
on the work to date.  
6.12.1 Inclusion criteria 
Based on the findings of the feasibility study and the qualitative study reported in 
Chapter 3, it is recommended that inclusion for studies in thumb CMC OA should not be 
based on self-report functional score. The inclusion criteria for the present study 
included stipulated severity thresholds of pain NRS ≥4/10 and FIHOA score ≥6/30 as 
recommended per the OARSI clinical trials group recommendations for hand OA 
(Kloppenburg, Maheu, et al., 2015). However, the FIHOA does not adequately capture all 
those who need and would benefit from treatment. Furthermore, pain is the largest 
concern to most people with thumb CMC OA and this outcome is more likely to change 
in response to treatment. This refutes the OARSI clinical trials group recommendations. 
It suggests rather that for thumb CMC OA clinical trials, a pain score ≥4/10 should be 
the only stipulated severity threshold criterion. 
6.12.2 Primary and secondary outcomes 
A clearly delineated rationale for the choice of primary and secondary endpoints is 
essential for good clinical trial design (Losina et al., 2015). Based on the clinical findings 
in the feasibility study, the patient perspectives described in Chapter 3 where pain and 
pain at night were the greatest impact for most participants, and on the findings of the 
systematic review in Chapter 4, pain NRS is recommended as the primary outcome 
domain for a future full study recording both pain on average in the past week and pain 
on average at night. Pain, particularly pain at night, showed potential as the most 
sensitive measure to detect the effect of the splint intervention, in both the short- and 
medium-term.  
While functional limitations and restrictions in important life roles also have significant 
impacts on people with thumb CMC OA, these domains did not appear to be adequately 




should include a patient-reported functional measure; however, since it is not clear 
which instrument or instruments should be used, new or adapted measures are likely to 
be necessary to determine the effectiveness of splint for function in thumb CMC OA.  
For pain NRS outcomes and, in a smaller number of participants, functional self-
reported outcomes, a proportion of participants in both the splint and comparator 
groups showed reliable and clinically important responses. Future work should 
narratively explore these participants to identify any apparent characteristics that may 
warrant investigation as potential predictors of treatment response, to either splinting 
or the best practice usual care intervention. The intensive study of the individual known 
as the idiographic approach (Barlow & Nock, 2009) has high internal validity; it can 
discover key sources of inter-subject variability and begin to isolate factors responsible 
for this variability (Barlow & Nock, 2009).  
The OMERACT-OARSI responder ratio which captures a combination of pain and 
function makes it an alternate candidate for primary outcome. At present, instruments 
designed to measure functional outcomes in the hand are not yet satisfactory for 
contributing to the primary outcome in thumb CMC OA. Therefore, responder criteria 
are not the best choice for primary outcome. However, the benefits of this measure and 
the ability to detect a difference between groups as described in the earlier section, 
makes it a robust and useful secondary outcome. 
The GROC should also be part of the repertoire of secondary outcome measures even 
though its use is contentious. In musculoskeletal conditions, the GROC has been shown 
to be strongly biased toward a person’s current symptom state with little or no 
consideration of baseline symptom state and therefore unable to reflect accurately 
change over time (Norman, Stratford, & Regehr, 1997; Schmitt & Abbott, 2015). 
However, the GROC can serve as an anchor measure to help build literature of MCID for 
outcomes in the specific population and contribute to future research (Jaeschke et al., 
1989; Wright et al., 2011). It has therefore a useful role in a future trial.  
In the feasibility study, QoL measured by the EQ-5D-5L appeared to detect some 




irrespective of the maintained improvements in pain, is a possible anomaly relating to 
the small sample size. Whether another QoL instrument would serve better in the 
thumb CMC OA population is unclear. However, the EQ-5D-5L is a well-validated 
measure that can also be used in cost-effectiveness analysis (van Reenen & Janssen, 
2015), another dimension that should be added to a future full trial. Evaluation of the 
relative cost-benefit of a given intervention is necessary to make decisions about health 
service resources (Ramsey et al., 2015), yet evidence that non-surgical, non-
pharmacological interventions are cost effective in hand or thumb CMC OA is rare 
(Hiligsmann et al., 2013; Tveter et al., 2020). The EQ-5D-5L index score can serve as a 
QoL utility measure and can be analysed alongside direct health costs, such as health 
services and medications, and indirect costs, such as lost productivity, both absenteeism 
and presenteeism, and transport (Hiligsmann et al., 2013; Losina et al., 2015; Ramsey et 
al., 2015). While a cost effectiveness analysis was not an aim of the present study, the 
utility and acceptability of the EQ-5D-5L indicates that it is feasible to collect the data 
required to conduct such an analysis. Therefore, the EQ-5D-5L should be kept as a 
secondary outcome.   
Despite the apparent floor effect of medication use, its importance to patients and its 
potential to be more informative over longer time periods, qualify this end point as 
relevant to the outcome set of a future fully-powered study. Additionally, failure to 
record medication use or to control for it in analyses could mask important effects and 
could potentially over- or under-estimate responses. Additional analyses can be 
conducted for the proportions of patients achieving other NSAID-sparing endpoints, for 
example 50% decrease in NSAID score compared with baseline, NSAID score <10, or 
NSAID score = 0 (Dougados et al., 2014). 
Based on the findings of the feasibility study, the qualitative findings of Chapter 3, and 
previous literature outlined in the earlier section of this chapter, other secondary 
outcomes should include grip and pinch strength and measures of thumb palmar 
abduction. However, establishment of MCID for these measures and confirmation of the 
validity and reliability of the palmar abduction measures in thumb CMC OA require 
further research; the same is indicated for the GAT measure of physical function. An 




feasibility study from participants’ verbal reports at baseline, recording at the follow-up 
points would help to identify whether this is a confounding factor in treatment response 
in thumb CMC OA. Furthermore, the use of hand diagrams as reported in Chapter 3 
would be a feasible and more robust method to monitor local hand joint activity.  
The feasibility study demonstrated the feasibility of investigating splinting for thumb 
CMC OA for outcomes at both 4-weeks and 6-months. Good participant retention for 
data collection at these time points and over a longer period is also supported by 
previous studies (Gomes Carreira et al., 2010; Rannou et al., 2009). Given the long-term 
nature of thumb CMC OA it is recommended that 6-months rather than 4-weeks is a 
more appropriate primary endpoint. Additionally, 12- and 24-month follow-ups should 
be included. In summary, it is recommended that pain intensity at 6-months is used as 
the primary outcome. 
6.12.3 Sample size for future trial 
Factors affecting a sample size calculation are the precision and variance of 
measurements within any sample; the magnitude of a clinically important difference; 
with how much certainty a type 1 error is to be avoided; and the type of statistical test 
performed (Cook et al., 2018; Portney, 2015).  
While the feasibility study was not statistically powered to give precise estimates of 
effect size and variability, it was the first study conducted in people with thumb CMC OA 
in which the benefit of a splint in addition to standardised best practice usual care was 
investigated. Therefore, the findings, alongside those of previous large trials, are 
important to inform what constitutes a realistic estimate of variability (Sim, 2019).   
The size of the target difference to be used for calculation of the sample size for a future 
trial can be approached in several ways. Reassurance that a target difference can be 
reliably detected is given by a sample size that is sufficiently powered to do so, in this 
case, power of 90% (Cook et al., 2018), and by setting the level of statistical significance 
at that planned for the statistical analysis, i.e. 5% (Cook et al., 2018). Using these data, a 
priori sample size calculations can be modelled to give a range of sample sizes, using 
G*Power 3.1.9.7 (Universität Kiel, Germany), for a future randomised controlled two-




primary endpoint assessed with a two-tailed t-test and accounting for loss to follow up 
of 10%.   
One approach is to take the median of the estimates of the change over time for the 
splint (MD -2.2) and comparator groups (MD -0.5) reported at 6-months in the high-
quality studies identified in the systematic review and use the variability of the groups 
from the feasibility study for pain at night NRS (SD 3.06 and 3.21 for splint and 
comparator group, respectively) (Table 5.13). With this option, the required sample size 
is 102 participants.  
An alternate approach is to take the previously published MCID for pain NRS in an OA 
population of 2.0 points as the basis for a target difference and variability from either 
that reported in previous high-quality studies (estimated at SD 2.39 for both groups) 
(Table 5.13), or that found in the feasibility study for pain NRS at night (Table 5.13). 
Using these parameters, total sample size requirements of 86 and 143 are calculated. A 
caveat is that the MCID for a thumb OA population representative of that in the 
feasibility study may well differ to the MCID previously published. Furthermore, MCID 
specifically for pain at night NRS may differ again.   
A trial of N=143 would require a third centre to ensure successful recruitment within a 
reasonable time frame, for example, 1-year. A large urban centre in the North Island of 
New Zealand is recommended, such as Wellington, Hamilton, or South Auckland. Such 
urban populations with higher proportions of potential Māori participants would also 
support a greater rate of recruitment. The smaller sample size of 86 could be conducted 
across the same two centres as the feasibility study but may benefit from involving a 
third larger centre for the reasons above. Before proceeding with a full study, 
consultation with a biostatistician as well as careful consideration of what constitutes a 
clinically important change in pain on average and pain at night NRS from patient, 
clinician, and statistical perspectives would be essential to confirm specific values used 
for the sample size calculation (Sim, 2019). Patient and clinician stakeholder 
involvement in the study design stage including decisions around sample size 
calculation would help to ensure the study is capable of detecting change that is 




In summary, the work in Chapter 5 demonstrated the feasibility of conducting a  
fully-powered RCT of splinting for thumb CMC OA pain. The recommendations detailed 
in Chapter 5 and above would ensure that the study would be robust and of high quality.   
6.13 Conclusions  
Thumb CMC OA has a profound impact on a person’s health and well-being. Pain, 
including pain at night, is the major impact and it influences impact at other levels. 
Physical limitations, for example, loss of dexterity and hand strength, appear to be 
associated with thumb CMC OA pain.  
This thesis highlights the fact that the impact of thumb CMC OA reaches well beyond 
hand-specific symptoms and physical impairments, imposing significant limitations on a 
diverse range of functional activities. It restricts people’s important life roles including 
work, caring for others, and recreational activities. Its broader impact gives rise to 
negative emotions, concerns about the future, and an altered sense of self related to 
ageing. The findings of the qualitative study suggest that the impact of thumb CMC OA 
has been underestimated. As a consequence, these findings emphasise the importance 
of going beyond the physical impairments in order to assess the impact of thumb CMC 
OA adequately. The immediate benefit would be more appropriate and potentially more 
successful treatment plans.  
The findings of this thesis support the contemporary move towards patient-centred 
outcome evaluation. However, they also highlight the extensive knowledge gap in this 
area, as well as limited previous research, for thumb CMC OA.   
The qualitative study found that personal, social, and societal factors play important 
roles in the overall impact of thumb CMC OA. For example, cold weather and 
involvement of the dominant hand are negative influences while social supports, 
religious faith, self-efficacy, and access to health services are positive influences. Quality 
information and advice is highly sought-after by people with thumb CMC OA, and non-
pharmacological, non-surgical interventions are preferred.  
Splinting is an intervention well-matched to the biomedical problems of CMC OA and to 




care education, advice, and exercises, may play a key role in improving outcomes that 
are important to people with thumb CMC OA. 
The systematic review in this thesis demonstrated low-quality evidence for splinting as 
an effective treatment for thumb CMC OA with a moderate-to-large effect on pain and a 
small-to-moderate effect on function in the medium-term and, in the short-term, very 
low-quality evidence of no effect. Although this showed that splints are a promising 
treatment for thumb CMC OA, further research is needed because of the present lack of 
high-quality studies. A high-quality fully-powered trial, robustly informed by patient 
perspectives and able to address some or all of the challenges identified by the 
systematic review, would provide much needed evidence for the effectiveness of 
splinting in thumb CMC OA.     
To this end the thesis, in its feasibility study, developed and tested design elements for a 
trial to investigate the effectiveness of a soft off-the-shelf splint for thumb CMC OA. The 
study blinded assessors and partially blinded participants, assessed outcomes 
important to patients including pain at night and QoL, trialled alternate functional 
outcomes, and explored the role of ultrasound imaging. A splint dosage much higher 
than reported in earlier studies, including overnight wearing, was found to be feasible 
and acceptable to participants and a standardised best practice usual care was 
determined to be acceptable and well adhered to. Modifications to the study design 
were identified that would optimise the interventions, recruitment, outcome 
assessment, and the overall conduct of the study.   
Change in pain at night NRS exceeded a known estimate of MCID in the splint group at 
4-weeks and 6-months, and an apparent between-group difference in favour of the 
splint group was present at both time points. Calculations were made that estimate a 
sample size of between 86 and 143 participants may be capable of testing for a clinically 
meaningful difference in pain at night NRS at 6-months.  
In light of the recent OTTER trial, exploration of dose effect and further optimisation of 




thesis is conducted. If the routine prescription of splints can be shown to be effective, it 
will lead to significant improvements in patient care.  
In conclusion, this thesis presents clinicians, health services, researchers, and funders 
with a greater understanding of the patient experience of thumb CMC OA and enables a 
more nuanced approach to its management. The findings provide the impetus for 
researchers and funders to take up and support the work required to provide a more 
robust evidence base for this long-term, high-impact condition. Finally and importantly, 
the work in this thesis can help patients to feel validated in their experiences of this 
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Appendix I Interview schedule – Qualitative study 
 
Impact of thumb CMC OA qualitative study – Interview schedule 
1. Introduction 
a. Welcome the participant and introduce the interviewer (Miranda). 
Explain about the research and the purpose of the interview.  
b. Outline the format of the interview including use of visual tool (see p.)  
c. Opportunity for any questions 
2. Procedural information 
a. No right or wrong answers  
b. You can change your mind  
c. Can take ‘time-out’ at any time, without needing to give any reason 
d. The interview will be recorded, are you ok with that? 
e. Any information that could identify you will not be disclosed to anyone 
other than the researcher (Miranda), so please speak freely and fully.  
f. Opportunity for any further questions 
g. Confirm consent to participate 
3. The interview questions 
Main questions Probing questions 
1) Can you tell me about your 
thumb osteoarthritis… 
Can you tell me more about that? 
Can you give an example of that? 
Can you describe a good day… a bad 
day? 
How does that make you feel? 
What about stiffness, does that concern 
you? 
Are you happy with how your thumb(s) 
look? 
 
…how do these things impact on your 
physical, mental, family or spiritual well-
being? 
 
2) What kind of things do you have 
difficulty with because of your 
thumb osteoarthritis? 
At home… around the house, in the 
garden, in the kitchen, with tools, 
washing and dressing, toileting, getting 
lids off, getting through doors, doing the 
groceries?  
At work…  
With driving… or other means of 
transport 
With writing or using media, technology 
or communication devices… computers, 
cell phones, newspapers? 




Appendix I Interview schedule – Qualitative study 
In your social life… going out for normal 
social activities… interacting with 
people socially… do you limit this in 
anyway? 
In your family or community roles… e.g. 
caring for others – grandchildren, 
partner, family or friends, community? 
In your personal/intimate relationships? 
 
…how do these things impact on your 
physical, mental, family or spiritual well-
being? 
 
3) Can you tell me more about the 
pain... (sensitising question) 
Can you describe what it’s like? 
How often do you get the pain? 
If the pain comes and goes… Do you 
know when the pain is going to come 
on? 
Are there specific activities on which 
your thumb gives you more pain? 
How is the pain at night time? 
What bothers you the most about your 
pain? 
How does the pain make you feel? 
 
…how do these things impact your 
physical, mental, family or spiritual well-
being? 
 
4) How has your thumb 
osteoarthritis impacted on your 




Is there anything else you would like 
to add? 
 
In your physical/mental/spiritual 
wellbeing? In the wellbeing of your 
family, community and relationships? 
What would be the 3 most significant 
ways in which your thumb osteoarthritis 




4. Complete demographic and disease information (x) 
5. Invite participant to share any feedback about their participation in the study, 
the interview, and completing the diary. 
Draw the session to a close and review what happens next (per Participant 
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Appendix U.3 Summary of consultation responses 
 
Summary of stakeholder consultation with expert hand therapists 




 Type of splint and fitting 
 □ Splint type 
• The Comfort Cool neoprene splint is a good option for 
wide range of patients and is not too costly compared 
to other splints. 
• In Northland patients are sweating in summer so 
neoprene may not be so good. 
• Thermoplastic might be better, or light elastic. 
Australia would be same problem. In Nelson, the 
neoprene is well tolerated, although some challenges 
in height of summer. Look out for skin rash in heat.  
• Tend to start with thermoplastic splint first – lower 
cost to DHB as just uses a small piece, vs neoprene 
splint is more expensive off the shelf.  
• Neoprene splint sometimes harder to get hold of in 
DHB (one centre), especially different sizes.  
• Push Brace is pricier especially in private practice, and 
harder to fit off the shelf. 
• Neoprene ok for little old ladies not doing too much, 
but ‘men’ need something more supportive because 
working and greater demand on hands. 
• The evidence tells us that splinting helps – doesn’t 
matter what splint – let the patient choose. Unless MCP 
hyperextension in which case aim to control MCP 
position.   
• Show patient the options, see what patient thinks will 
work for them. Find that find that patients often don’t 
like hard rigid thumb spicas.  
• Have been playing around with soft cast long thumb 
spica for colleague with hand OA and this has been 
The neoprene Comfort 
Cool splint is suitable 
for study intervention.  
Need to consider what 
time of year (which 
season) study will take 
place in.  
Consider climate 
generally.  
Look out for skin 
irritation with 
neoprene splint.  
Neoprene may not 
work for everyone, or 
currently be available 
to all therapists (but 
most respondents 
agreed is accessible). 
Cost of labour to 
produce thermoplastic 
splint is further 
consideration. Result of 
future study would help 
inform resource 
decisions in DHB and 
other settings.  
A range of splint 
options are used.  
Patient choice is part 
of current practice. 
This is an area for 
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successful for tasks such as gardening – offers near full 
immobilization of the CMC joint.  
• Little USL splint colleague found good for light tasks 
e.g. knitting.  
• Often use “ordinary old thumb-wrist wraps – neoprene 
(therapist in department makes them).  
• Orfit – light thermoplastic – is nice material to make 
thermoplastic splint – has some flexibility, well 
tolerated, but more support, can include MCP.  
• Consider Orficast?  
• These alternate (thermoplastic or casting tape) splints 
take more skill to fabricate.  
• Also have Push brace splints. Find these are good in 
early OA. But they are expensive. Can be good for 
working people who must do repetitive tasks. 
• Indicate the season – neoprene may be more beneficial 
and better tolerated in cooler climate. 
• Patients like heat – likely the neoprene provides some 
benefit in this regard. 
• Neoprene splint a good option because it is the easiest 
to fit, although some patients have difficulty pulling on 
and may not wear because of difficulty donning.  
• Consider USL splint? 
• In hospital system lucky – can change around to see 
what works for patient without having to charge. 
Tailoring the splint to 
the individual has 
perceived benefit 
however requires a 
range of splints to be 
available. Future study 
may include algorithm 
for splint choice, or 
stepped approach, e.g. 
where first line not 
successful, try second 
line.  
May be sex and age 
difference in splint 
effectiveness due to 
different demands on 
thumb CMC joint. This 
is an area to consider 
for future study. 
Check patient donning 
and doffing during 
intervention session, 
record any difficulties. 
□ Sizing – measure strictly or try on? 
• Comfort Cool splint can be a bit narrow  
• Patients are often between sizes. 
• Try on rather than measure for sizes.  
• Fit well if no deformity, but if adduction deformity or 
big wrist/forearm then poor fit - can’t do up 
proximally or is saggy in the volar web area and not 
supportive.  
• A lot of ½ sizing (between sizes) are available 
• If don’t fit properly then no good 
Include option of in-
between sizes.  
Have different sizes 
available for 
participants to try on. 
Ensure good fit 
□ Cut/trim to fit? 
• Yes, do snip a bit 
• Often need to cut off the top of the thumb bit  
Have good fabric 
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• Need to “brutalise” the neoprene splint to get it to fit – 
often too tight but right size, so man handle to stretch 
out.  
Give splint a good 
stretch before 
participant takes away. 
□ Sew on additional strap length? 
• Agree the webspace strap is sometimes too short, good 
idea to extend when need to.  
• Recommend use ‘OneWrap’ to extend the Velcro strap, 
or NRX strap. 
• May use rivet. Rarely take to orthotist to adjust.  
• Don’t do any sewing – too firm at wrist end to adjust 
there.  
Have options available 
to extend webspace 
strap: ‘OneWrap’ or 
‘NRX strap’. These 
options more feasible 
than sewing. 
Rivet is too complex 
for general practice 
setting. 
Wearing schedule (dosage) 
□ Hours per day and during which parts of day? 
• Prescribe for use during day for activity or whenever 
patient needs to wear.  
• Usually recommend to patients they “wear when 
helpful”; wear as much as can first 2-3 weeks, then 
wean.  
• Use for rest in the day 
• Day and night for 23 out of 24 hours would be 
possible. It is longer than usually prescribed. 
• 23-24 hours is a lot, perhaps unrealistic.  
• Maybe 20/24 hours to allow some tasks 
• Find patients do wear a lot especially if helping 
• For more frequent wearing, would need two splints – 
one to wash, one to wear, if wearing long periods for 
long duration. 
• Tend not to wear at night if splint is dirty from use in 
the day e.g. gardening. Patients find splint is good 
when gardening, so they wear for gardening tasks. One 
to wash, one to wear is good idea. 
• Push brace or thermoplastic is well-tolerated in the 
North, like to wear as working splint. Or little thumb 
USL splint. 
• Recommend wear gloves over top for some tasks? But 





Long duration is 
possible but not usual. 
Wearing over night as 






23 hours/24 not 
acceptable but 20 
hours probably would 
be.  
Would require two 
splints, one for wash, 
one for wear.  
Concern the splint may 
cause thumb muscles 
to become weaker. 
This has been 
demonstrated not to 
occur – summary of 
evidence provided 
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• Yes, recommend patient wear at night – based on 
Rannou 2009 study (in presentation to stakeholders).  
• Often recommend wear at night (one therapist) 
• If really sore, recommend wear night and day for 1-2 
weeks. Then just when doing activities.  
• Recommend reduce splint wearing to avoid muscles 
becoming weaker (due to splint wearing causing dis-
use). 
• Agree that higher dosage is better for optimizing effect, 
especially for study 
□ Remove just for hygiene? 
• Always need to take off for wet tasks so perhaps 
stipulate this.  
• Agree, patients usually take off for dishes etc.  
• Often also take off for dirty tasks. 
Advise participants to 
remove splint for wet 
tasks. 
Leave ‘dirty’ tasks up 
to participant, provide 
two splints. 
□ Remove for exercises? 
• Yes 
Do so 
Duration of splint intervention 
□ 4 weeks? 
• Agree 4 weeks is good duration as patients often busy; 
if 2-3 weeks then things may be happening, they don’t 
have a chance to give it a good go. Allows for ups and 
downs of life 
• 8 weeks might be better – based on Rannou study?  
• 4 weeks sensible. 
• 1-2 weeks as above – not too long or get weakness 
Splint intervention of 
4-weeks duration is 
suitable.  
Delivery 
□ Number and timing of clinic appointments? 
• Usually initial appointment, then follow-up at 2 weeks 
to check patient applying splint correctly and if 
working.  
• Usually see first to institute splint and give 
advice/education/exercise, then touch base at 3-4 
weeks.  
• Minimise follow up in private practice because of cost. 
Or see again at 2 weeks, mainly for one therapist for 
One-off session in 
context of the study 
aims could work. 
High quality 
instruction and 
support materials, and 
sufficient time to 
provide participant 
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whom the exercises are very important and therefore 
check quality of exercises and check splint.  
• If custom-made splint, see at 1-2 weeks to check up if 
needs adjusting.  
• If off-the-shelf splint, just telephone follow up to see 
how they get on. If not successful, then follow up to 
provide alternate splint. If is successful, then may 
provide second splint. 
• One-off session could work. Makes sense for study 
purpose. Patient understanding of splint donning and 
wearing would need to be good.  
• One-off may be reasonable, although important to 
check treatment is being implemented correctly 
including exercises. In light of evidence from 
presentation, understand that it is unclear as to the 
importance of the exercises, or which exercises, so 
more in favour of one-off session at this point. 
exercises and correct 
adherence to splint 
wearing.  
Quality audit 
important to monitor 
quality of intervention 
delivery.   
□ Phone follow-up? 
• No – this often occurs in studies but doesn’t translate 
to practice; clinicians don’t want to be receiving phone 
calls and emails. Rather, patient come into clinic, sort 
things and that’s that.  
• Follow-up in clinic would better reflect practice. 
No formal telephone 
follow-up scheduled as 
part of intervention 
but leave open for 
participant.  
Standardised best practice usual care: Education and advice 
 Content 
 □ About the condition: anatomy, disease process? 
• Don’t talk a lot – just very briefly: convex/concave 
joint, lots of movement, females have more shallow 
joint surfaces so less stability; aim is to reduce loading 
and swelling. 
Keep concise 
Cover joint structure, 
high mobility, low 
stability, aim of 
treatment. 
Sex-related features not 
accurate according to 
current evidence – 
leave out.   
 □ CMC joint kinematics – optimal joint congruency? 






Appendix U.3 Summary of consultation responses 
 □ Ergonomics – increase size and grip for reduced joint 
loads? 
• Yes  
Include 
 □ Joint care principles – use bigger, more proximal joints; 
micro-pauses/macro-pauses; assistive devices; task 
modification? 
• Yes 




 □ Additional suggestions? 
• What about heat? Usually mention this to patients – 
that they might like to try.  
• Often issue arthritis gloves 
• Sometimes piece of non-slip mat for lids etc.  
• Encourage patient to take Arthritis NZ pamphlet – 
available in the department. 
• If stiff fingers then patient uses thumb more to grip 
with more adduction and MCP hyperextension, in 
which case more important to increase size of grips to 
ensure fingers doing the work. Rubbery matting for 
jars etc. can help here. 
 
Look at evidence for 
heat treatment 
Arthritis gloves are 
additional device, no 
specific guideline 
recommendations.  
Given undoing lids and 




qualitative study – 
suggest participant 
consider nonslip mat 
as option. Won’t supply 
as additional device.   
 Format 
 • A4 page? 
• Use 2-sided folded A4 pamphlet.  
• Provide sheet with info, along with catalogue from 
local ‘mobility’ shop 
Written information is 
well utilised.  
Max 2-sided A4 
 □ On-line information? 
• Sometimes refer to e.g. Mayo Clinic resources, but 
don’t know how many patients use. Suggest put 
information on hand therapy website?  
• Don’t currently routinely use online info (most), but 
keen to if something good is produced. 
Use study website to 
make available 
Arthritis NZ pamphlet 
and information about 
where to buy adaptive 
equipment. Could also 
be more widely 
disseminated, e.g. NZ 
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 • One-off ca. 10 minutes? 
• About the amount of time usually spent  
• Best when supported with written information 
Allocate 10-15 minutes 
for Education and 
Advice.  
 □ Discussion of material vs goal setting, problem-solving 
• Agree simple discussion of material is fine, as not 
investigating an education intervention per se.  
• Agree simple is fine 
• Agree – does minimal talking, main thing to provide 
written info, and fit splint. 
Individualise, but not 
necessary to carry out 
goal-setting process. 
Standardised best practice usual care: Exercises 
 Content 
 □ Generic hand – opposition; open; gentle fisting? 
• Agree reasonable to keep simple/generic. No 
consensus on what exercise is best.  
• Thumb palmar abduction exercise *Everyone does 
this* so should include – either free active movement, 
or place and hold (isometric), or trace line on tennis 
ball.  
• Get patient to “show me what you’ve done” to check 
quality of exercise.  
• “Make an “O” grip” and using fingers to grip rather 
than thumb to decrease MCP joint hyperextension. 
Include: thumb palmar 






 □ Specific exercise? 
• Agree manual techniques in Jan Albrecht often used 
Include: self-massage 
of 1st webspace; self-
traction; 1st webspace 
stretch.  
 □ General exercise, e.g. walking? 
• If guidelines recommend this, sure 
Include: general 
exercise such as 
walking 
 Delivery 
 □ One-off ca. 10 minutes? 
• Usual practice (for the patients referred to hand 
therapists in secondary care) is first session – 
overview of the condition + splint = rest first to reduce 
inflammation, and older patients often aren’t able to 
take everything on board at once; so yes, further 
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session might be a good idea – for the education side. 
However, this study not an investigation of education, 
rather the splint + ‘standardised usual care’. Most 
patients don’t get referred to hand therapists so would 
be acceptable just to provide one session of education. 
Standardised best practice usual care: GP/Physician care 









































































































Appendix FF Pain numeric rating scale (NRS) – pain 













Appendix II Demographic and disease characteristics data collection form 
 
 
